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Abstract 
 
Dietary restriction (DR), defined as a moderate reduction in food intake short of malnutrition, 
has been shown to extend healthy lifespan in a diverse range of organisms, from yeast to 
primates. In this work we aim to uncover the mechanism by which DR extends lifespan. The 
prevailing theory of somatic maintenance by resource reallocation proposes that the balance of 
nutrient allocation is weighted either towards reproduction, when environmental nutrients are 
abundant, or towards maintenance of the soma when food is limited, thereby aiding organismal 
survival during food shortages. This theory has found support in reports that dietary restricted 
Drosophila melanogaster (fruit fly) benefit from increased lifespan but have compromised 
reproduction, and that the inverse is true of fully fed flies. It has recently been found that 
addition of the ten essential amino acids (EAA) to a DR diet is sufficient to decrease lifespan 
and increase fecundity to the same degree as full feeding, implicating EAAs as the dietary 
mediators of the responses of lifespan and fecundity to DR. In this thesis I characterise the 
physiological and metabolic parameters that define DR flies, fully fed flies and EAA-
supplemented DR flies, with the aim of identifying candidate factors that consistently correlate 
with lifespan for the three treatments in order to identify the causes of longer life in response 
to DR. We also use genetic tools to explore the role of nutrient signalling pathways in 
mediating the relationship between nutrition and ageing, with special focus on the amino acid 
sensitive target of rapamycin (TOR) pathway, the insulin/insulin-like growth factor signalling 
(IIS) pathway, and the general amino acid control (GAAC) pathway. These studies find a role 
for TOR signalling in mediating the effects of DR on lifespan and this effect appears to be 
different from those caused by altered IIS and GAAC pathways. These data also implicate 
accumulation of fat as consistently correlated with, and so possibly causal for, longer life. 
Finally, I investigated the potential roles that these nutrient sensing/signalling pathways might 
play in modifying feeding behaviour in response to changes in dietary nutrient quality. Here, 
the GAAC pathway proved to play an important and specific role in the way single amino acid 
deficient foods are detected to alter feeding behavior. These data are somewhat consistent with 
mammalian studies on nutrient-specific feeding alterations and establish the groundwork for 
detailed studies into the molecular processes involved. As a combined body of work, this 
thesis outlines important data on the mechanisms of DR to extend life as well as new 
information about the nutrients and molecular signals involved in shaping feeding choices.   
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Chapter 1 - General introduction 
 
 
1.1. Ageing 
 
The broad definition of ageing encompasses chronological, biological, psychological and 
social factors. Biogerontology is an active field of science researching the biological 
causes, effects, and mechanisms of ageing. In the biological sense, ageing is defined as a 
functional deterioration over time that increases mortality (Finch, 1990), also known as 
senescence. Senescence can arise at any level of biological organisation, from 
macromolecules, to cells, to tissues and organs, and contributes to dysfunction at the whole 
organism level, thereby increasing the incidence of disease and the probability of death. 
Ageing has been defined by four major features: it is universal, intrinsic, progressive and 
deleterious (Strehler, 1977; Viña et al., 2007). 
 
Ageing affects most multicellular organisms and its universality suggests that the basic 
mechanism may be conserved across species. Whether the cumulative effect of physical 
and chemical changes that give rise to senescence is caused by extrinsic factors or whether 
it is initiated by some intrinsic clock is still a point of uncertainty. It is likely that both 
environmental and genetic factors contribute to senescence. The degree to which these two 
factors influence senescence and whether there is an interaction between them is the focus 
of research in the ageing field. The maximum potential lifespan of an organismal 
population is probably largely determined by genetics, whereas the mean lifespan is 
subject to change in response to environmental influences (Finch, 1990), and ageing 
research is largely based on this assumption. Efforts to lengthen the lifespans of model 
organisms through both genetic and non-genetic interventions have done so to a limited 
extent - as yet, no single intervention has lengthened the lifespan of an organism 
indefinitely. Thus, if there is a single master regulator of ageing, either it has not yet been 
identified or its effects on aging are independent of the influence of external factors. It is 
possible that the interventions that have been found to extend lifespan have done so by 
targeting one of potentially many downstream effectors of such a master regulator, which 
may explain the relatively modest effects on lifespan of interventions so far reported. An 
interesting feature of the ageing process is that within a given species the characteristic 
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phenotypes of ageing manifest at around the same age – there appears to be a degree of 
synchrony with the onset of various age-associated diseases, such as cancer, cardiovascular 
disease, cerebrovascular disease and diabetes (Holliday, 1996), suggesting the workings of 
some intrinsic determinant of ageing onset. Additionally, there is evidence for lifespan-
extending interventions having ameliorative effects for other aspects of ageing pathology. 
For example, downregulation of the target of rapamycin (TOR) pathway in mice, a 
lifespan-extending intervention, also extends healthspan, protecting against age-related 
pathologies such as immunosenescence, motor dysfunction and insulin resistance (Selman 
et al., 2009). Thus, it may be possible to ameliorate more than one aspect of the ageing 
phenotype with a single environmental or genetic intervention.  
 
 
1.1.1. Evolutionary theories of ageing 
 
Most living organisms exhibit biological senescence, culminating in their eventual death. 
However, some organisms, such as Hydra vulgaris, appear not to undergo biological 
senescence   art  ne   1    , and the jellyfish Turritopsis dohrnii is able to reverse the 
ageing process and escape death (Piraino et al., 1996). Thus, ageing appears not to be 
inevitable - so why do most organisms age?  In light of Darwin’s theory of Evolution, 
which postulates that randomly-arising heritable traits that bestow some fitness advantage 
to an individual will accumulate in a population, where fitness is defined as reproductive 
success (Darwin, 1859), could there be some fitness advantage of ageing? Senescence does 
not have any apparent benefit for reproductive fitness – in fact, most organisms experience 
a decline in fecundity with age, that is, the reproductive rate as measured by the number of 
offspring, gametes or asexual propagules (Aigaki and Ohba, 1984; Partridge and Barton, 
1993; Rauser et al., 2003). We might predict that the lack of senescence would increase 
reproductive fitness, presuming that reproduction is limited by declining somatic integrity. 
So how is such a deleterious and deadly process so widespread? Is ageing actively 
conserved, or has it managed to escape elimination by natural selection? The apparent 
paradox of ageing has led to a number of evolutionary theories to explain it.  
 
The underlying basis for the evolutionary theories of ageing is that aging is a matter of 
evolutionary neglect - traits with deleterious effects manifesting later in life fail to be 
selected against, since the force of natural selection declines after reproduction (reviewed 
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in Partridge and Gems, 2002). Most animals in nature fail to reach an age where these 
deleterious effects would manifest, since their environment is such that they are prone to 
death by disease, starvation, predation, or by other environmental hazards (Haldane, 1941). 
Therefore, there is little reason for the body to maintain fitness for the long-term, so there 
is little selection pressure for traits that would maintain survival beyond the time when 
environmental hazards would claim the lives of most animals anyway. As such, late-acting 
deleterious mutations/alleles in the population evade the action of natural selection and are 
thus allowed to persist in the subsequent generation  under a “selection shadow” (Fabian 
and Flatt, 2011; Medawar, 1952; Figure 1.1). The result is the accumulation of 
maladaptive mutations manifesting later in life, and culminating in the ageing phenotype. 
This is known as the Mutation Accumulation theory of ageing.  
 
 
Figure 1.1. The force of selection as a function of age.  Figure from Fabian and Flatt (2011). 
 
The Antagonistic Pleiotropy theory of ageing was developed from the Mutation 
Accumulation theory and hypothesises that there exist alleles with multiple distinct 
phenotypes that occur at different life history stages, where at least one is beneficial and 
manifests early in life, and another is detrimental and manifests later in life (Williams, 
1957). Since evolution aims to maximise offspring production, strong selection for 
enhanced fertility early in life would favour mutations with beneficial effects on 
reproduction and survival before the reproductive period, even if these mutations have 
deleterious effects later in life. The result is that the deleterious effects of such alleles 
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manifest later in life as age-related pathology. In this sense, ageing can be viewed as a by-
product of enhanced fertility, or as the result of a trade-off between reproduction and 
longevity. Although Antagonistic Pleiotropy has become a prevailing theory of aging, it 
has yet to be sufficiently experimentally verified. Some of the reported ageing genes seem 
to have an associated beneficial effect on fertility, but not all. 
 
The related Evolutionary Life History theory predicts that an animal's lifespan is 
determined by the allocation of finite resources (e.g. nutrients, time, energy) between traits 
that contribute to fitness, and that variations of life history characteristics such as ageing, 
reproductive lifespan, and number and size of offspring between different species reflect 
differential allocation of resources. The allocation of these resources is shaped by natural 
selection and is influenced by environmental selection pressures (Hamilton, 1966; 
Kirkwood and Shanley, 2005). Theoretically, an animal with an infinite supply of 
resources would not be subject to such trade-offs, and would therefore be able to 
simultaneously maximise all aspects of fitness, resulting in an unlimited lifespan. This 
hypothetical organism is referred to as the 'Darwinian Demon' and is used in thought 
experiments to explore the life history strategies among different organisms (Law, 1979). 
Intuitively, natural selection would favour the maximisation of both fecundity and 
longevity since both facilitate genetic contribution to the next generation. In reality, 
however, these two traits commonly display an inverse relationship with each other, such 
as in mammals and birds (Holmes et al., 2001; Read and Harvey, 1989). Moreover, 
experimental manipulations often have antagonistic effects on lifespan and fecundity 
(Reznick et al., 2000). Experiments have shown that fruit flies that were selected for later-
life reproduction were long-lived but their early-life fecundity was compromised, 
suggesting that ageing is under pleiotropic genetic control. Moreover, unstable 
environments select for flies with shorter lifespans and higher fecundity, presumably 
because in such an environment when survival is threatened it is better to invest resources 
into producing offspring than to potentially waste resources on survival (Luckinbill et al., 
1984; Rose, 1984; Rose and Charlesworth, 1980).  
 
The Disposable Soma theory attempts to explain the trade-off between reproduction and 
longevity from a metabolic viewpoint, where the limiting resource is nutrients  (Kirkwood, 
1977). The theory proposes that an organism invests its limited nutritional resources in 
either reproduction or somatic maintenance, depending on the amount of this resource 
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available in its environment, where reproduction is favoured under conditions of nutrient 
abundance and somatic maintenance is favoured during nutrient scarcity. The Disposable 
Soma theory is based on the idea that longevity is a function of an organism’s ability to 
maintain its body to optimal levels, and argues that this degree of maintenance lasts only 
for as long as the typical reproductive period, after which the body is disposable and 
deterioration is not prevented. The optimal level of resource allocation to somatic 
maintenance evolves to be lower than that required for infinite survival - a greater level of 
investment is not likely to pay off as the organism will most likely die at the hands of 
extrinsic mortality before any benefits of such an investment would be realised. Thus, 
according to the Disposable Soma theory, intrinsic longevity is defined by the degree of 
resource allocation to somatic maintenance, and conversely it is the compromised 
allocation of resources to somatic maintenance that causes the body to deteriorate with 
age. Thus, a trade-off exists as alleles that use energy to increase reproductive fitness are 
favoured at the expense of energy investment in the soma for long-term survival, which 
fits the Antagonistic Pleiotropy model. The molecular mechanism of this phenomenon 
remains to be elucidated, but it seems to be one that is evolved and conserved, and 
necessitated by a resource-limited environment. An alternative hypothesis to that proposed 
by the Disposable Soma theory is that the process of reproduction directly inflicts somatic 
damage, thereby increasing the rate of ageing (Barnes and Partridge, 2003; Williams, 
1966). However, this seems unlikely since sterile female flies exhibit extension of lifespan 
under DR, suggesting that there is no obligatory trade-off (Mair et al., 2004).  
 
It has been suggested that ageing is not entirely neglected by natural selection and that 
senescence is indeed actively selected against (Williams, 1957). The competitive 
environment of nature is such that even slight degrees of senescence can be fatal to an 
animal if, for example, it causes the animal to be slower or if it reduces the efficiency of its 
immune system. Demographic studies have demonstrated the influence of senescence on 
the rate of death in nature. 
 
There has also been some opposition to the idea of aging being maladaptive, and this has 
given rise to the theories of "Programmed Death" (Goldsmith, 2013) which support the 
idea that aging evolved as an adaptation and is actively selected for. Implicit in these 
theories is the notion that limiting lifespan has some evolutionary benefit, in effect causing 
the retention of adverse traits that give rise to ageing. Theories of Programmed Ageing 
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generally propose non-individual (population-wide) benefits of limited lifespans, where 
ageing evolved to the advantage of the species rather than to the individual, which is also 
known as group selection (Wynne-Edwards, 1986). One such theory hypothesises that 
ageing is necessary to remove older individuals in a population to free up resources and 
make room for the younger, more prolific generation, thereby sustaining the genetic 
turnover required for evolution (Weismann, 1889; Yang, 2013). However, while ageing 
may indeed have this advantage for a population in the long-term, this theory has not been 
substantiated by an accompanying mechanistic theory – how would individuals acquire 
‘ageing genes’  and how would these individuals be more successful than other individuals 
without such genes? It seems counter-intuitive since ageing reduces individual fitness, and 
this theory has largely been discounted. However, another theory that supports the idea 
that longevity is actively selected for is the Grandmother Hypothesis (Hawkes, 2003; Hill 
and Hurtado, 1991), which is rooted in the Kin Selection strategy theory of Evolution 
(Bourke, 2007). The Grandmother Hypothesis attributes the reproductive success of an 
individual to the post-reproductive lifespans of their mother and grandmother. The 
reasoning is that post-reproductive mothers contribute to the reproductive success of their 
offspring through altruistic behavior - helping to care for the young, thereby enabling their 
offspring to breed earlier and more often (Hamilton, 1963). Demographic analysis of pre-
modern Finnish and Canadian human populations revealed that women with a greater post-
reproductive lifespan have more grandchildren, indicating greater fitness (Lahdenperä et 
al., 2004). In the context of the Grandmother Hypothesis, it is possible that natural 
selection may have selected for menopause in females to preserve a post-reproductive 
lifespan, thereby permitting greater investment in existing offspring and increasing the 
reproductive success of those offspring in turn. An alternative theory for the origin and 
preservation of menopause is that it is the result of a physiological trade-off (or 
antagonistic pleiotropy) where the genes that determine menopause onset may have 
primarily been favoured for their contribution to reproductive success early in life (Peccei, 
2001).  
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1.1.2. Theories of the downstream mechanisms of ageing 
 
There are several theories that attempt to explain the molecular and cellular mechanics of 
ageing, owing to the fact that ageing is a complex process with many and varied biological 
manifestations. The Damage Accumulation theory postulates that the build-up of various 
forms of molecular and cellular damage over the course of life results in the failure of 
maintenance processes that counter deterioration, such as wound healing, cell replacement, 
cell growth, homeostasis, detoxification and immunity, in turn giving rise to age-
associated pathology and disease (Holliday, 1997). This theory encompasses a number of 
sub-theories, which are not necessarily mutually exclusive. One form of damage 
accumulation that has been widely studied in the context of ageing is that inflicted upon 
the genetic material. Known as the DNA Damage theory, it is proposed that DNA 
alterations contribute to aging by interfering with the processes of transcription and 
translation, thereby causing aberrant protein synthesis resulting in inhibition of protein 
formation or impaired protein function, and in turn cellular dysfunction (Gensler and 
Bernstein, 1981). Insults to DNA mostly come in the form of hydrolysis, oxidation, and 
alkylation and can be caused by reactive oxygen species (ROS), viruses, ionising radiation, 
and environmental chemical pollutants (Ames and Gold, 1991; Best, 2009). Although  
specialised proof-reading mechanisms exist within cells to recognise and repair DNA 
damage, the DNA repair processes are not entirely proficient and the resultant 
accumulation of unrepaired DNA damage is what is thought to bring about some of the 
pathologies of ageing (Best, 2009; Freitas and de Magalhães, 2011). Moreover, genes 
involved in DNA repair can themselves become damaged, rendering them incapable of 
recognising DNA damage, resulting in the replication of this mutated DNA. In this way, 
cells can accumulate DNA damage and mutation, themselves consequently becoming 
increasingly dysfunctional. Studies have drawn correlations between DNA repair capacity 
and lifespan (Hart and Setlow, 1974). 
 
Damage to DNA by ROS is encompassed in the Free-Radical theory of ageing, which also  
implicates ROS in the damage to cellular structures, which givies rise to senescence 
(Harman, 1956). Free radicals, a type of ROS, are molecules with an unpaired electron, 
which makes them extremely and non-specifically reactive, with damaging effects. They 
are by-products of respiration within mitochondria (Harman, 1972), but external factors 
such as X-rays and UV-light can also cause free-radical production. Free radicals readily 
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attach to and react with almost any cellular structure, including DNA and cell membranes, 
disrupting their structure and compromising the integrity of their function (Barja, 2004; 
Fridovich, 1978). Several protective mechanisms are employed by organisms to defend 
against free radicals, including enzymes such as superoxide dismutase (SOD), catalase and 
glutathione peroxidase, as well as various antioxidants including vitamins C, E, selenium, 
and glutathione (Cutler, 1991). It is thought that the efficiency of these defenses to clear 
free-radicals decreases over time and becomes less sufficient to prevent the constant 
accumulation of persistent low-level damage. 
 
Another mechanism of damage accumulation within cells is through the harmful effects of 
waste build-up. The Waste Accumulation theory (Terman, 2001) states that over time cells 
accumulate waste products from metabolic processes and that this can have a toxic effect 
to interfere with normal cell function. The cell is well-equipped to remove metabolic waste 
products such as urea, electrolytes and carbon dioxide through urine, faeces, sweat and 
breathing. Larger waste molecules such as proteins and nucleic acids must first be broken 
down by specialised digestive enzymes for removal. Cross-linked proteins and other cross-
linked cellular structures are particularly difficult to remove and are thus prone to 
accumulation into large poorly-soluble aggregates. Although proteases exist to break down 
such protein aggregates, at some point the rate of their production exceeds their break-
down, resulting in aggregation and accumulation. One example is the long-term build-up 
of lipofuscin, which is a brown lipid pigment, in the lysosomes of cells (Mann and Yates, 
1974; Reichel et al., 1968). In humans, lipofuscin exists in most tissue types, particularly 
the heart, brain, nerves and muscle. Lipofuscin and other age-pigments do not have any 
toxic effect, rather they are thought to exert deleterious effects on cells by taking up space, 
thereby interfering with the normal traffic of molecules, nutrients and structural units 
around, into and out of the cells and slowing the removal of wastes. Significant 
correlations have been noted between the amount of lipofuscin in neurons and heart 
muscle cells and the severity of dementia or heart failure, respectively (Dowson, 1982; 
Allaire et al., 2002).  
 
Underlying these collective damage accumulation theories of ageing is the idea that the 
body’s ability to repair damage becomes exceeded by the rate of damage accumulation. 
Not only is the amount of damage insufficiently cleared by the repair processes, but the 
repair processes themselves become a victim of the damage. The Misrepair Theory of 
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Ageing argues that faulty repair molecules contribute to further damage accumulation 
(Wang et al., 2009). 
 
An alternative theory to the damage accumulation theories of ageing is that ageing is the 
detrimental result of the failure of developmental processes to be turned off, which may 
lead to hypertrophy and/or atrophy (Blagosklonny, 2006a). For example, unregulated 
biosynthesis, driven by growth-promoting pathways such as target of rapamycin (TOR) 
and insulin/IGF-like signalling (IIS), can lead to detrimental hypertrophy. This theory can 
be reconciled with antagonistic pleiotropy, since growth promotes early life fitness, yet its 
continuation into later life is harmful. The theory argues that ageing is ‘quasi-programmed’ 
in that such early-life fitness-promoting programmes fail to be regulated in later life, due to 
the decreased force of natural selection post-reproduction. This theory is supported by the 
observation that decreased TOR and IIS activity extends lifespan in laboratory organisms 
(reviewed in chapter 1.3). 
 
 
1.1.3 Ageing research 
 
With advances in medical research and improvements in living standards, life expectancy 
in developed countries has been steadily increasing over the past 160 years (Murray, 2015; 
Wilmoth, 2000). This increase in lifespan, however, is not owed to research into ageing – 
instead it is the result of improved hygiene, immunisation and advancements in treatments 
for disease. In fact, one consequence of these improvements to public health is an increase 
in age-associated diseases, since more people are living long enough to suffer such late-
onset diseases. As global life expectancy continues to increase, it becomes more important 
to improve healthspan as well as lifespan, because elongation of lifespan is unappealing 
and increases suffering without enhanced behavioural vitality and improved functional 
capacity. Thus, there is now a greater need to improve health during old age. 
 
A principle goal of ageing research is to understand the mechanisms that give rise to loss 
of function at different levels of biological organisation in an organism over time. At some 
point, irreversibility of this functional decline occurs. Thus if we are to intervene to slow 
or prevent the ageing process, treatments must be targeted to cellular and tissue changes 
before the point of irreversibility (Partridge et al., 2005). It is therefore necessary, in 
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consideration of possible interventions, to identify the root cause of the biological changes 
that amass to physical senescence. In this research we explore the role of diet in 
modulating the physiological changes that give rise to ageing, and how dietary status is 
signalled to the body to maintain homeostasis. We use Drosophila melanogaster as a 
biological system to study ageing through genetic and dietary interventions. 
 
  
1.1.4. Drosophila melanogaster as a model for ageing 
 
Research into ageing takes advantage of the genetic conservation of metabolic and 
developmental pathways, and other genetic material, across different species. Drosophila 
is a good model for ageing in humans because they share many genes and interventions 
that alter lifespan between species. For example, certain proposed biological determinants 
of lifespan, such as the TOR nutrient signalling pathway and the IIS pathway, are present 
in both humans and in Drosophila (to be discussed later). Approximately 75% of known 
disease genes in humans have homologs in the Drosophila genome (Reiter et al., 2001). 
Drosophila have an advantage over other commonly-used model organisms, such as the 
nematode worm Caenorhabditis elegans, in that they have greater genetic similarity to 
humans, making them comparably more relevant for studying human ageing. Many basic 
physiological properties are conserved between Drosophila and mammals, and Drosophila 
also displays measurable changes in morphology and function with age. 
 
The are many practical advantages of using Drosophila as a model organism in research; 
they have a relatively short lifespan of 3 months, and a development time of 10 days from 
egg to adult (at 25
o
C, 65% humidity), meaning that rapid progress can be made, especially 
in the context of ageing research, compared to the use of mice, which typically live up to 3 
years old. 
 
Mated female Drosophila can lay ~400 fertilised eggs during their lifetime. 21-24 hours 
after egg-laying, these embryos hatch into larvae, which feed and grow for ~4 days, 
molting twice – once at 24 hours after hatching and once at 48 hours. The larvae then 
wander from their food and enter a pupal phase for ~4 days, during which they undergo 
metamorphosis into adult flies. Flies eclose from their pupae 9-10 days from the egg stage 
(Figure 1.2). Drosophila have 4 pairs of chromosomes – an X/Y and 3 autosomes.  
 21 
 
   
 
Figure 1.2. Life cycle of Drosophila melanogaster from egg to adult.  
Image taken from (Hartwell et al., 2011). 
 
 
Other practical advantages of using Drosophila for research include their ease of culture to 
large numbers, their ease of handling and the relatively low costs required for their 
maintenance. Moreover, sequencing of the Drosophila genome has made it possible to 
genetically manipulate them for gene function studies.  
 
The use of Drosophila in biological research allows the use of genetic tools that permit the 
spatial and temporal control of gene expression in the fly, and this has proved to be very 
useful for analysing gene function. Tissue-specific expression of a gene of interest is 
enabled by the UAS (upstream activating sequence)/GAL4 system (Brand and Perrimon, 
1993; Figure 1.3). Two distinct transgenic fly lines are required; in the first, a yeast 
transcriptional activator gene, GAL4, is placed under the control of the promoter (or 
enhancer) of a tissue-specific driver from Drosophila.  In the second transgenic fly line, 
the upstream activation sequence (UAS), containing GAL4-binding sites, is cloned 
upstream of the gene of interest. GAL4 induces the transcription of this GAL4-responsive 
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(UAS) target gene. Only upon crossing of the GAL4 line to the UAS-target gene line is the 
target gene activated (in the progeny). 
A further level of control can be introduced by the gene switch (GS) system. Here, 
temporal activation of the UAS/GAL4 system can be achieved with the addition of the 
inducing drug RU486 (Osterwalder et al., 2001). This is desirable in cases where the 
misexpression or overexpression of the target gene is lethal at the developmental stage, 
thereby preventing analysis of gene function in adults using drivers that also express 
during development. In this case, the driver lines express a modified version of the GAL4 
transcriptional activator that is RU486-dependent. In the absence of the RU486 activator, 
the GAL4 protein is expressed in the tissues of interest but remains transcriptionally silent, 
and the transgene remains unexpressed. Administration of RU486 (e.g. orally via food) 
activates the GAL4 protein, thereby permitting the expression of the gene of interest in 
only the tissues containing the GAL4 protein. Transgene activation is only possible in the 
progeny of the cross between the two transgenic fly lines. 
 
 
Figure 1.3. The Gene Switch/UAS expression system in Drosophila. 
Mutagenised fly lines expressing the tissue-specific GAL4 transcriptional activator are crossed 
to UAS-reporter fly lines with the target gene fused to GAL4 binding sites. In the F1 progeny, 
expression of the GAL4 gene is activated by a tissue-specific promoter. In the presence of the 
RU486 activator, the resulting GAL4 protein in the target tissues becomes transcriptionally 
active and binds to and activates the transcription of the UAS (upstream activating sequence), 
which in turn activates expression of the transgene within the target tissues. 
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Although Drosophila has many strengths as a model system for ageing research, the 
ultimate aim of this research is to enhance human healthspan, and so the focus of such 
research must be on those aspects of ageing that are relevant to humans. It is in 
consideration of genetic resemblance to humans that Drosophila stands at a disadvantage 
in comparison to mammalian models. Thus, any experimental result that comes from 
Drosophila must be verified in multiple different animal models to establish evolutionary 
conservation of function, thereby increasing the relevance to humans. Indeed Drosophila 
has been instrumental in establishing evidence of conservation for an effect of the 
insulin/IGF pathway and dietary restriction on aging (Piper et al. 2005; Giannakou and 
Partridge 2007). 
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1.2. Dietary restriction  
 
Dietary restriction (DR) is an intervention that extends lifespan in a diverse range of 
organisms. DR is defined as a moderate reduction in food intake that is just short of 
malnutrition. Originally, DR was defined as a 20-40% reduction from ad libitum feeding. 
However, it now refers to a broader spectrum of dietary interventions, including more 
specific limitations of one or more macronutrients to varying degrees. DR is considered 
one of the most robust environmental interventions that extends lifespan in diverse animal 
models, including yeast (Jiang et al., 2000), worms (Klass, 1977), fruit flies (Chapman and 
Partridge, 1996), rats (McCay, 1935) and even dogs (Lawler et al., 2008). Almost 100 
years after it was first demonstrated that the lifespan of an animal could be extended by 
restricting its diet (Osborne et al., 1917; McCay, 1935), and despite subsequent research 
efforts, the biological mechanism underlying this phenomenon remains to be elucidated.  
 
In most organisms, DR results in reduced fecundity, however, it has been shown to have a 
wide range of health benefits. DR rodents have a delayed onset or a lesser severity of age-
related diseases such as cancer, type 2 diabetes, cardiomyopathy, nephropathy, chronic 
lung diseases, autoimmune diseases, and motor dysfunction and neurodegenerative 
diseases (Blackwell et al., 1995; Fontana and Klein, 2007; Ingram et al., 1987; Martin et 
al., 2006; Masoro, 2005; Weindruch et al., 1979). DR rodents are also protected against 
sarcopenia, left ventricular diastolic dysfunction, decline in heart rate variability, and age-
related hearing loss (Martin et al., 2006; Marzetti et al., 2009; Meyer et al., 2006; Someya 
et al., 2010). Moreover, data from postmortem pathological studies have shown that 30% 
of the DR rats versus 6% of fully-fed rats die without any sign of morphologic lesions 
(Shimokawa et al., 2003). Thus DR appears to maintain physiological functions in more 
youthful states, rather than just extending the moribund period of life. 
 
DR studies in rhesus monkeys suggest that the beneficial effects of DR on health are 
conserved in primates. The percentage of rhesus monkeys free of age-related diseases has 
been reported to be higher in DR monkeys compared to control groups. For example, 
monkeys maintained on a DR diet long-term have been shown to have a reduced incidence 
of type 2 diabetes, glucose intolerance, cancer, cardiovascular disease and brain atrophy, 
and DR improves age-related survival in some, but not all, cases (Bodkin et al., 2003; 
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Colman et al., 2009, 2014; Kemnitz, 2011; Mattison et al., 2012). Short-term DR has also 
been correlated with beneficial effects on health in humans; it was reported that DR 
reduced risk factors for type 2 diabetes and atherosclerosis, including reduced obesity, 
increased insulin sensitivity, reduced cholesterol, reduced blood pressure, and improved 
left ventricular diastolic function (Fontana et al., 2004; Holloszy and Fontana, 2007; 
Fontana and Klein, 2007). However, the optimal degree of DR implementation for humans 
remains unknown. This is dependent on what is considered as the optimal body weight, 
level of adiposity, and metabolic profile. 
 
Longevity is difficult to study in humans, thus the effects of long-term DR on human 
lifespan are as yet unknown. However  ‘natural experiments’  such as the conditions 
producing the high centenarian population of Okinawa, Japan, have offered insights into 
the effect of DR on lifespan in humans. Okinawa has the highest proportion of 
centenarians in the world (Chan et al., 1997). The people of Okinawa not only have the 
longest life expectancy in the world, but are also comparatively healthier – they have the 
lowest frequency of coronary heart disease, stroke, and cancer, and they spend an average 
of 97% of their lives disease and disability-free (Bernstein et al., 2004; Willcox et al., 
2008b). The Okinawa Centenarian Study, which began in 1975, aims to determine the 
genetic and lifestyle factors owing to the success of this particular aging population. It is 
believed that the Okinawans owe their exceptional health and longevity to their low 
calorie, but nutrient-rich, diet. They are reported to consume only 83% of the average 
caloric intake for Japan (Kagawa, 1978; Willcox et al., 2007, 2014). The Okinawan diet is 
necessitated by a rural lifestyle, however the quality of their diet is sufficient to protect 
them against malnutrition and infectious diseases. The case of the Okinawan centenarians 
is often used as evidence that DR can decelerate ageing in humans and protect against age-
related diseases. 
 
The broad spectrum of health benefits associated with DR suggest that the effect of DR to 
extend life is not achieved by averting some single cause of death, but rather by slowing 
the ageing process itself. Alternatively, DR may alter the rate of aging by averting multiple 
causes of death that would otherwise manifest as senescence and increase age-related 
mortality. In Drosophila, DR increases both mean and maximum lifespan. DR delays the 
onset of age-specific mortality, but subsequently advances at the same rate as control flies 
(Pletcher et al., 2002). Age-specific mortality trajectories generated for DR and control 
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female flies, as well as for DR flies switched to control food (and vice versa) at 14 and 22 
days of treatment, revealed that control flies that were switched to DR food rapidly 
adopted the mortality profiles of chronically treated DR flies (Mair et al., 2003). This study 
suggested that DR removes the short-term risk of death, rather than slowing age-related 
damage, since the rapid (48hr) drop in mortality seen for the control-to-DR switched flies 
implies that any pre-existing damage before the switch had no effect on mortality at the 
ages tested.  
 
 
1.2.1. Caloric restriction Vs. dietary restriction  
 
Historically, the lifespan and health benefits of DR have been attributed to a reduction of 
dietary calorie intake; as such, DR is often referred to as ‘caloric restriction' or 'CR'. Some 
studies have shown support for this theory - restriction of calories in rats without a 
reduction in protein resulted in lifespan extension (Masoro et al., 1989). Another study 
showed that rats fed an isocaloric diet with reduced fat and mineral levels did not have 
increased lifespan (Iwasaki et al., 1988a). One problem with these kinds of studies is that 
when a particular dietary component is omitted from the diet, it is necessarily replaced by 
something else to compensate for the physical reduction in volume. Consequently, not 
only is there a reduction of calories, but the balance of all the other dietary components is 
altered.  
 
The idea that the caloric content of diet is responsible for the DR effects on lifespan is 
under scrutiny and other work in the field suggests that it is the balance of particular 
dietary components that mediates the effects of DR on lifespan. One study showed that the 
restriction of protein had lifespan-extending effects in rats, where calorie intake was kept 
the same (Yu et al., 1985). In another study, changing the protein source from casein to 
soy, again while keeping the caloric content the same, conferred an increase in the lifespan 
of rats (Iwasaki et al., 1988b). Moreover, rodent studies that apply DR by intermittent-day 
fasting regimens, which do not affect the overall calorie consumption compared to control 
animals, have reported increases in lifespan (Anson et al., 2003; Goodrick et al., 1990). 
The discrepancy between findings from different laboratories, animal strains, and methods 
of DR application only highlights the complexity of the mechanism of DR to enhance 
longevity, and it strengthens the notion that the lifespan and health benefits of DR cannot 
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always be attained simply by reducing ingested calories. The level of mechanistic 
complexity implied from these studies suggests that the lifespan response to DR is 
governed by specific nutritional components of the food and their relative abundance.  
 
In Drosophila, it was demonstrated that reducing the levels of dietary yeast or sugar 
increased lifespan, but to different degrees and by amounts unrelated to calorie content 
(Mair et al., 2005). Moreover, flies that were switched between DR and control yeast 
concentrations quickly adopted the mortality profiles of flies that had been chronically 
maintained on the food to which flies were switched. In contrast, switching between sugar 
concentrations had no effect on the mortality trajectory. Furthermore, the greater effect of 
altering dietary yeast, compared to altering sugar, on survival suggests that the nutritional 
mix found in yeast, which consists mainly of protein, is a more important determinant of 
lifespan than carbohydrate. 
 
 
1.2.2. Role of amino acids in dietary restriction 
 
Evidence suggests that the dietary determinants of the lifespan effect of DR may be 
narrowed down further from protein to amino acids. The absence of the non-essential 
amino acid cysteine, and low amounts of the essential amino acid methionine, resulted in 
lifespan extension in rats (Orentreich et al., 1993; Richie et al., 1994; Zimmerman et al., 
2003). Methionine restriction has also been shown to increase lifespan in mice (Miller et 
al., 2005). Similarly, tryptophan restriction extended lifespan in both mice (De Marte and 
Enesco, 1986) and rats (Ooka et al., 1988; Segall and Timiras, 1976). Methionine-
restricted animals, in addition to extended lifespan and reduced growth, also exhibit 
physiological changes that are similar to those seen in calorie-restricted animals, as well as 
some that are dissimilar, suggesting that methionine-restricted animals are not calorie-
restricted. It also suggests that the mechanistic pathways that govern the effect of 
methionine restriction and calorie restriction on physiology are separate, but perhaps 
overlapping to some degree. 
 
Recently in the Partridge lab, it was shown that it is the balance of amino acids that 
mediates the lifespan differences between DR and full feeding (FF) (Grandison et al., 
2009). This study used Drosophila as a model system for ageing. DR was implemented by 
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a two-fold dilution of yeast in the standard sugar / yeast diet. Supplementing the DR diet 
with the ten essential amino acids (EAA) produced the same relatively short lifespan as 
that in the FF condition. In the same study, EAAs were also shown to be responsible for 
the fecundity differences between DR and FF, where DR flies supplemented with EAAs 
had increased egg-laying to the same degree as the FF condition. Moreover, specific EAAs 
were implicated as being responsible for the increase in fecundity with EAA addition; 
supplementing a DR diet with methionine alone was sufficient to increase fecundity to the 
same level as FF. Omitting methionine from the artificial FF condition (DR+EAA) 
reduced egg-laying, indicating that methionine is necessary and sufficient to increase 
fecundity to the same level as FF. Methionine addition did not shorten lifespan, as would 
be expected under a model involving an obligate nutrient trade-off between traits. The 
omission of methionine from the DR+EAA condition increased lifespan, and this effect 
was not due to reversal of a detrimental effect of high levels of methionine since 
methionine addition to the DR condition increased egg-laying. Not only did this study 
demonstrate that it is the balance of EAAs that is responsible for the lifespan effects of 
DR, but also that a different balance of EAAs is responsible for the fecundity response of 
FF, such that the effect of DR on lifespan and fecundity in Drosophila cannot be attributed 
to reallocation of nutrients from somatic maintenance to reproduction, as the prevailing 
theory for the mechanism of DR would predict. 
 
DR extends lifespan in most species tested to date, and it is probable that the lifespan 
response to DR evolved very early as a mechanism to increase survival during times of 
environmental food shortage. The comparatively more modest effects of DR on primates, 
compared to simpler organisms, may be due to the fact that simpler organisms have shorter 
lifespans to begin with, and exposure to a period of famine represents a greater fraction of 
their lives, necessitating a more dramatic adaptation. It is not yet clear whether the 
mechanism is evolutionarily conserved or whether it evolved independently in these 
species. 
 
Many of the genetic interventions that have extended lifespan downregulate the activity of 
nutrient sensing pathways which regulate growth and metabolism in response to nutritional 
cues, making them attractive candidate mediators of DR-induced longevity. As such, 
research is focussed on uncovering the nutrient effector(s) of DR, how they are sensed, 
integrated and relayed as a signal, and how this in turn promotes longevity assurance 
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mechanisms to extend lifespan and healthspan. Moreover, studies into the workings of 
these pathways may uncover genes and proteins as targets for drug interventions that 
mimic DR, with the aim of achieving longer and healthier lives.  
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1.3. Nutrient sensing/signalling pathways 
 
In order to survive in a dynamic and ever-changing environment, animals must be able to 
sense and respond to change. Indeed, animals have evolved distinct signalling response 
pathways for different environmental stressors. The activity of such signal transduction 
pathways is induced by an extra-cellular signal, which then triggers a cascade of molecular 
events that culminates in a physiological and/or behavioural change that allows the 
organism to adjust to the environmental conditions in order to maintain metabolic 
homeostasis. Several biological pathways have been proposed to mediate the adaptive 
changes to environmental nutrient supply, and are collectively termed nutrient 
sensing/signalling pathways (NSP). The response to nutritional stress via these pathways 
often involves changes in gene expression that promotes the conservation of resources, for 
example, by downregulating global protein synthesis (Spriggs et al., 2010), thereby 
allowing the organism to endure the stress period.  
 
The three most widely studied NSPs are the target of rapamycin (TOR) pathway, the 
insulin/IGF (insulin-like growth factor) signalling (IIS) pathway, and more recently the 
general amino acid control (GAAC) pathway. These pathways are distinct, but they also 
share a considerable degree of mechanistic overlap with crosstalk between them. All three 
pathways regulate protein synthesis, and in each case have been shown to influence ageing 
in animal models. As such, these pathways are being studied as mediators of the lifespan-
extending effects of dietary restriction (DR). It is hoped that understanding the workings of 
these pathways will uncover genes and proteins that can serve as targets for drug 
interventions that mimic DR.  
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1.3.1. The target of rapamycin (TOR) pathway 
 
The TOR pathway integrates a range of environmental inputs, such as nutrient availability, 
energy availability, stress and growth factors, to regulate protein synthesis, thereby 
ensuring that an organism's growth rate matches its resources (Martin and Hall, 2005) 
(Figure 1.4). The TOR pathway has recently been referred to as the mechanistic target of 
rapamycin, abbreviated mTOR. However, this abbreviation is also used for mammalian 
target of rapamycin. To avoid confusion, we will refer to the pathway here simply as TOR. 
We will use mTOR when referring to mammalian TOR, dTOR when referring to 
Drosophila TOR, yTOR for yeast TOR and ceTOR for C. elegans TOR. We will omit the 
leading letter if we are referring to the TOR pathway in a general sense. We also 
distinguish between organism-specific names of the pathway components, summarised in 
Table 1.1. 
 
Table 1.1. The main genes of the target of rapamycin (TOR) pathway in mammals, and 
their orthologous genes in Drosophila melanogaster, Caenorhabditis elegans, and 
Saccharomyces cerevisiae, along with the biochemical functions of the gene products in 
mammals. 
Mammals D. melanogaster C. elegans S. cerevisiae 
Biochemical function 
in mammals 
mTOR dTOR let-363 TOR1/2 
4E-BP1 and S6K1 
phosphorylation 
Raptor dRaptor daf-15 KOG1 mTOR binding protein 
Rheb dRheb CeRheb ScRheb 
GAP activator of 
mTOR 
Tsc1/2 dTsc1/2 
No 
orthologue 
Tsc1/2 GAP activator of Rheb 
RagA/RagB dRagA raga-1 Gtr2 
GAP regulator of 
mTORC1 localisation 
RagC/RagD dRagC ragc-1 Gtr2 
GAP regulator of 
mTORC1 localisation 
S6K1 dS6K rsks-1 SCH9 
Ribosomal protein S6 
phosphorylation 
4E-BP1 d4E-BP spn-2 PHAS-1 Repressor of eIF4E 
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TOR pathway mechanisms 
The TOR pathway has been best described in mammals, and genetic orthologues of the 
components of the TOR pathway have been identified in yeast, in Drosophila and in C. 
elegans. In mammals, the TOR pathway exists in two multiprotein complexes; mTORC1 
and mTORC2, which localise to different subcellular compartments (Betz and Hall, 2013) 
and differ in some of their constituent proteins and functions. Both complexes share a 
common catalytic subunit - mTOR - a serine-threonine kinase that relays extracellular 
signals to downstream effectors. mTORC1 functions to regulate cell size and proliferation 
(Miron et al., 2001; Montagne et al., 1999; Oldham et al., 2000; Zhang et al., 2000), and its 
associated proteins, in mammals, include Raptor (regulatory associated protein of TOR), 
mLst8 (mammalian lethal with SEC13 protein 8), and PRAS40. mTORC2 has a role in the 
regulation of the actin cytoskeleton (Jacinto et al., 2004), and its associated proteins 
include Rictor (rapamycin insensitive companion of mTOR), Sin1, Proctor/PRR5L, mLst8, 
and Deptor (Guertin and Sabatini, 2005, 2009; Wullschleger et al., 2006). The two TOR 
complexes have distinct effector pathways; mTORC1 signals downstream to ribosomal S6 
kinase (S6K1) and eIF4E binding protein-1 (4E-BP1), which are translational regulators 
that are activated when TORC1 is active, resulting in increased growth. mTORC2 signals 
to downstream AKT, a protein kinase with roles in glucose metabolism, apoptosis 
inhibition, and the promotion of cell survival.  
 
The tuberous sclerosis proteins 1 and 2, also known as TSC1 (hamartin) and TSC2 
(tuberin) form a heterodimeric protein complex and serves to integrate signals that indicate 
low energy availability and stress (e.g. DNA damage, hypoxia) into mTORC1 signalling 
(Figure 1.4). These stress signals activate the TSC1/2 complex, which is a negative 
regulator of mTOR signalling, resulting in a downregulation of protein synthesis. Growth 
factor signals are also integrated through the TSC1/2 complex, but they inhibit the 
complex, and therefore derepress mTOR signalling and promote protein synthesis. The 
GTPase activity of TSC2 in turn stimulates the GTPase activity of the mTOR activator 
Rheb (Ras homolog enriched in brain) (Inoki et al., 2003).  
 
Activated mTOR phosphorylates the eukaryotic translation initiation factor 4E-binding 
protein 1 (4E-BP1). 4E-BP1 is a translational repressor that binds the eukaryotic 
translation initiation factor 4E (eIF4E), preventing its association with the translation 
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initiation complex, which is required for protein synthesis. Phosphorylation by mTOR 
causes the dissociation of 4E-BP1 from eIF4E, thereby permitting assembly of the 
initiation complex and enabling the translation of mRNA. Another major downstream 
target of mTOR phosphorylation is ribosomal protein S6 kinase 1 (S6K1). S6K1 is a 
serine/threonine kinase that phosphorylates the S6 ribosomal protein, which is a 
component of the 40S ribosomal subunit involved in mRNA translation, resulting in 
increased protein synthesis. 
 
 
 
Figure 1.4. The mammalian target of rapamycin complex 1 (mTORC1) signalling 
network.  
The mTORC1 pathway integrates extracellular amino acid signals via the Rag proteins and 
other extracellular inputs, such as energy, stress, and growth factors via TSC1/2 to regulate cell 
growth. These signals are transmitted to downstream effectors via Rheb, Raptor and mTOR. 
S6K1 phosphorylation and 4E-BP1 inhibition result in an upregulation of mRNA translation 
and increased protein synthesis. Activation of mTORC1 also inhibits autophagy. mTOR is 
inhibited by the drug rapamycin.  
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Amino acid sensing and the Rag proteins 
The specific nutrients that modulate TOR pathway activity have been shown to be amino 
acids. Withdrawal of amino acids from cell culture medium was shown to result in the 
deactivation of the downstream mTORC1 effectors S6K1 and 4E-BP1. Even in the 
presence of growth factors, mTORC1 remained inactive in the absence of amino acids, 
implicating amino acids as a main activator of mTORC1 pathway activity. This was 
reversed upon supplementation with amino acids (Hara et al., 1998). Deficiencies of most 
amino acids singly have been shown to lessen mTORC1 signalling to different degrees, 
however, deficiencies in leucine and arginine in particular reduces TORC1 signalling in 
cell culture, as measured by dephosphorylation of S6K1 and 4E-BP1, as effectively as the 
withdrawal of all amino acids (Hara et al., 1998), suggesting a particularly important role 
for these amino acids in the mediation of mTORC1 activity. In another study, leucine-
mediated activation of mTORC1 was shown to be dependent on the preloading of cells 
with glutamine, which itself has no effect on mTORC1, but rather acts as an efflux solute 
enabling the intracellularisation of leucine through an amino acid transporter (Nicklin et 
al., 2009). 
 
Exactly how the presence, quality and quantity of nutrients is sensed within the cell 
cytoplasm and how these nutrient signals are relayed to downstream translation machinery 
remains to be fully elucidated. However, the recently discovered heterodimeric Rags (Ras-
related GTP-binding) GTPases, RagA/RagC and RagB/RagD, have been found to have a 
significant role in transmitting the amino acid signal to mTORC1 (Kim et al., 2008; 
Sancak et al., 2008). In mammalian cells it was found that in the presence of amino acids, 
RagD dimerises with GTP-bound RagB and associates with the Raptor subunit of 
mTORC1, and in doing so promotes the translocation of mTORC1 to endosomal 
membranes within the cell, where its activator, Rheb, is thought to reside (Sancak et al., 
2008; Figure 1.5). The specific endosome that hosts these mTORC1 interactions has been 
identified as the lysosomal membrane, and in particular the Lamp2 (lysosome-associated 
membrane protein 2) and Rab7 positive regions, which are markers of lysosomes and late 
endosomes. Within this membrane region a heterodimeric protein complex, dubbed 
Ragulator, was discovered as being the intermediate link between mTORC1 and the 
lysosomal membrane (Sancak et al., 2010). The three proteins that make up the 
mammalian Ragulator complex are MP1, p14 and p18, encoded by the genes MAPKSP1, 
ROBLD3 and c11orf59 respectively. The interaction of the Ragulator with the Rag proteins 
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is not dependant on amino acids, however the integrity of the Ragulator has been shown to 
be critical for mTORC1 activation by amino acids. Amino acids, through a mechanism 
unknown, encourage the loading of RagB with GTP, inducing the binding of the Rag 
heterodimer to the Raptor subunit of the mTORC1 protein complex. mTORC1 then 
translocates to a Ragulator region bound area of the lysosomal membrane where it 
interacts with the Ragulator via Rag, forming a Rag-Ragulator-mTORC1 super-complex 
which in turn promotes the interaction of mTORC1 with its lysosome-localised activator, 
Rheb. 
 
 
Figure 1.5. A model for Rag-mediated amino acid-induced activation of mTORC1 in 
mammals.  
In amino acid depleted cells, mTOR cannot associate with the lysosomal membrane on which 
its activator, Rheb, resides. The Rag GTPases are held to the lysosomal surface by the 
Ragulator. Amino acids promote the loading of RagB with GTP, thereby enabling the 
association of the Raptor subunit of mTORC1 with the Rag-Ragulator complex. This 
conformation brings mTORC1 to a close enough proximity to interact with Rheb, which 
stimulates its kinase activity. 
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Rapamycin as an inhibitor of the TOR pathway 
As the name suggests, TOR is sensitive to suppression by the drug rapamycin (also known 
as sirolimus), which is an antifungal macrolide produced by the bacterium Streptomyces 
hygroscopicus. Rapamycin was originally discovered in a soil sample from Easter Island, 
or Rapa Nui in the native language (Sehgal et al., 1975; Vezina et al., 1975), and was soon 
found to be a potent inhibitor of the mammalian cell cycle, arresting activity at the G1 
phase (Houchens et al., 1983). Further genetic studies that screened for rapamycin-
resistant mutants of the baker's yeast, Saccharomyces cerevisiae, revealed three genes 
whose protein products were targeted by rapamycin; yTOR1 and yTOR2 (Heitman et al., 
1991) and FPR1. Several years later, the mammalian TOR pathway was identified as an 
orthologue of the yTOR1/2 proteins and confirmed as being the rapamycin target in 
mammals (Brown et al., 1994; Sabatini et al., 1994). The single mammalian TOR protein 
has a 42% amino acid sequence similarity to the yeast TOR1/2 proteins (Hay and 
Sonenberg, 2004). Subsequently, the mammalian homologue of yeast FPR1 was identified 
– called FKBP12. 
 
Further work showed that rapamycin binds to FKBP12, and this rapamycin-FKBP12 
complex in turn attaches to a binding domain on mTORC1. This binding domain lies 
adjacent to the mTOR kinase domain, which becomes disrupted upon FKBP1 binding, 
compromising the interaction between mTOR and its activator Raptor. In reference to the 
fact that rapamycin can only inhibit mTOR as a complex with FKBP12, mTOR has also 
been called FRAP (FKBP-rapamycin-associated protein) and RAFT (rapamycin and FKBP 
target). Rapamycin has been thought to bind to the mTOR in complex 1 exclusively, 
indicating that only mTORC1 is subject to inhibition by rapamycin (Loewith et al., 2002; 
Sarbassov et al., 2004). However, recent evidence suggests that prolonged treatment with 
rapamycin can also inhibit complex 2, shown both in vitro (Sarbassov et al., 2006) and in 
vivo (Guertin et al., 2009; Lamming et al., 2012). Rapamycin's anti-proliferative properties 
have meant that it has a clinical use in treating cancer patients - rapamycin inhibits tumour 
cell proliferation by inducing apoptosis of the tumour cell and suppressing angiogenesis in 
the tumour. Additionally, the ability of rapamycin to inhibit T and B cell proliferation 
makes it a useful immunosuppressant, and is often administered to organ transplant 
patients to prevent organ rejection. 
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The role of TOR in growth control 
Loss of function experiments support a critical role for TOR in organismal growth control; 
deficiency of CeTOR in C. elegans resulted in developmental arrest at larval stage L3, as 
well as gonadal degeneration and intestinal cell atrophy. Similar phenotypes were also 
observed for C. elegans with loss of function of daf-15, an orthologue of mammalian 
Raptor (Jia et al., 2004). These phenotypes are attributed to an inhibition of mRNA 
translation (Long et al., 2002). In Drosophila, dTOR (Drosophila orthologue of 
mammalian TOR) null flies exhibited phenotypes including developmental arrest and 
decreased size of endoreplicating tissue (Oldham et al., 2000). Studies in mice have shown 
that disruption of the kinase domain of TOR results in early embryonic lethality due to 
defective cell proliferation (Hentges et al., 2001; Murakami et al., 2004), and the absence 
of Raptor only from mouse skeletal muscles induces muscular dystrophy due to impaired 
protein synthesis (Bentzinger et al., 2008). Altogether these results confirm a conserved 
role for the TOR pathway in the control of cell growth. 
 
 
The role of TOR in lifespan regulation  
The TOR pathway was first found to be involved in the regulation of ageing when deletion 
of the yeast homolog of S6K1 - SCH9 - doubled the chronological lifespan of the yeast 
(Fabrizio et al., 2001). Soon after, reduced TOR activity was shown to extend lifespan in 
worms: let-363 (C. elegans orthologue of mammalian TOR) deficiency doubled the 
lifespan of worms (Vellai et al., 2003), RNAi knockdown of daf-15 (C. elegans orthologue 
of mammalian raptor) also increased lifespan (Jia et al., 2004), as did mutations in rsks-1 
(C. elegans orthologue of mammalian S6K1) (Pan et al., 2007). Lifespan extension by 
inhibition of TORC1 pathway genes was subsequently demonstrated in flies (Kapahi et al., 
2004), further in yeast (Kaeberlein et al., 2005), and in mice (Selman et al., 2009). It was 
also demonstrated that pharmacological downregulation of TORC1 by rapamycin extends 
lifespan in yeast (Powers et al., 2006), worms (Robida-Stubbs et al., 2012), flies (Bjedov et 
al., 2010) and mice (Harrison et al., 2009). Crucially, TOR pathway downregulation has 
been shown to confer broad-spectrum health benefits in mice (Selman et al., 2009). 
Deregulation of the TOR pathway has also been implicated in age-related diseases in 
humans, such as cancer, diabetes, obesity, atherosclerosis, osteoporosis, arthritis, psoriasis, 
Al heimer’s disease  and Parkinson’s disease (Tee and Blenis, 2005; Tsang et al., 2007), 
due to over-proliferation.  
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TORC1 regulates several processes that could be involved in the lifespan response to DR. 
One major effect of TORC1 downregulation is reduced global mRNA translation. There 
are several hypothesises for how reduced protein synthesis may be favourable for 
longevity, and one such theory proposes that the resultant alleviation of stress on protein 
folding produces fewer misfolded proteins that could otherwise aggregate in a harmful 
way. Accordingly, mouse models of Huntington Disease showed a decrease in the 
formation of toxic huntingtin aggregates
 
upon rapamycin treatment (Ravikumar et al., 
2004). Another theory postulates that aberrant growth and differentiation with high 
TORC1 activity can exhaust the stem cell pool. In fact, the abundance of stem cells and 
their ability to differentiate has been shown to decline with time and this causes cellular 
senescence (Janzen et al., 2006; Molofsky et al., 2006).  
 
As well as alleviating the effects of damage, inhibition of TORC1 may also trigger repair 
mechanisms to counter any damage. One such repair mechanism brought about by TORC1 
inhibition is autophagy, which is a catabolic mechanism that employs the action of 
lysosomes to degrade and recycle excess or dysfunctional cellular components, thereby 
limiting their potential to cause deterioration of normal cell function. During this process, 
targeted cellular constituents are isolated within an autophagosome, which then fuses with 
a lysosome and unloads its contents for degradation. Autophagy also promotes survival by 
degrading unnecessary proteins, thereby freeing amino acids and bioenergic components to 
be synthesised into proteins that are essential for survival. As such, autophagy may be 
regarded as an adaptive response to stress. Autophagy is induced during starvation, via 
TORC1, enabling short-term viability through the starvation period (Lum et al., 2005). 
Work from several model organisms implicates autophagy in the ageing process; in worms 
and flies activation of autophagy has been shown to extend lifespan (Bjedov et al., 2010; 
Hansen et al., 2008; Hars et al., 2007; Jia et al., 2007; Meléndez et al., 2003; Tóth et al., 
2008), and in mice overexpression of Atg5, a protein involved in the formation of 
autophagosomes, extends median lifespan by 17.2%. Atg5 transgenic mice were also 
leaner, and had increased insulin sensitivity and improved motor function, and embryonic 
fibroblasts cultured from these mice were more resistant to oxidative stress (Pyo et al., 
2013). 
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Suppression of growth programs like those activated by TORC1, or reduced food intake, 
result in the activation of stress-response mechanisms, like autophagy, that preserve the 
functionality of cells for extended periods of time (Fontana et al., 2010). In yeast, Gis-1, a 
transcription factor lying downstream of yTOR, regulates stress response programs. In 
flies, 4E-BP1 activation by DR resulted in the increased translation of components of the 
mitochondrial electron transport chain, leading to more efficient mitochondrial respiration 
(Zhang and Cuervo, 2008). In worms, TOR downregulation enhances thermotolerance 
(Hansen et al., 2007).  
 
Thus, downregulation of TOR may extend lifespan either via reduced protein synthesis 
and/or via upregulation of stress-response mechanisms  improving the animal’s ability to 
protect against damage by preventing it or repairing it (Syntichaki and Tavernarakis, 
2006). According to the Disposable Soma Theory of Ageing, reduced nutrient availability 
shifts cells from a state of nutrient usage for protein synthesis and growth to one favouring 
cell maintenance and survival. It is possible that TOR mediates such a shift in resource 
allocation by inhibiting translation, and therefore growth, to allow for mechanisms 
involved in maintenance and repair, thereby enhancing survival (Hansen et al., 2007).  
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1.3.2. The insulin/IGF signalling (IIS) pathway 
 
IIS is a highly conserved biochemical pathway with a primary role in regulating growth, 
differentiation and metabolism in response to nutrient availability (Figure 1.6). In 
mammals, insulin is produced by the beta-cells of the pancreas in response to increased 
blood glucose after food consumption, primarily in response to digestible carbohydrates, 
and to a lesser degree  protein. Insulin binds to the α-subunit of its receptor, which is 
embedded in the cell membrane, forming a receptor-ligand complex. Upon extracellular 
ligand binding  the β-subunit of the receptor, a tyrosine kinase, phosphorylates, and 
consequently binds, the insulin receptor substrate (IRS) within the cytoplasm. IRS is a 
signalling adaptor protein that plays a key role in transmitting signals from the receptor, to 
downstream effector proteins. IRS phosphorylates and activates two signalling pathways: 
the mitogen-activated protein kinase (MAPK) pathway and the phosphatidylinositol-3-
kinase (PI3K) pathway. The MAPK pathway (Zhang and Liu, 2002) regulates mitogenic 
processes such as cell growth and gene expression, and the PI3K pathway regulates 
metabolic processes, as well as acting as a negative regulator of the forkhead box protein 
O (FOXO) transcription factor. After glucose enters the cell, PI3K binds the glucose 
transporter, GLUT4, and sends it back to the cell membrane (Chang et al., 2004). The 
isolated glucose is then sent to the mitochondria where it is either used to make ATP, or is 
stored as glycogen if in excess. PI3K also regulates protein and lipid synthesis. 
Downstream of PI3K lies the serine/threonine-specific protein kinase AKT (also known as 
protein kinase B, PKB), which plays a key role in glucose uptake and protein, lipid and 
glycogen synthesis (Manning and Cantley, 2007).  
 
AKT phosphorylates FOXO, thereby preventing it from entering the nucleus and inducing 
FOXO-dependent transcription of genes involved in apoptosis, cell cycle arrest, cell 
differentiation and protection against reactive oxygen species (ROS). It is instead 
sequestered in the cytoplasm, where it is ubiquitinated and degraded (Greer and Brunet, 
2008). AKT is also a major link between the IIS and the TOR pathway (McCormick et al., 
2011). It suppresses the inhibitory action of the TSC1/TSC2 complex on the TOR activator 
Rheb, which in turn activates the TOR pathway.  
  
 41 
 
 
Figure 1.6. The mammalian insulin/IGF signalling (IIS) signalling pathway. 
Insulin binds to the insulin receptor, which in turn phosphorylates and binds, the insulin 
receptor substrate (IRS). IRS phosphorylates and activates the mitogen-activated protein kinase 
(MAPK) pathway, which regulates cell growth and gene expression. IRS also phosphorylates 
the phosphatidylinositol-3-kinase (PI3K) pathway, which involves activation of AKT/PKB to 
regulate metabolic processes such as protein, lipid and glycogen synthesis, and inhibition of the 
forkhead box protein O (FOXO) transcription factor, which suppresses processes such as 
apoptosis, cell cycle progression, stress resistance and DNA repair. AKT also links IIS to the 
target of rapamycin (TOR) pathway, suppressing the inhibitory action of the TSC1/TSC2 
complex on the TOR activator Rheb, thereby activating the TOR pathway.  
 
 
The role of IIS in lifespan regulation  
IIS was the first pathway to be shown to influence ageing in a model organism; in C. 
elegans; mutation of age-1, a gene encoding the C. elegans homologue of PI3K, was found 
to extend lifespan (Friedman and Johnson, 1988; Morris et al., 1996). Additional 
components of the IIS pathway have also been shown to play a role in the regulation of 
ageing in C. elegans; a loss-of-function mutation in daf-2, encoding an insulin/IGF 
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receptor homologue, resulted in more than doubling of lifespan (Kenyon et al., 1993). 
Lifespan extension with both daf-2 and age-1 downregulation requires daf-16, the C. 
elegans homologue of FOXO (Kenyon et al., 1993). In accord with this finding, 
upregulating dfoxo in Drosophila adipose tissue extends lifespan (Giannakou et al., 2004; 
Hwangbo et al., 2004; Tatar et al., 2003), and flies with overexpression of a dominant 
negative form of the insulin receptor also have increased lifespans - as with C. elegans, 
this lifespan extension is dependent on dFOXO (Slack et al., 2011). The requirement of 
FOXO for lifespan extension upon reduction of IIS suggests that FOXO plays an important 
role in mediating the physiological changes that give rise to extended lifespan. Indeed, the 
multitude of roles attributed to FOXO fall in line with a change in physiology conducive to 
a lower rate of cellular senescence (Eijkelenboom and Burgering, 2013). For example, 
FOXO upregulation results in increased resistance to oxidative stress, induction of 
apoptosis, cell cycle inhibition and a metabolic shift towards catabolism.  
 
Mouse models suggest a conserved effect of IIS downregulation to extend life; fat-specific 
insulin receptor knockout mice (FIRKO) (Bluher et al., 2001), mice with heterozygous 
knockout of the insulin growth factor-1 receptor (IGF-1R) (Holzenberger et al., 2003; 
Kappeler et al., 2008), mice lacking the insulin receptor substrate 1 (IRS-1) (Selman et al., 
2008, 2011) and mice with brain-specific IRS-2 knockdown (Taguchi et al., 2007) all had 
enhanced longevity. Moreover, hepatic deletion of Foxo1 in mice rescued the adverse 
effects of IIS disruption by Akt1 and Akt2 deletion in the liver, such as glucose intolerance 
and insulin resistance (Lu et al., 2012). In humans, variants of the FoxO3A locus are 
correlated with longevity (Willcox et al., 2008a).  
 
Animal models of IIS pathway component mutants have been used to study the role of IIS 
in mediating the lifespan-extending effects of DR. In Drosophila, loss of chico, deletion of 
dilps 2, 3 and 5, overexpression of a dominant negative form of the insulin receptor, and 
fat-body-specific dfoxo overexpression – all of which downregulate IIS – resulted in a shift 
of the lifespan peak to a higher food concentration than that for wildtype flies (Clancy et 
al., 2002; Giannakou et al., 2008; Grandison et al., 2009; Grönke et al., 2010). These 
observations suggest that reduced IIS induces a DR-like state at higher food-intake levels, 
implicating IIS as having a role in regulating, at least partially, the effects of dietary 
restriction on lifespan. Moreover, flies that have defects in an odorant receptor have 
extended lifespans, and exposure of flies to odorants partially reverses the lifespan-
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extending effects of DR (Libert et al., 2007). In humans, the sight or smell of food alone 
can induce increased insulin secretion, known as cephalic phase insulin secretion (Johnson 
and Wildman, 1983; Sjostrom et al., 1980). 
 
Reduced IIS is proposed to extend lifespan by the upregulation of processes that shift 
physiology towards somatic maintenance, which originally evolved as an adaptive survival 
response to harsh environmental conditions, but also has the potential to counter somatic 
assaults that cause cellular senescence and accelerates ageing. When starved, C. elegans 
L1-L2 larvae have the ability to enter a form of diapause called dauer, during which 
development is arrested and various physiological changes ensue; their old cuticle is 
replaced with a more impermeable cuticle and they cease to feed as a result of pharyngeal 
muscle inactivity. Interestingly, they retain a normal level of motility for the first 2-3 
weeks, and develop heightened resistance to harsh chemicals. The dauer state can last up 
to 70 days, and upon refeeding larvae exit the dauer stage and resume their moulting cycle 
to adulthood (Klass, 1977). Extraordinarily, there is no effect of the duration of the dauer 
state on post-dauer lifespan or fecundity. Because the dauer stage is induced by nutrient 
starvation, it has been hypothesised that the molecular mechanisms that give rise to the 
increased longevity of dauer worms may also underlie lifespan extension under DR. 
Several genes control dauer formation in C. elegans, collectively called daf (dauer 
formation) genes, and some of these encode constituents of the IIS pathway; namely, daf-2 
and daf-16 (Kenyon et al., 1993; Kimura et al., 1997). It is therefore possible that IIS may 
be responsible, to some degree, for the lifespan difference between dauer and non-dauer C. 
elegans. Adult Drosophila also exhibit a form of diapause, affecting reproductive 
development; in response to low temperatures coupled with a short-day photoperiod, 
female flies have reduced vitellogenesis (Saunders et al., 1989). Ovarian diapause in flies 
is subject to control by the juvenile hormone (JH). There is evidence for cross-talk 
between JH signalling and IIS in Drosophila (Jindra et al., 2013); long-lived insulin 
receptor mutants have reduced JH levels. Lifespan was shortened and vitellogenesis was 
restored upon administration of methoprene, a JH analogue (Tatar et al., 2001). It was 
subsequently discovered that the insulin receptor is required for JH biosynthesis 
(Belgacem and Martin, 2007). Drosophila and C. elegans diapause seem to have some 
parallels at the molecular level, which could prove to be interesting for ageing studies 
given that the involvement of IIS is implicated in both processes, as well as in the 
regulation of ageing - there may be some overlap between these pathways.  
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1.3.3. The general amino acid control (GAAC) pathway 
 
The GAAC pathway primarily responds to environmental nutrient starvation, and 
functions to decrease protein synthesis and to enhance cellular amino acid uptake and 
biosynthesis (Dever and Hinnebusch, 2005). The activity of the GAAC pathway changes 
in response to direct nutritional cues, and affects pathways involved in metabolism and 
biosynthesis. It is thus considered to be a nutrient sensing/signalling pathway. The GAAC 
pathway was originally described in the yeast Saccharomyces cerevisiae (Roussou et al., 
1988; Wek et al., 1989; Hao et al., 2005) and has since been found to be conserved in 
mammals (Sood et al., 2000). The central component of the GAAC pathway is GCN2, a 
serine/threonine-protein kinase. Upon stimulation by uncharged transfer ribonucleic acids 
(tRNA), which accumulate during amino acid starvation, GCN2 phosphorylates and 
inactivates the eukaryotic initiation factor 2α (eIF2α), resulting in a decrease in global 
protein synthesis, whilst the translation of selected mRNAs coding for proteins involved in 
amino acid biosynthesis is allowed. In this way, resources are efficiently conserved, and 
cell division is limited under inadequate growth conditions (Figure 1.7). 
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Figure 1.7. The GAAC pathway in yeast. 
Amino acid starvation results in the accumulation of uncharged tRNAs, which bind to the 
HisRS-related domain of GCN2, resulting in the activation of the adjacent kinase domain. The 
kinase in turn phosphorylates the α-subunit of eIF2 on serine 51, thereby inhibiting eIF2β and 
blocking protein synthesis. The inhibition of eIF2β leads to the translation of GCN4 mRNA, 
which encodes a transcription factor that activates transcription of genes encoding enzymes 
involved in amino acid biosynthesis.  
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GAAC mechanism 
GCN2 is a multi-domain protein; at its carboxy-terminus, juxtaposed to a kinase catalytic 
moiety, is a region that is homologous to the entire sequence of histidyl-tRNA synthetase 
(HisRS) (Wek et al., 1989). Based on the fact that aminoacyl-tRNA synthetases bind 
uncharged tRNAs, it was proposed that the HisRS-like region of GCN2 also binds 
uncharged tRNAs. In yeast, mutations in the HisRS-related domain of GCN2 prevented the 
binding of uncharged tRNAs and impaired eIF2α phosphorylation (Wek et al., 1995). 
GCN2-phosphorylation of the α subunit of eIF2 in vivo was stimulated by histidine 
starvation (Dever et al., 1992), and mutating the gene encoding histidyl tRNA synthetase 
was found to induce GCN2 phosphorylation of eIF2α  even in the presence of histidine 
(Wek et al., 1995). In fact, GCN2 binds several de-aminoacylated tRNAs with similar 
affinities and limitation of several amino acids can activate the GAAC (Dong et al., 2000; 
Wek et al., 1995), making it a sensor of general amino acid limitation. The binding of 
uncharged tRNAs to the HisRS-like region of GCN2 induces a conformational change of 
the entire GCN2 protein that disrupts its autoinhibitive conformation (Dey et al., 2007). As 
a result, the kinase domain is activated, permitting the inhibitive phosphorylation of eIF2α 
at Serine 51 (Dever et al., 1992). Other domains of the GCN2 protein include a ribosome 
binding and dimerisation domain at the C-terminal domain (Qiu et al., 1998), a RWD 
domain at the N-terminus proposed to have a function in protein interaction (Kubota et al., 
2000; Sattlegger et al., 2004) and a pseudo kinase domain  ψK  with unknown function. 
 
During translation initiation, an eIF2-GTP-tRNA
met
 ternary complex is formed which 
facilitates the binding of the initiator tRNA
met
 to the 40S ribosomal subunit to form the 43S 
preinitiation complex. tRNA
met
 is transferred to the ribosome in a GTP-dependant manner 
and binds to the mRNA at the capped 5’end  forming the 4 S complex (Hershey, 1991). 
This complex scans the mRNA until it encounters an AUG start codon. Upon completion 
of initiation, The GTP is hydrolysed to GDP and the GDP-bound eIF2 is released from the 
ribosome. eIF2 must exchange its GDP for GTP  via its β-subunit which acts as a guanine 
nucleotide exchange factor, before it can engage in another round of translation initiation. 
Phosphorylation of eIF2α impairs this rate of GDP-GTP exchange, thereby inhibiting 
protein synthesis. In mammals  eIF2α is a target for four kinases – GCN2, PERK, PKR 
and HRI – all of which are regulated by different stimuli; amino acid deprivation, ER 
stress, double stranded RNA and heme deficiency, respectively (Figure 1.8).  
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Figure 1.8. Regulation of eIF2α phosphorylation in mammals.  
Phosphorylation of eIF2α is regulated by four known protein kinases that are activated by  
different cellular stresses. Phosphorylation of eIF2α inhibits mRNA translation and in turn 
protein synthesis. Figure adapted from Kimball and Jefferson, 2004. 
 
Another downstream effect of GCN2 phosphorylation of eIF2α in yeast is the activation of 
the transcription factor GCN4. Paradoxical to the effect of eIF2α phosphorylation to 
inhibit general protein synthesis, translation of GCN4 activates more than 30 genes 
involved in amino acid biosynthesis and also genes encoding aminoacyl-tRNA synthetases 
(Dever, 2002). GCN4 translation is controlled by four short upstream open reading frames 
(uORFs) in the leader strand of GCN4 mRNA, which is dependent on both GCN2 and 
eIF2α phosphorylation. When amino acids are in abundance, the uORFs restrict the 
migration of ribosomes downstream towards the start codon of GCN4, thereby hindering 
the initiation of translation of GCN4 mRNA. When amino acid supply is limited and the 
levels of ternary complex are low, the inhibitory effect of the uORFs is overcome and the 
scanning ribosome is able to bypass the start codons of the uORFs in the GCN4 mRNA 
and initiate translation at the authentic start codon of GCN4 (Abastado and Miller, 1991; 
Dever et al., 1992). ATF4 encodes a transcription factor and is the mammalian counterpart 
of yeast GCN4. It, too, is subject to control by uORFs in its mRNA leader, and is activated 
by eIF2α phosphorylation. ATF4 upregulates amino acid biosynthesis and activates genes 
encoding amino acid transporters, such as SLC7A5, so as to enhance cellular amino acid 
uptake (Chen et al., 2014; Harding et al., 2000, 2003; Malmberg and Adams, 2008; Vattem 
and Wek, 2004). As well as inducing GCN4/ATF4 translation, amino acid starvation also 
increases the levels of their mRNA.
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The role of GAAC in amino acid sensing 
The GAAC regulatory response allows cells to conserve their amino acid stores and 
channel resources into amino acid biosynthesis during environmental nutrient limitation. 
Not only is this regulation in effect at the cellular level, but there is evidence that this 
signal transduction pathway culminates in some behavioural manifestation that induces an 
aversive response to an imbalanced food source, thereby encouraging the organism to seek 
an alternative nutritional environment that can better support reproduction and survival. 
Yeast, which have the ability to synthesise all 20 amino acids, regulate metabolism 
through the GAAC, producing an adaptive response to nutrient availability (Niederberger 
et al., 1981). In contrast, mammals can only produce a subset of amino acids, and must 
obtain the others from the environment. It has been known that animals have an innate 
ability to detect dietary imbalances; rats, for example, are able to sense and decisively 
reject diets deficient in a single amino acid, without the influence of peripheral sensations 
such as taste (Markison et al., 1999) and smell (Leung et al., 1972), implicating some 
internal mechanism that senses a dietary imbalance and communicates it to neural 
regulators of feeding behaviour. Because GCN2 activity depends on the level of uncharged 
tRNAs, which is a direct indicator of amino acid supply, it was hypothesised that GCN2 
may play a role in coupling environmental nutrient availability to foraging behaviour. 
Indeed, increased eIF2α phosphorylation on serine 51 was reported in the brains of rats fed 
a diet lacking threonine (Gietzen et al., 2004), and GCN2 null mice are unable to avoid 
imbalanced diets when starved of essential amino acids. It is possible that ATF4 links 
eIF2α phosphorylation to downstream effectors that control feeding behaviour (further 
discussed in chapter 5).  
 
Interaction between GAAC and other nutrient sensing pathways 
There is some indication of coordination between the GAAC pathway and other NSPs, 
such as TOR and IIS. The TOR inhibitor, rapamycin, has been shown to increase eIF2α 
phosphorylation in a GCN2 dependent manner; a phosphorylation site at Serine 577, 
located between the kinase and the pseudo kinase domains of GCN2, is the target of an 
unknown kinase (Garcia-Barrio et al., 2002). Rapamycin inhibits phosphorylation at this 
Ser-577 site (Cherkasova and Hinnebusch, 2003), thereby activating GCN2 and increasing 
its affinity for uncharged tRNAs in vitro (Kubota et al., 2003). Mutation of this site 
resulted in the constitutive activation of GCN2, even in low levels of uncharged tRNAs, 
but also impaired the effect of rapamycin to increase eIF2α phosphorylation. Thus, 
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downregulation of the TOR pathway, which primarily reduces protein synthesis through 
decreased S6K1 phosphorylation and increased 4E-BP1 phosphorylation, also decreases 
protein synthesis through activation of GCN2. Moreover, TOR-mediated upregulation of 
autophagy during starvation was found to be dependent on ATF4  B’chir et al.  2013; 
Rouschop et al., 2010; Rzymski et al., 2010); knockdown of ATF4 inhibited TOR 
activation upon nutrient stimulation and resulted in high levels of autophagy (Chen et al., 
2014). 
 
The GAAC pathway also interacts with IIS; in mice, leucine deprivation increased insulin 
sensitivity by activating hepatic GCN2, as well as decreasing TOR pathway activity (Xiao 
et al., 2011). In fact, this study placed GCN2 as an upstream negative regulator of TOR, 
since GCN2 null mice did not have reduced TOR signalling in the liver under leucine- or 
valine-deprived conditions. Moreover, insulin increases the levels of ATF4 mRNA and its 
translation, implicating a role for ATF4 in regulating the anabolic effects of insulin 
(Malmberg and Adams, 2008). Accordingly, ATF4 null mice exhibit growth defects 
(Hettmann et al., 2000; Masuoka and Townes, 2002; Tanaka et al., 1998). Interestingly, 
insulin-mediated regulation of ATF4 is not dependent on GCN2, and in fact the effects of 
the GAAC and the IIS pathways are additive, suggesting that these pathways work in 
parallel to regulate amino acid synthesis. It has been suggested that signalling pathways 
that offer an additional level of hormonal control over metabolism, like IIS, evolved after 
the ancient cell-autonomous regulatory systems, like GAAC, of unicellular organisms 
(Malmberg and Adams, 2008). 
 
There is abundant evidence implicating TOR and IIS as having vital roles in modulating 
lifespan in a wide range of organisms, and the interaction of GAAC with these pathways 
makes it an additional interesting molecular target for studies into longevity. Coupled with 
the fact that it has an important role as an amino acid sensor, it is likely that the GAAC 
pathway is an important member of the nutrient sensing web that coordinates the 
regulation of metabolic processes that influence lifespan. 
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1.4. Aims and Objectives 
 
As previously discussed, the effect of DR to extend lifespan has been robustly observed for 
a range of taxonomically diverse animal species. While there is a broad literature 
describing the contributions of the NSPs to regulating the DR effect on longevity, these 
data can sometimes be contradictory or inconclusive. Moreover, although it is clear that 
the NSPs interact with each other within a complex feedback web, the exact nature of the 
links between the NSPs have yet to be defined, highlighting the complexity of the biology 
underlying the relationship between nutrition and lifespan. Little is also known about the 
specific effector nutrients that govern the DR effect on longevity, although recent work has 
begun to highlight the importance of dietary amino acid balance, i.e. the relative 
abundance of individual amino acids to each other, as well as collectively in relation to 
other dietary components. 
 
The main aim of this PhD project was to elucidate the molecular mechanisms by which 
DR confers benefits to lifespan and health. Because the nature of nutrient sensing is so 
broad and complex, we sought an approach that could narrow the focus of this task. 
Previously, DR has been experimentally studied as a dilution of the entire diet, and only 
relatively recently is the importance of more specific dietary effects being realised. We 
reasoned that identifying the specific dietary components responsible for the DR effect on 
lifespan could concentrate our investigations on more targeted experimental questions. We 
were particularly interested in the influence of the amino acids, since they have been 
previously shown to be an important dietary regulator of the lifespan response to DR 
(Grandison et al., 2009), therefore we have limited our dietary manipulations mainly to the 
protein/amino acid component of the diet. We have focused on the evolutionarily 
conserved TOR, IIS and GAAC nutrient signalling pathways, since these are most likely to 
bear relevance to human health and have previously been implicated in regulating health 
and longevity in laboratory animals. The hypothesis that I have been investigating is that 
nutrient signalling pathways mediate the lifespan-extending effects of DR in flies. Here, 
we define DR by the balance of amino acids in the diet relative to other dietary 
components. This specific definition of DR has not yet been experimentally explored in 
flies. 
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To address this hypothesis, I used Drosophila as an established biogerontological model to 
study ageing in a living system. We used genetic interventions to alter the activity of 
nutrient sensing pathways in order to assess the effect on fly physiology and to correlate 
this to any roles that these nutrient sensing pathways might have in mediating the effect of 
DR on longevity. We also took advantage of a recently-developed holidic fly food medium 
(Piper et al., 2014), where the amount of each dietary component is defined and can be 
manipulated at the single nutrient level, to assess the effect of specific nutrients on fly 
physiology and lifespan. Combining these two interventions (genetic and dietary) enabled 
us to identify interaction effects between diet and nutrient sensing, and to characterise the 
nature of this interaction. 
 
In parallel to lifespan measurements, we characterised various aspects of fly physiology in 
response to our interventions in order to draw correlations between lifespan and 
physiology. This allowed us to build a physiological profile characteristic of long-lived 
versus short-lived flies, and ask whether these profiles were shared by all long-lived 
models. Any differences could provide clues as to the unique causation factors by which a 
particular intervention conferred changes to fly lifespan. Using this unique approach, we 
identified fly triacylglycerides (TAG) levels as being correlated with TOR-mediated DR 
dependent lifespan change, where elevated levels of TAG was associated with a longer 
lifespan under DR. 
 
We also investigated the hypothesis that animals regulate their food intake in order to 
achieve a diet optimal for various aspects of physiology, including reproduction and 
somatic maintenance. This hypothesis was based on published work from rodent models 
that show that mice and rats readily reject a nutrient-deficient diet, particularly amino acid 
deficiency, with evidence that this is at least partly regulated by the GAAC pathway. We 
further characterised this phenomenon in flies, establishing support for a role of the GAAC 
pathway in regulating the feeding response to single amino acid deficiency, where 
methionine deficiency was highlighted as being of particular interest in this context. We 
also characterised the effect of genetically downregulating the GAAC pathway in flies in 
the context of lifespan and physiology, of which little was known, and which revealed 
further support for a role for GAAC in mediating dietary methionine signals. 
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Chapter 2 - Materials and methods 
 
 
2.1. Drosophila melanogaster stocks 
 
2.1.1. Wildtype flies 
Our wildtype stock, Dahomey, was originally collected in 1970 from Dahomey (now 
known as the Republic of Benin, Africa) and since maintained outbred in large population 
cages (measuring 45x25x25cm) in the Partridge laboratory at 25
o
C in a non-humidified 
controlled-temperature room, on a 12h light:12h dark cycle. Each population cage contains 
8 bottles of 1x SY food (see chapter 2.2), 3 of the oldest of which were replaced with 3 
bottles of fresh food routinely every 7 days. These conditions allow for inter-generational 
breeding and the life expectancy of flies remain similar to that of newly caught wild flies 
(Sgro et al., 2001). 
 
The w
Dah 
stock, used as the controls in this project, were generated by backcrossing the 
mutated white gene (w-) from stock w
1118
 into a wildtype Dahomey background 
(Broughton et al., 2010), thereby producing a stock of Dahomey with white eyes. This 
white-eyed Dahomey background made it possible to follow transgenes marked with a w+ 
(wildtype) eye colour. The w
Dah
 stocks were maintained in the same way as described for 
Dahomey above.  
 
 
2.1.2. Transgenic flies 
In Drosophila research, genetic markers are commonly used as a means of detecting the 
presence of a transgene in a fly stock and its inheritance through subsequent generations. 
The gene of interest is closely linked to a marker gene, whose expression is identifiable in 
transformed flies. The transgenes used in this project were linked with a mini-white marker 
gene (a truncated version of the white gene). One copy of the transgene partially rescues 
the white mutation, producing yellow/orange eyes. A more complete rescue with two 
copies produces darker, red eyes in a white mutant background. This allows homozygous 
flies to be distinguished from heterozygous flies for a particular insertion (Klemenz et al., 
1987).  
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dilp2-3,5 null flies: 
Insulin/IGF signalling mutant flies lacking three of the Drosophila insulin-like peptides 
(DILPs), dilp2, dilp3 and dilp5 were generated as described in Grönke et al. (2010).  
 
UAS-dRagA transgenic flies: 
Mutant flies with alterations of the upstream dTOR signalling component, dRagA, were 
generated as described in Kim et al. (2008), and supplied by T. P. Neufeld. The three 
different dRagA transgenic flies used in this work are described in Table 2.1.  
 
Table 2.1 Description of the molecular effects of the UAS-dRagA transgenes used: UAS-
dRagA
Q61L
, UAS-dRagA
T16N
, UAS-dRagA
WT 
(Kim et al., 2008). 
Transgene name Activity Description 
UAS-dRagA
Q61L
(CA) 
Constitutively 
active 
dRagA gene contains a mutation on the 
catalytic residue Q61, which is responsible for 
stabilising the transition state for GTP 
hydrolysis. The result is that GTP hydrolysis 
is prevented and the gene is locked in an 
active state. 
UAS-dRagA
T16N
(DN) 
Dominant 
negative 
dRagA gene product is altered so that it binds 
less GTP, rendering it inactive. It decreases 
normal dRag function by competing with the 
corresponding wildtype protein for 
dimerization with wildtype dRagC. 
UAS-dRagA
WT
 Wildtype Overexpression of the wildtype dRagA gene. 
 
 
dGCN2 null flies: 
In collaboration with Sebastian Grӧnke (Max Planck Institute for the Biology of Ageing, 
Cologne), we generated a Drosophila mutant with a knockout of the entire open reading 
frame (ORF) of the dGCN2 gene by homologous recombination (unpublished; Figure 
2.1a). The absence of the dGCN2 gene in the mutants was confirmed by PCR analysis 
targeting distinct regions of the ORF (Figure 2.1b), and western blot analysis probing for 
reduced phosphorylation of the dGCN2 target, eIf2α  Figure 2.1c).  
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Figure 2.1. Generation of dGCN2 null flies.  
(a) The dGCN2 transgene used in our experiments is a knockout of the entire open reading 
frame (ORF) of the dGCN2 gene, including the protein interaction domain (RWD), the pseudo 
kinase  ѱK  domain  the protein kinase  PK  domain  the Histidyl tRNA synthetase  HisRS  
tRNA binding domain, and the ribosome binding (RB)/dimerization domain (DD) (functions of 
these gene regions are reviewed in chapter 1.3.3). Flies were generated by homologous 
recombination  unpublished  supplied by S. Grӧnke . (b) PCR analysis of genomic DNA, 
confirming the absence of the dGCN2 ORF in dGCN2 null flies; lanes i-iv represent 
amplification target regions of dGCN2, representing the RWD, the PK, the HisRS, and a region 
outside of the ORF, respectively. (c) eIF2α phosphorylation is reduced in dGCN2 null flies 
compared to wildtype flies  as measured by western blot analysis. α-Actin levels were 
measured as a loading control. Samples were prepared from fly head extracts. 
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2.2. Drosophila food media 
 
2.2.1. Standard laboratory food 
Our standard laboratory media is composed mainly of sugar, yeast and agar and henceforth 
referred to as 1x SY. This medium was used for the development and maintenance of all 
flies used, unless otherwise stated. 1 litre of 1x SY was prepared according to the recipe 
and method in Bass et al. (2007): 15g agar (Sigma-Aldrich, Dorset, UK) in 700ml distilled 
water was heated to boiling while stirring, at which point 100g of autolysed yeast powder 
(1x; MP Biomedicals, Solon, OH, USA) and 50g of sugar (Tate & Lyle, London, UK) was 
added. This was thoroughly mixed using a whisk until returning to the boil, at which point 
the heat was turned off and an additional 170ml water was added. This mixture was left to 
cool to below 60
o
C before adding 30ml of nipagin (100g/l in 95% ethanol (EtOH) (nipagin 
supplied by Chemlink Specialities, Manchester, UK; EtOH supplied by Sigma-Aldrich, 
Dorset, UK) and 3ml propionic acid (Sigma-Aldrich, Dorset, UK), which act as anti-
microbial agents. The mixture was then dispensed into glass vials or bottles, in volumes of 
~4ml or 60ml respectively, and allowed to set at room temperature overnight before being 
stored at 4
o
C. Details of any variations of this basic recipe will be given within the relevant 
chapters. 
 
 
2.2.2. Specialised SY food 
 
Essential amino acid supplementation (chapter 3): 
In order to test the effects of supplementing a DR diet with only the 10 essential amino 
acids, we used the standard 1x SY food (representing the DR diet) and added to it a 
solution containing the 10 essential amino acids. The essential amino acids were dissolved 
in MiliQ water to the concentrations shown in Table 2.2. Per litre of 1x SY food, 50ml of 
this stock solution was added upon cooling of the SY food to below 60
o
C. As a control 
measure, MiliQ water was added to the food conditions within the same experiment that 
did not contain essential amino acids. 
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Table 2.2. Stock solution of essential amino acids for yeast food media. 
Essential amino acids are dissolved in MiliQ water, pH adjusted to 4.5 with hydrochloric acid, 
and sterilised by passing through a 45µm filter. 
Essential amino acid Stock concentration (mol/L) 
L-arginine 0.041 
L-histidine 0.027 
L-isoleucine 0.052 
L-leucine 0.073 
L-lysine 0.057 
L-methionine 0.013 
L-phenylalanine 0.031 
L-threonine 0.062 
L-tryptophan 0.009 
L-valine 0.068 
 
 
Rapamycin (chapters 3 & 4): 
We used rapamycin as a pharmacological inhibitor of the target of rapamycin (TOR) 
pathway to test its effects on essential amino acid-supplemented flies. Rapamycin (LC 
Laboratories, MA, USA) was dissolved in ethanol and added to essential amino acid-
supplemented 1x SY food (see above), to a final concentration of 200µM. As a control 
measure, ethanol alone was added to the food conditions within the same experiment that 
did not contain rapamycin.  
 
RU486 (chapter 3): 
The drug Mifepristone (RU486; Sigma-Aldrich, Dorset, UK), required for dRagA 
transgene expression, was dissolved in ethanol and added to 1x SY food at a final 
concentration of 200µM. As a control measure, ethanol alone was added to the food 
conditions within the same experiment that did not contain RU486.  
 
Yeast:sugar manipulations (chapter 4): 
We altered the amounts of yeast against sugar in the SY medium to test the relative effects 
of altering the protein and carbohydrate supply to the flies. Table 2.3 shows how the 
amounts of yeast, sugar and water in the standard SY medium (1x yeast : 1x sugar) were 
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altered to produce food conditions varying in yeast and sugar concentration combinations. 
The ‘final volume’ value refers to the volume of water added at the final stage of the SY 
preparation. 
 
Table 2.3. Amounts of yeast, sugar and water required for SY food conditions varying in 
yeast:sugar concentration combinations.  
  Yeast concentration 
  
0.5x 1x 2x 
 
S
u
g
a
r 
co
n
ce
n
tr
a
ti
o
n
 
1x 
Yeast: 50g/l Yeast: 100g/l Yeast: 200g/l 
 
Sugar: 50g/l Sugar: 50g/l Sugar: 50g/l 
 
Final water: 196ml/l Final water: 170ml/l Final water: 118ml/l 
 
2x 
Yeast: 50g/l Yeast: 100g/l Yeast: 200g/l 
 
Sugar: 100g/l Sugar: 100g/l Sugar: 100g/l 
 
Final water: 170ml/l Final water: 144ml/l Final water: 92ml/l 
 
4x 
Yeast: 50g/l Yeast: 100g/l Yeast: 200g/l 
 
Sugar: 200g/l Sugar: 200g/l Sugar: 200g/l 
 
Final water: 118ml/l Final water: 92ml/l Final water: 40ml/l 
 
 
2.2.3. Defined medium 
 
In order to test physiological and behavioural responses of flies to foods lacking specific 
components of the diet, we used a chemically defined and tractable medium (Piper et al., 
2014). This holidic medium is agar-based and contains all the necessary dietary 
components required to support Drosophila development, growth and fecundity. The 
medium allowed us to readily omit specific dietary components of interest. Below we 
describe the preparation of 1 litre of the standard nutritionally-complete medium; details of 
any variations of this basic recipe will be given within the relevant chapters. 
 
In the first step of the preparation of the medium, the nutritional components shown in 
Table 2.4 were combined and made up to 799.4ml with MiliQ water. All components were 
supplied by Sigma-Aldrich (Dorset, UK), except for acetic acid, which was supplied by 
Fisher Scientific (Surrey, UK). Stock solutions were sterilised by passing through a 45µm 
filter. 
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Table 2.4. Components of defined medium combined and made up to 799.4ml MiliQ 
water before the autoclaving step of the preparation (to make 1L medium).  
Nutritional component Preparation of stock 
Quantity in 799.4ml 
MiliQ water 
Order of 
addition 
Sucrose  17.12g 1 
Acetate buffer 
Acetic acid (30g/L), 
KH2PO4 (30g/L) and 
NaHCO3 (10g/L) in 
MiliQ water 
100ml 1 
Tyrosine  0.84g 1 
CaCl2 250g/Lin MiliQ water 1ml 2 
MgSO4 250g/Lin MiliQ water 1ml 2 
CuSO4 2.5g/Lin MiliQ water 1ml 2 
FeSO4 25g/L in MiliQ water 1ml 2 
MnCl2 1g/L in MiliQ water 1ml 2 
ZnSO4 25g/L in MiliQ water 1ml 2 
Agar  20g 3 
Cholesterol 0.02g/ml in EtOH 15ml 3 
 
 
This solution was autoclaved for 15 minutes at 121
o
C, and then allowed to cool to below 
60
o
C. Table 2.5, Table 2.6 and Table 2.7 show the nutritional components added to the 
defined medium after autoclaving, and after the solution was allowed to cool to 60
 o
C. The 
solution was continuously mixed using a magnetic stirrer. All components were supplied 
by Sigma-Aldrich (Dorset, UK), except for nipagin which was supplied by Chemlink 
Specialities (Manchester, UK). 
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Table 2.5. Components of defined medium added after the autoclaving step of the 
preparation, once the solution cooled to below 60OC (to make 1L medium). 
Nutritional 
component 
Preparation of stock 
Quantity of 
stock in 1L 
defined medium 
Order of 
addition 
Nucleic acid/lipid 
solution 
choline chloride (6.25 g/L), 
myo-inositol (0.63g/L), 
inosine (8.13g/L), 
and uridine (7.5g/L) 
8ml 1 
Vitamin solution 
thiamine (0.1g/L), 
riboflavin (0.05g/L), 
nicotinic acid (0.6g/L), 
Ca pantothenate (0.775g/L), 
pyridoxine (0.125g/L) 
and biotin (0.01g/L) 
14ml 1 
Folic acid 0.5g/L in MiliQ water 1ml 1 
Non-essential  
amino acids 
(See Table 2.6) 60.51ml 1 
L-glutamate 0.1g/ml in MiliQ 18.21ml 1 
L-cysteine 0.05g/ml in MiliQ 5.28ml 1 
Essential amino acids (See Table 2.7) 90.77ml 1 
Nipagin 100g/L in 95% EtOH 15ml 2 
Propionic acid  6ml 2 
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Table 2.6. Stock solution of non-essential amino acids for defined medium. 
Essential amino acids are dissolved in MiliQ water, pH adjusted to 4.5 with hydrochloric acid, 
and sterilised by passing through a 45µm filter. 
Non-essential amino acid Stock concentration (mol/L) 
L-alanine 0.295 
L-aspartic acid 0.080 
L-glycine 0.238 
L-asparagine 0.105 
L-proline 0.081 
L-glutamine 0.206 
L-serine 0.119 
 
 
Table 2.7. Stock solution of essential amino acids for defined medium. 
Essential amino acids are dissolved in MiliQ water, pH adjusted to 4.5 with hydrochloric acid, 
and sterilised by passing through a 45µm filter. 
Essential amino acid Stock concentration (mol/L) 
L-phenylalanine 0.061 
L-histidine 0.048 
L-isoleucine 0.097 
L-lysine 0.105 
L-leucine 0.138 
L-methionine 0.025 
L-arginine 0.074 
L-threonine 0.120 
L-valine 0.126 
L-tryptophan 0.024 
 
The solution was thoroughly mixed and then dispensed into sterilised (autoclaved) glass 
vials  at a volume of 3ml per vial. After being left to set at room temperature for ~2 hours, 
the vials were inverted into plastic trays lined with paper towels, covered with plastic film 
and stored at 4
o
C. 
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2.2.4. Specialised defined media 
 
Amino acid dilution (chapter 5): 
In order to test the effect on feeding of differing amounts of dietary amino acids, we used 
the defined medium which allowed us to specifically alter the concentration of amino acids 
in the diet, while keeping the amounts of other nutrients constant. Food conditions as 
outlined above except that the volumes of the amino acid stock solutions were diluted in 
MiliQ as shown in Table 2.8. In the case of food containing 1.5x amino acids, the stated 
amount of water (75.65ml per 1L food) was subtracted from the volume of water in the 
defined medium mixture before autoclaving.  
 
Table 2.8. Volumes of essential and non-essential amino acid solutions required for 
defined media food conditions with varied concentrations of amino acids. 
Target concentration 
of amino acids 
Quantity of essential 
amino acid stock 
solution (ml) 
Quantity of non-
essential amino 
acid stock 
solution (ml) 
MiliQ 
water (ml) 
0 0 0 +151.28 
0.25x 22.69 15.13 +113.46 
0.5x 45.39 30.26 +75.63 
1x 90.77 60.51 0 
1.5x 136.16 90.77 -75.65 
 
 
Amino acid group omissions (chapter 5): 
We wanted to distinguish the effects on feeding of the essential amino acids from the non-
essential amino acids from the total amino acid effect. Where a food condition required the 
absence of all the essential or all of the non-essential amino acids, or both, the stock 
solutions corresponding to those groups (i.e. Table 2.7 and Table 2.6, respectively) were 
omitted from the medium and replaced with the equivalent volume of MiliQ water to 
control for the reduced overall volume of the medium. 
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Single essential amino acid omissions (chapters 4 & 5): 
The defined medium allowed us to investigate the effect on feeding, lifespan and fecundity 
of removing a single amino acid from the food source. Where a food condition required 
the absence of a particular amino acid, that amino acid was omitted from the stock solution 
in Table 2.7, and the defined medium recipe outlined above was followed through as 
normal. 
 
 
2.2.5. Grape medium 
 
An agar-based grape juice medium was used as a surface for egg collection, required for 
the 'egg squirt' protocol (see chapter 2.3.3). Grape plates were made by melting 25g agar in 
500ml distilled water and heating to boiling, at which point 300ml red grape juice 
 Young’s  West  idlands, UK) was added, thoroughly mixed, and brought to the boil 
again. The medium was removed from the heat and combined with a further 50ml of 
distilled water and, once left to cool to below 60
o
C, 21ml nipagin (100g/l in 95% EtOH) 
was added and stirred in. The mixture was poured into plastic petri dishes, filling to half-
way, and left to set at room temperature before being stored at 4
o
C. 
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2.3. General methods and animal husbandry 
 
2.3.1. Backcrossing 
The backcrossing of transgenic lines is necessary to ensure that any differences seen 
between mutant and control flies are due to the expression of the transgene alone, and not 
some non-specific effect of hybrid genetic backgrounds (Partridge and Gems, 2002). For 
this reason, before the transgenic stocks could be used for experimentation, they were 
backcrossed into the w
Dah
 background. In the first cross, transgenic males were mated with 
w
Dah 
females to ensure that the maternally-inherited cytoplasmic and mitochondrial 
components in the offspring originates from w
Dah
. From this first generation, transgenic 
(identified as having red or orange eye pigmentation) virgin females were collected and 
crossed to w
Dah 
males. From the resultant offspring of this cross, transgenic virgin females 
were collected and again crossed to w
Dah
 males. This type of cross was repeated a further 5 
times with each generation of transgenic offspring, totalling 6 backcrossing rounds overall. 
This is expected to result in 98.44% of the genetic material being of w
Dah
 origin. 
 
 
2.3.2. Virgin collection 
It was necessary to collect unmated female flies in order to control crosses to desired male 
flies for setting up backcrosses and for generating experimental flies. Female Drosophila 
do not respond to copulating males during the first 12 hours after eclosion at 25
o
C 
(Manning, 1967). Therefore, any emerged female flies collected within 4 hours after 
clearing the bottles of adults were virgins. Female virgins, which can be identified by their 
pale complexion, shrivelled wings, and meconium (a ventrally-visible dark spot on their 
abdomens, a remnant of their last larval meal), were collected under light CO2 anaesthesia 
using a fine paint brush. Collected female virgins were maintained in glass vials containing 
1x SY, with 20 females per vial, for at least 2 days as a check to ensure that no larvae 
appeared, thereby confirming that the females were unmated. Only flies from larvae-free 
vials were used for subsequent crosses. In the case of larvae being detected, all the females 
in that vial were discarded. 
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2.3.3. Lifespan set up and maintenance 
 
When studying traits relating to fitness, such as lifespan and fecundity, it is important that 
all variables are controlled. A number of measures were taken to ensure that flies used for 
experimentation could be comparable between experimental groups.  
 
To control for the effects of parental age on longevity (Priest et al., 2002), it was necessary 
to ensure that the parents of the experimental flies were all the same age at egg laying and 
that they were reared under the same conditions as each other. 
 
To standardise the effect of larval density on longevity (Priest et al., 2002; Zwaan et al., 
1991), an 'egg squirt' protocol (Clancy and Kennington, 2001) was undertaken. Flies were 
allowed to lay eggs for ~18 hours on grape medium plates, with a small amount of live 
yeast paste to increase egg laying and encourage remating. The eggs were collected from 
the plate by washing with phosphate buffered saline (PBS; Sigma-Aldrich, Dorset, UK) 
solution (in MiliQ water) and the wash collected into a screw cap ‘Falcon’ tube. The eggs 
were left to settle to the bottom of the tube and the excess supernatant was discarded. 
Using a 100µl Gilson pipette and a wide-bore tip, ~18µl of the PBS egg suspension was 
taken up and dispensed into 200ml glass bottles containing 70ml 1x SY food. This equates 
to a standard density of ~300 eggs per bottle (Bass et al., 2007).  
 
After 9.5 days of development at 25
o
C, the flies emerged from their pupae and were 
transferred from each of the egg-squirted bottles into bottles containing fresh 1x SY 
medium. Experimental adults were collected within a 12 hour period after eclosion. In 
order to standardise their mating status, flies were left to mate for 48 hours after eclosion. 
The experimental female flies were then separated from males under CO2 anaesthesia 
using a fine paintbrush. These females were randomly allocated to the experimental food 
treatments and housed in glass vials containing the food (or disposable plastic vials when 
the food contained a drug, e.g. RU486 or rapamycin), at a density of 15 flies per vial. For 
each genotype or experimental food condition 10 vials were set up, totalling 150 flies per 
genotype per condition as standard. In order to minimise the effects of any variation 
between experimental flies emerging from different bottles, flies were sorted between vials 
such that those from the same bottle were distributed between all the experimental food 
treatment conditions. 
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All experiments were conducted at 25
o
C on a 12h light:12h dark cycle, at a constant 
humidity of 65%. Flies were transferred to fresh vials of food three times a week 
throughout life. If left unchanged, the fly larvae hatching from the eggs laid by the 
experimental flies would burrow into the food, making it moist and posing a risk to the 
adult flies of becoming stuck in it. Regularly changing the food ensured that any case of 
death could not be attributed to reduced food quality. The number of dead flies found 
during each transfer was recorded, beginning from the first transfer. Accidental deaths and 
escapees were distinguished from deaths and were censored from the experiment. 
 
From this data, a survivorship graph could be generated, making it possible to compare 
survival curves over time between different genotypes and/or food conditions. 
Survivorship is a measure of the probability of an individual surviving until a given age, 
and these data were expressed as proportion survival for each experimental group. 
Statistical analysis of the differences between the survivorship of experimental groups was 
done using the log-rank test, which uses a cumulative chi-squared statistic to assign a P-
value to assess null hypotheses. Differences were regarded as significant if the P-value was 
less than 0.05. Cox Proportional Hazards (CoxPH) regression analysis was used to assess 
any interaction between the effects of one or more variables on survival. 
 
 
2.3.4. Fecundity assay 
Fecundity was measured as the mean number of eggs laid per female fly over a 24-hour 
period. ~18 hours after transferring experimental flies to fresh vials, the number of eggs 
laid in these new vials was counted. The counting was done by eye under a light 
microscope. Differences in egg-laying between conditions were analysed using a non-
parametric Wilcoxon rank-sum test and a significance threshold of P<0.05 was used. 
 
 
 2.3.5. Feeding behaviour 
Feeding was measured by observing fly proboscis extension onto a food source, where the 
probability of proboscis extension is used as a quantitative measure. Proboscis extension 
has been shown to be correlated with electrophysiological responses of the gustatory 
receptor neurons (Dahanukar et al., 2007) and is also correlated with calcium responses to 
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tastants (Marella et al., 2006), and is therefore a reliable measure of feeding. Experimental 
flies were generated in the same way as described for the lifespan assay set-up. Flies were 
allowed to mate for 24 hours after eclosion and were then transferred to the treatment food 
types for 4 days before the assay. Flies were sorted as 5 per vial under CO2 anaesthesia at 
least 12 hours prior to the assay, to ensure sufficient recovery from the anaesthesia. Also 
during this time, flies were assembled onto observation racks and left to acclimatise 
overnight (25
o
C, non-humidified). To avoid observer bias, assay vials with different food 
types and/or genotypes were anonymised to the experimenter and were assembled in 
random order. Observations were started one hour after lights on, at 11am, and this time 
was kept consistent for all feeding experiments in order to account for any effects of 
circadian rhythm. During the assay, the number of flies feeding in each vial was recorded 
in turn. Flies were scored as feeding if their proboscis was extended onto the surface of the 
food, and each vial was observed for no longer than 2 seconds. Each vial was scored in 
succession and the entire set counted repeatedly every ~5 minutes over a 90-minute period. 
The identity of each vial was decoded at the end of the observation period. 
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2.4. Stress Experiments 
 
We measured flies’ ability to resist a range of different stresses. The responses to 
various stressors can inform about the physiological status of the flies under a 
particular intervention, and in turn provide clues as to the underlying molecular 
changes. 
 
Experimental flies were reared and housed as described for the lifespan experiment. Mated 
female flies were kept on the experimental food types for 7 days before being transferred 
to the stress conditions. 
 
2.4.1. Heat shock 
A minimum of 12 hours before the start of the assay, flies under CO2 anaesthesia were 
individually assigned to a vial containing the experimental food that they had previously 
been maintained on. This was done to ensure sufficient recovery from the anaesthesia 
before the start of the assay. At the time of the assay the flies were transferred to dry empty 
2ml glass vials, which were then plugged with cotton wool. The vials were placed in a rack 
and arranged so that each different pre-treatment condition was represented evenly. The 
rack was then placed inside a glass water bath in which the water temperature was 
maintained at 39
o
C. The racks were positioned such that the vials were submerged in the 
water up until the point before the rim, so that the cotton wool plug was kept dry. The 
assay vials were observed by eye from the outside, and the time taken for each fly to fall 
onto their backs and stop twitching (knockout) was recorded. 
 
 
2.4.2. Starvation 
Measuring the resistance of flies to starvation can provide an insight into the status and 
availability of internal energy stores. Flies were transferred to vials containing plain agar 
medium (1.5%). Flies were assayed at a density of 10 flies per vial, and deaths were scored 
3 times per day.  
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2.4.3. DDT stress  
DDT (dichlorodiphenyltrichloroethane) induces the unfolded protein response by blocking 
the formation of disulfide bonds necessary for the folding of many endoplasmic reticulum 
(ER) proteins, and is therefore used in the laboratory to induce ER stress. Flies were 
transferred to vials with 1x SY medium food containing 0.03% DDT, made by adding a 
2% stock solution of DDT (Supelco Sigma-Aldrich, Dorset, UK) dissolved in EtOH. Flies 
were assayed at a density of 10 flies per vial, and deaths were scored 3 times per day.  
 
 
2.4.4. Paraquat stress 
Paraquat  N N′-dimethyl-4 4′-bipyridinium dichloride) induces oxidative stress in flies – it 
is an electron acceptor in redox and radical reactions, thereby producing destructive 
reactive oxygen species. Flies were transferred to vials with 1x SY medium food 
containing 20mM paraquat, made by addition of a 1M stock of methyl viologen dichloride 
hydrate (paraquat; Sigma-Aldrich, Dorset, UK) dissolved in MiliQ water. Flies were 
assayed at a density of 10 flies per vial, and deaths were scored 3 times per day.  
 
 
2.4.5. H2O2 stress 
Hydrogen peroxide (H2O2) induces an acute oxidative stress in flies. Flies were transferred 
to vials with 1.5% agar medium food containing 5% H2O2 made from a 30% stock solution 
of H2O2 (Sigma-Aldrich, Dorset, UK) and 50g/l sucrose. Flies were assayed at a density of 
10 flies per vial, and deaths were scored 3 times per day.  
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2.4.6. Immune stress  
 
Adult septic injury 
Erwinia carotovora (strain Ecc15) were grown overnight in Luria Bertani (LB) at 29°C 
and adjusted to optical density (O.D.) 200. Adult flies were anesthetised with CO2 and 
were pricked in the lateral thoracic epithelium, just under the wing attachment, with a thin 
metal needle (0.5 mm diameter) dipped in the bacterial culture. Control flies were pricked 
with a sterilised needle dipped in LB to ensure that the pricking itself had no effect. The 
flies were separated from the needle with a brush and transferred to a clean vial containing 
1x SY food medium at density of 10 flies per vial. Deaths were scored daily. 
 
Larval oral infection 
Erwinia carotovora (strain Ecc15) were grown overnight in Luria Bertani (LB) at 29°C 
and adjusted to O.D. 200. 200μl of a bacterial pellet was then combined with 400μl of 
crushed banana in a 2ml microfuge tube. 20 third-instar larvae were transferred into this 
tube at the same time and shaken to mix thoroughly. The tube was then plugged with a 
small amount of cotton wool to allow an air supply and to prevent larvae from wandering 
out. After 30 minutes at room temperature the entire contents of the tube was emptied into 
a clean vial containing 1x SY food and maintained at 25°C through pupation. Eclosing 
flies were emptied from the vial to avoid eggs being laid by the emerging adults. After 10 
days the rate of eclosion of adults was scored by observing the pupae within the vials 
under a light microscope. Uneclosed pupae were distinguished from empty pupal cases as 
having a darker colour, due to the dark-coloured fly still inside the semi-transparent pupal 
case.  
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2.5. Metabolic measurements 
 
Experimental flies were reared and housed as described for the lifespan experiment. Mated 
female flies were kept on the experimental food types for 7 days before being frozen in 
liquid nitrogen and stored at -80 until use.  
 
2.5.1. Triacylglycerides 
To quantify triacylglyceride levels, a colorimetric assay kit (Thermo Fisher Scientific, 
Surrey, UK) was used; 6 replicas of 5 female flies were homogenised in 0.05% Tween 20 
(Sigma-Aldrich, Dorset, UK) in MiliQ water and incubated for 5 minutes at 70ºC. The 
samples were then centrifuged for 5 minutes at 7000 rpm. The supernatant was transferred 
to fresh Eppendorfs and centrifuged for 10 minutes at maximum speed. For each sample, 
175µl was transferred to a fresh Eppendorf. 10µl of each sample was dispensed into a well 
on a 96-well plate, with each sample in triplicate. To each well, 200µl of Thermo Infinity 
Triglycerides solution was added and the plate was left to incubate at 37ºC for 10 minutes, 
after which time absorbance in each well was measured at 574nm. The lipid standards, 
made from a stock solution of triglycerides (20mg/ml; Fisher Scientific, Surrey, UK), were 
treated in the same way as the samples. The samples were prepared as 7 serial dilutions in 
0.05% Tween 20, and these were 2, 1, 0.5, 0.25, 0.125, 0.0625 and 0 µg/µl triglyceride. 
 
 
2.5.2. Glycogen 
10 replicas of 2 female flies were homogenised in 200µl saturated Na2SO4 (Fisher 
Scientific, Surrey, UK) solution and centrifuged for 1 minute at 10,000 rpm. 80µl of each 
sample was transferred to new Eppendorf tubes and 800µl chloroform:methanol (1:1) 
solution was added (chloroform supplied by Sigma-Aldrich, Dorset, UK; methanol 
supplied by VWR International, West Sussex, UK). Samples were then centrifuged for 5 
minutes at 10,000 rpm. The supernatant (containing lipids) was removed and the 
remaining pellets, containing precipitated glycogen, were resuspended in 1ml anthrone 
solution (anthrone in 50ml 70% H2SO4; anthrone supplied by Sigma-Aldrich, Dorset, UK; 
H2SO4 supplied by Fisher Scientific, Surrey, UK). These were then incubated at 90
o
C for 
20 minutes, mixing several times to ensure dissolving of the pellet, and a colour developed 
during this time. The glycogen standards were treated in the same way as the samples and 
were prepared as 5 serial dilutions in water from a stock (2.5µg/µl MiliQ; glycogen 
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supplied by Sigma-Aldrich, Dorset, UK). These were 1.25µg/µl, 0.63µg/µl, 0.31µg/µl, 
1.16µg/µl, 0.08µg/µl and 0µg/µl. 200µl of each sample and standard was dispensed into a 
96 well plate, and the absorbance was measured at 620nm.  
 
 
2.5.3. Trehalose 
10 replicas of 2 female flies were homogenised in 50µl 0.2M Na2CO3 (Sigma-Aldrich, 
Dorset, UK) and incubated for 2 hours at 95ºC. The pH was adjusted to 5.2 by addition of 
30µl 1M acetic acid (Sigma-Aldrich, Dorset, UK) and 120µl 0.2M Na-acetate pH 5.2 
(Sigma-Aldrich, Dorset, UK). 0.05 U of trehalase (Sigma-Aldrich, Dorset, UK) was then 
added to each sample and left to incubate overnight at 37
o
C. A 0-10mM dilution series of 
D-(+)-Trehalose (Sigma-Aldrich, Dorset, UK) in 0.2M Na2CO3 was made, and these 
standards were treated in the same way as the samples. Liberated glucose was measured 
using the Glucose Affinity kit (Thermo Fisher Scientific, Surrey, UK); 1µl of each sample 
and standard was dispensed into a 96-well plate, and to each well 150µl of Affinity reagent 
was added. The plate was left to incubate for 5 minutes at 37ºC, and the absorbance was 
measured at 340nm. 
 
 
 
2.6. Western blot analysis 
 
Protein extracts for western blot analysis were made from whole flies, sampled after 7 days 
of food treatment, using a TCA-based extraction protocol. 10µl of each sample was loaded 
into a 12% SDS-PAGE gel and blots were probed with anti-phospho-Thr398-S6K 
antibody (#9209, Cell Signaling Technologies, MA, USA), and total-S6K (re-made using a 
peptide sequence previously used to generate the total S6K antibody in Stewart et al., 1996 
[54]). Both antibodies were used at a dilution of 1:12000 and normalised by probing with 
an anti-actin antibody at a dilution of 1:5000. Secondary antibodies conjugated to HRP 
(AbCam, Cambridge, UK) were used at a dilution of 1:5000, and the signals were detected 
by chemiluminescence. 
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Chapter 3 - The role of nutrient sensing/signalling pathways in 
mediating lifespan extension with dietary restriction by essential 
amino acid alteration 
 
The contents of this chapter have been published in part in Emran et al., (2014) - see appendix. 
 
 
3.1. Introduction  
 
Dietary restriction (DR) to extend lifespan has been shown to be effective in a wide range 
of evolutionarily diverse organisms, and is considered one of the most robust 
environmental interventions to extend lifespan (Mair and Dillin, 2008). The molecular 
mechanisms underlying the physiological changes elicited by DR have yet to be 
elucidated. However, experimental data point towards nutrient sensing/signalling pathways 
(NSP) as playing an important role. Two such NSPs are the target of rapamycin (TOR) 
pathway (Hansen et al., 2007; Kaeberlein et al., 2005; Kapahi et al., 2004), and the 
insulin/insulin-like growth factor signalling (IIS) pathway (Apfeld and Kenyon, 1999; 
Clancy et al., 2002). There is evidence for significant roles played by both of these 
pathways in determining organismal lifespan in response to DR.   
 
DR-mediated lifespan extension has often been correlated with a reduction in TOR 
complex 1 (TORC1) signalling, and genetically downregulating TORC1 has been shown 
to modify lifespan in a similar way to DR, suggesting that the effect of DR on lifespan 
may be mechanistically regulated by the TORC1 pathway. In the roundworm, 
Caenorhabditis elegans, eat-2 mutants with pharyngeal pumping defects, which 
presumably eat less food, have been used as a DR model (Lakowski and Hekimi, 1998). 
Indeed, these mutants have been shown to have increased lifespans relative to control 
worms, and TOR pathway inhibition in these worms did not further extend lifespan (Chen 
et al., 2009), suggesting overlapping mechanisms for the action of DR and decreased 
TORC1 activity to increase lifespan. In the yeast Saccharomyces cerevisiae, glucose 
restriction, as a means of implementing DR, extended replicative lifespan, but did not 
further extend the lifespan of long-lived tor1Δ mutants (Kaeberlein et al., 2005). In the 
fruit fly Drosophila melanogaster, inhibition of the TORC1 pathway by overexpression of 
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dTsc1/2 (orthologue of mammalian Tsc1/2), which are negative upstream regulators of 
TORC1, significantly increased lifespan (Kapahi et al., 2004). These mutant flies were not 
further long-lived under DR, as implemented by dietary yeast extract dilution. Also in 
Drosophila, rapamycin treatment, as a means of inhibiting dTORC1 activity, extended 
lifespan beyond that which could be achieved by DR, and lessened the reduction in 
lifespan with full feeding, suggesting that the mechanism by which DR extends lifespan 
and that by which decreased TORC1 pathway activity extends lifespan is overlapping 
(Bjedov et al., 2010). However, studies using Drosophila null mutants of d4E-BP, 
encoding a translational repressor downstream of dTORC1, have yielded conflicting 
results; one study showed a diminished extension of lifespan for these mutant flies upon 
DR (Zid et al., 2009), such that it suggests an overlapping mechanism between TORC1 
downregulation and DR, whereas another study reported a robust DR effect on lifespan for 
these flies (Partridge et al., 2011), suggesting that dTORC1, or at least the d4E-BP effector 
branch of dTORC1, is not required for DR-dependent lifespan extension. Moreover, a 
recent study using mice suggests that DR- and rapamycin-induced lifespan extension may 
result from distinct mechanisms, given the observed differences in endocrine and 
metabolic profiles from mice subjected to either of these two interventions (Miller et al., 
2013). 
 
The IIS network is commonly associated with biological ageing. Mutations in components 
of the IIS pathway have extended lifespan in a host of model organisms (reviewed in 
chapter 1.3.2). Because the IIS pathway signals nutrients, and IIS is reduced by fasting 
(Ikeya et al., 2002), considerable effort has been made to assess the role of IIS in 
modulating the longevity responses to DR. In C. elegans, eat-2 mutants that were also null 
for daf-2, the gene encoding the worm orthologue of the insulin-like growth factor 1 (IGF-
1) receptor, not only retained their longevity, but were even longer lived than eat-2 single 
mutants (Lakowski and Hekimi, 1998), suggesting that the lifespan benefits of the mutants 
were additive and independent. Likewise, an increase in lifespan with DR was achieved by 
both wildtype worms and those with a null mutation in daf-16, the gene encoding the 
worm orthologue of the FOXO family of transcription factors (Houthoofd et al., 2003). In 
Drosophila, dfoxo null flies exhibit the same lifespan response to DR as control flies (Min 
et al., 2008), as do chico heterozygote flies (Clancy et al., 2002). Moreover, flies with 
individual knockouts of the insulin-like ligands dilp2, dilp3 or dilp5, which are normally 
expressed in brain median neurosecretory cells of the adult fly brain (Broughton et al., 
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2005), exhibit a normal response to DR (Grönke et al., 2010). However, when mutations 
for dilps 2, 3 and 5 were combined in the same fly the DR response was attenuated, 
suggesting that these three dilps are required for the lifespan response to DR, and that in 
the case of the single mutants there is compensation from the remaining functional dilps. 
While IIS does not seem to be solely accountable for DR, the published data suggest a 
partially common mechanism for IIS- and DR-mediated lifespan extension. 
 
In this chapter, we explore the potential roles of the TOR and IIS pathways in mediating 
the Drosophila lifespan response to DR. We use genetic fly models and a pharmacological 
approach to characterise the nature of the association between NSPs and DR, specifically 
asking whether it is the signalling of nutrients through the particular nutrient sensing 
pathway or the end fate of those nutrients that affects lifespan. 
 
Work from the Partridge lab has shown that adjustments to the dietary amino acid balance 
can mimic the benefits to lifespan by DR in Drosophila (Grandison et al., 2009). 
Supplementing a DR diet with the 10 essential amino acids (EAAs) phenocopies the 
lifespan and fecundity effects of a diet corresponding to high yeast levels, referred to 
herein as full feeding (FF), indicating that the beneficial effects of DR are a consequence 
of improved amino acid balance. Experimentally, the addition of the EAAs to DR 
(DR+EAA) offers a sharper instrument with which to dissect the potential causes of 
lifespan change in response to nutritional balance than the FF condition, which is achieved 
by increasing the concentration of dietary yeast.  
 
Long-lived animal models often have an enhanced ability to resist environmental stresses, 
assumed to reflect a general increase in their health, which may also reveal something 
about the underlying cause of lifespan extension through increased somatic maintenance. 
Long-lived IIS mutant flies have been shown to be resistant to acute toxic doses of DDT, 
paraquat and hydrogen peroxide (H2O2) (Broughton et al., 2005; Grönke et al., 2010; Slack 
et al., 2010). Long-lived DR C. elegans have increased resistance to heat stress (Chen et 
al., 2009; Kaeberlein et al., 2006). We therefore characterised the physiological and 
metabolic parameters that define DR and EAA-supplemented flies, with the aim of 
identifying physiological changes that explain the cause of the lifespan response to DR. 
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3.2. Results 
 
3.2.1. The effect of EAAs on lifespan and egg-laying 
 
Wildtype w
Dah
 flies maintained under DR are longer-lived and lay fewer eggs than FF flies 
exposed to a high proportion of yeast in their diet (DR vs FF: lifespan, P<0.001, log-rank 
test; egg-laying, P<0.001, Wilcoxon rank-sum test; Figure 3.1a-c). Moreover, we found 
that the effect of full feeding to shorten lifespan and increase egg-laying can be mimicked 
by the addition of the 10 EAAs to DR food (FF vs DR+EAA: lifespan, P=0.94, log-rank 
test; egg-laying, P=0.19, Wilcoxon rank-sum test; Figure 3.1a-c), supporting the notion 
that the decrease in lifespan with FF can be accounted for by EAAs alone (Grandison et 
al., 2009). 
 
 
 
 
 
Figure 3.1. The effect of EAAs to mediate lifespan and fecundity changes under DR.  
(a) Summary of Drosophila median lifespans under dietary restriction (DR), full feeding (FF) 
and essential amino acid supplementation of DR (DR+EAA) (DR vs FF, P<0.001; FF vs 
DR+EAA, P=0.94; DR vs DR+EAA, P<0.01; n=13 biological replicates; Wilcoxon rank-sum 
test) (b) A representative lifespan experiment: adding EAAs to DR food shortened lifespan 
(P<0.001) to that of FF flies (P=0.194); n=150 per treatment, compared using the log-rank test. 
(c) Adding EAAs to DR food increased egg-laying (P<0.001) to that of FF flies (P<0.936); 
n=15; compared using the Wilcoxon rank-sum test. Egg counts were made at 8 days of food 
treatment. 
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3.2.2. The role of NSPs in mediating the effect of EAAs on lifespan 
 
We used genetically modified fly models for the IIS and TORC1 signalling pathways to 
test the effect of EAA supplementation on lifespan upon down-regulation of these 
longevity-associated NSPs. Dietary amino acids have been shown to stimulate the IIS 
pathway in Drosophila (Britton et al., 2002; Zhang et al., 2000). dilp2-3,5 null flies, which 
are long lived due to deletion of three of the eight Drosophila insulin-like peptide 
genes, dilp2, dilp3 and dilp5 (Grönke et al., 2010), showed no difference from wildtype 
flies in their responses to the addition of EAA to DR food, indicating that although these 
mutations to IIS are sufficient to extend life, they are not required for the lifespan 
extension by DR (Figure 3.2; work done by Jelle Zandveld).  
 
 
 
 
Figure 3.2. The lifespan response of dilp2-3,5 null flies to DR. 
dilp2-3,5 mutants were longer-lived under dietary restriction (DR) than when maintained on a 
fully fed (FF) diet or a DR diet supplemented with the essential amino acids (EAA) (DR vs FF, 
P<0.001; DR vs DR+EAA, P=0.007; n=100 per treatment; log-rank test). Median lifespans 
(days): DR=88, FF=85.5, DR+EAA=83. Data supplied by Jelle Zandveld. 
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To test whether the dTOR pathway might have a role in mediating the DR response to 
lifespan, we used flies with mutations of dRagA, an upstream amino acid sensing 
component of the dTORC1 pathway (Figure 1.4, Figure 1.5). We tested the effect of both 
the upregulation and downregulation of dRagA using three transgenic fly lines 
overexpressing a different modified version of dRagA: constitutively active (CA), UAS-
dRagA
Q61L
; dominant negative (DN), UAS-dRagA
T16N
, and; wildtype, UAS-dRagA
WT
  
(Kim et al., 2008). 
 
One of the main outputs of TORC1 activity is growth (Loewith and Hall, 2004). Using the 
apterous-GAL4 (ap-GAL4) driver, which drives the expression of a UAS transgene to the 
dorsal cell layer of the fly wing (Calleja et al., 1996), we were able to assess dTOR activity 
by observing the growth effects of our transgenic UAS-dRagA fly lines, such that 
increased cell growth should result in a downward curvature of the wing, or upward wing 
curvature in the case of decreased cell growth. When driven with ap-GAL4, flies 
expressing UAS-dRagA
Q61L
(CA) had downward curvature of the wings (Figure 3.3a) 
indicating increased growth of the dorsal layer of cells of the wing compared with those of 
the ventral layer. This is compatible with overgrowth caused by UAS-dRagA
Q61L
(CA) 
increasing dTORC1 activity. Flies expressing UAS-dRagA
T16N
(DN) had an upward 
curvature of the wings (Figure 3.3b), suggesting reduced growth of the dorsal layer of cells 
of the wing, consistent with downregulation of TORC1 activity. Flies expressing UAS-
dRagA
WT
 showed no curvature of the wing (Figure 3.3c), indicating no effect of this 
transgene on growth. This could be because although dRagA may still be overexpressed, 
an activator (amino acids) is required for the growth phenotype to manifest. In this case, 
perhaps the level of amino acids in the DR food medium was insufficient to cause 
increased cell growth. 
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Figure 3.3. The effect on lifespan and fecundity in response to DR of genetically altered 
dRagA activity. 
Wing curvature phenotypes of the offspring of the ap-GAL4 wing-specific driver fly line 
crossed with (a) UAS-dRagA
Q61L
(CA), showing wing tips curved down due to overgrowth of 
dorsal cells, (b) UAS-dRagA
T16N
(DN), showing wing tips curved up due to reduced growth of 
dorsal cells, and (c) UAS-dRagA
WT
, showing no curvature of wing tips, indicating no effect of 
this transgene on growth. These data are consistent with the anticipated effect of each 
transgene to alter dTOR activity. (d) The effect on lifespan of UAS-dRagA
Q61L
(CA) transgene 
expression under dietary restricted (DR). Flies expressing the transgene upon administration of 
RU486 showed a significant decrease in lifespan (median lifespan 59.5 days), compared to 
controls (median lifespan 73.5 days, P<0.001, log-rank test, n=40 per condition). (e) The effect 
on lifespan of UAS-dRagA
T16N
(DN) transgene expression under DR and with EAA 
supplementation. Both control flies and transgene-expressing flies showed a DR effect on 
lifespan, where the lifespan of DR flies was significantly greater than DR+EAA flies (DR vs 
DR+EAA, P<0.001; DR+RU486 vs DR+EAA+RU486, P=0.02; log-rank test; n=60 per 
condition). The magnitude of the difference in the DR effect was greater in the control flies 
(24%) than in the transgene-induced flies (3%). Median lifespans (days): DR=78.1, 
DR+RU486=73.5, DR+EAA=59.5, DR+EAA+RU486=71.1. (f) The effect on lifespan of 
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UAS-dRagA
WT
 transgene expression under DR and with EAA supplementation. Both control 
flies and transgene-expressing flies showed a DR effect on lifespan, where DR flies were 
significantly longer lived than DR+EAA flies (DR vs DR+EAA, P<0.001; DR+RU486 vs 
DR+EAA+RU486, P<0.001; log-rank test, n=80 per condition). The magnitude of the 
difference in the DR effect was greater in the control flies (44%) than in the transgene-induced 
flies (14%). Median lifespans (days): DR=73.5, DR+RU486=66.6, DR+EAA=40.9, 
DR+EAA+RU486 =57. (g) Index of cumulative lifetime egg-laying for control and transgene-
induced UAS-dRagA
Q61L
(CA) flies maintained under DR conditions. There was no significant 
difference in fecundity between the two groups (P=0.92, Wilcoxon rank-sum test, n=40 per 
condition). (h) Effect on egg-laying of UAS-dRagA
T16N
(DN) transgene expression under DR 
and with EAA supplementation. There was an effect on egg-laying of food, no effect on egg-
laying of RU486, and no interaction effect between food and RU486 on egg-laying (food, 
P=0.02; RU486, P=0.63; interaction, P=0.31; linear model; n=60 per condition). (i) Effect on 
egg-laying of UAS-dRagA
WT
 transgene expression under DR and with EAA supplementation. 
There was an effect on egg-laying of food, no effect on egg-laying of RU486, and an 
interaction effect between food and RU486 on egg-laying (food, P=0.004; RU486, P=0.08; 
interaction, P=0.03; linear model; n=80 per condition). For figures g-i, error bars represent the 
s.e.m. 
 
 
3.2.3. The effect of RagA transgene expression on lifespan 
 
We tested the effect of increased dRagA activity on lifespan by driving the UAS-
dRagA
Q61L
(CA) transgene in the gut and fat-body using the RU486-inducible S1106 gene-
switch UAS/GAL4 driver (Roman et al., 2001) (see Figure 1.3 for an overview of the gene 
switch system). These tissues are particularly interesting since the gut is where nutrients 
are initially broken down and absorbed into the body, and the fat-body functions as a site 
of nutrient storage and has been shown to have a humoral role in sensing nutrient 
availability and controlling the growth of peripheral tissues accordingly (Arrese and 
Soulages, 2011; Colombani et al., 2003). Moreover, it was shown that targeted 
downregulation of dTOR in the fat-body was sufficient to extend lifespan (Kapahi et al., 
2004). We refer to the flies that were not given the RU486 inducer as the controls.  
 
Expression of UAS-dRagA
Q61L
(CA) resulted in a significant reduction in lifespan 
compared to controls (P<0.001; log-rank test; Figure 3.3d), consistent with dRagA 
increasing dTORC1 activity, which in turn is expected to decrease lifespan. 
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To test if amino acid signal transduction through RagA is responsible for the effect of 
EAAs to shorten lifespan, we measured the effect on survival of each of the UAS-dRagA 
transgenes when they were exposed to a DR diet supplemented with the 10 EAAs. For 
both UAS-dRagA
T16N
(DN) and UAS-dRagA
WT
 control flies (i.e. not expressing the 
transgene) DR flies were longer-lived than flies fed DR+EAA (UAS-dRagA
T16N
(DN), 
P<0.001; UAS-dRagA
WT
, P<0.001; log-rank test; Figure 3.3e-f).  
 
Having verified a DR effect for each set of control flies, we tested whether inducing 
expression of each of the UAS-dRagA transgenes could modify this response. As with the 
controls, both induced UAS-dRagA
T16N
(DN) and induced UAS-dRagA
WT
 transgenic flies 
were still longer-lived under DR than when supplemented with EAAs (UAS-
dRagA
T16N
(DN), P=0.02; UAS-dRagA
WT
, P<0.001; log-rank test; Figure 3.3e-f). However, 
expression of both UAS-dRagA
T16N
(DN) and UAS-dRagA
WT
 significantly changed the way 
the flies responded to EAA supplementation (P-value for interaction between diet and 
transgene expression P<0.001; Cox Proportional Hazards); the magnitude of the decrease 
in lifespan with EAA addition was reduced upon transgene expression for both UAS-
dRagA
T16N
(DN) (24% decrease to 3% decrease in median lifespan upon transgene 
expression) and UAS-dRagA
WT
 flies (44% decrease to 14% decrease in median lifespan 
upon transgene expression). In summary, modification of dRagA did not change the 
direction of the lifespan response of flies to EAA-supplementation relative to DR (i.e. 
EAA-supplemented flies were still shorter lived than DR flies), but the magnitude of this 
difference was reduced upon transgene induction, and more drastically so for UAS-
dRagA
T16N
(DN) flies than for UAS-dRagA
WT
 flies. 
 
We could not conduct these comparisons for the UAS-dRagA
Q61L
(CA) transgenic flies 
because we did not have enough parental flies to generate a sufficient number of progeny 
for experimentation.  
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3.2.4. The effect of RagA transgene expression on egg-laying 
 
To further characterise the effects of EAA signalling through dTORC1 we measured the 
changes in fecundity upon altering nutrient availability and nutrient signalling from dRagA 
to dTORC1. We compared the egg-laying of control and UAS-dRagA transgene-
expressing flies under DR. For all three UAS-dRagA transgenic lines tested, no significant 
difference was detected between transgene induced and control flies (UAS-
dRagA
Q61L
(CA), P=0.92; UAS-dRagA
T16N
(DN), P=0.65; UAS-dRagA
WT
, P=0.62; 
Wilcoxon rank-sum test; Figure 3.3g-i).  
 
For UAS-dRagA
T16N
(DN) flies we found that there was an effect of EAA supplementation 
on egg-laying, such that flies maintained on DR+EAA food laid more eggs than those 
maintained on DR food (P=0.02; linear model; Figure 3.3h). There was no effect on egg-
laying upon administration of RU486 (i.e. transgene induction) for these flies (P=0.63; 
P=0.09; linear model). We found no effect of an interaction between food and RU486 on 
egg-laying (P=0.31; linear model), indicating that the induction of UAS-dRagA
T16N
(DN) 
transgene does not affect the egg-laying response to food.  
 
UAS-dRagA
WT
 flies had higher egg-laying when supplemented with EAAs (P<0.01; linear 
model; Figure 3.3i). There was no effect on egg-laying upon transgene induction for these 
flies (UAS-dRagA
WT
, P=0.09; linear model). When we tested for an interaction effect 
between transgene expression and food treatment on egg-laying we found that induction of 
the UAS-dRagA
WT
 transgene resulted in a significantly more pronounced increase in egg-
laying upon EAA supplementation compared to control flies (P=0.03; linear model), 
suggesting that the modification of egg-laying in response to EAAs depends on the 
induction of the UAS-dRagA
WT
 transgene.  
 
Again, egg-laying data for these conditions could not be obtained for UAS-dRagA
Q61L
(CA) 
flies due to inadequate numbers. 
 
In summary, genetically altering dTOR activity resulted in a reduction of the magnitude of 
lifespan difference between long-lived DR and shorter-lived EAA-supplemented flies and 
increased the difference in egg-laying between these food conditions. 
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3.2.5. Rapamycin in mediating the effect of EAAs on lifespan and egg-laying 
 
We used the TOR inhibitor drug rapamycin as an alternative method for genetically 
downregulating dTOR to test whether it could rescue the effect of EAAs on lifespan. 
Consistent with the effect of dRagA downregulation in dRagA
T16N
(DN) flies, addition of 
rapamycin extended the lifespan of wildtype flies maintained on EAA-supplemented DR 
food (P<0.001, log-rank test) such that their lifespan was not shorter than those subjected 
to DR (Figure 3.4a). Rapamycin treatment also prevented the increase in egg-laying seen 
for EAA addition to DR food. In fact egg-laying was effectively blocked by rapamycin 
treatment (P<0.001, Wilcoxon rank-sum test; Figure 3.4b). We confirmed that 
phosphorylation of the TORC1 target S6K was reduced by the addition of rapamycin as 
anticipated (Figure 3.4c). Together with data from the UAS-dRagA
T16N
(DN) flies, these 
data are consistent with dTOR signalling playing a role in mediating the change in lifespan 
upon DR. 
 
 
 
Figure 3.4. The effect of rapamycin treatment on EAA-supplemented flies. 
(a) Rapamycin treatment extended the lifespan of DR+EAA flies beyond that of DR 
(DR+EAA vs DR+EAA+Rapamycin, P<0.001; DR vs DR+EAA, P=0.01; n=150 per 
treatment; log-rank test). (b) Rapamycin treatment decreased the fecundity of DR+EAA flies 
(P<0.001, n=10 flies per condition, error bars represent the s.e.m., Wilcoxon rank-sum test). 
Egg counts were made at 8 days of food treatment. (c) Levels of phospho-T398-S6K were 
measured from whole-ﬂy protein extracts. Treatment with rapamycin for 7 days decreased 
phospho-T398-S6K levels in DR+EAA+Rapamycin flies relative to DR+EAA flies. 
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3.2.6. Identifying phenotypic correlates of lifespan change under DR 
 
Because long-lived animal models often have an associated increase in the ability to resist 
environmental stresses, we tested whether long-lived DR flies are protected from the 
harmful effects of a number of stress-inducing compounds. These phenotypic correlates of 
lifespan change under our dietary conditions may help us to understand the causal 
mechanisms of increased lifespan under DR. Phenotypes that are consistently correlated 
with longevity may indicate something about the mechanisms that regulate longevity, just 
as those phenotypes that differ between long-lived fly models can be said to be uncoupled 
from longevity. These data can help us to address the overarching aim to understand the 
mechanism of lifespan modulation in response to DR. 
 
Toxic stressors 
DR flies were significantly more resistant than DR+EAA flies to a toxic dose of H2O2 
(P<0.01, long-rank test, Figure 3.5a). In contrast, DR flies were no better able to survive 
under paraquat stress than DR+EAA flies (P=0.52, long-rank test, Figure 3.5b). DR flies 
were more sensitive to a toxic dose of DDT than DR+EAA flies (P=0.04, long-rank test, 
Figure 3.5c), indicating that, at least for DDT resistance, DR does not protect against this 
toxin in the same way that lowered insulin signalling has been shown to (Grönke et al., 
2010).  
 
Environmental stressors 
We also tested the response of DR flies to environmental stressors. Under conditions of a 
39
o
C heat stress we found that DR flies were significantly less resistant than DR+EAA 
flies (P<0.001, long-rank test, Figure 3.5d), indicating that in flies, longevity associated 
with EAA reduction comes at a cost to heat stress resistance. We found that DR flies 
showed greater resistance to starvation than DR+EAA flies (P<0.001, long-rank test, 
Figure 3.5e), suggesting a possible mechanistic coupling between longevity and starvation 
resistance.  
 
Metabolic measurements 
Resistance to starvation stress could depend on the availability of enhanced energy stores 
within the fly. While we found no difference between dietary treatment groups in the 
levels of the storage carbohydrates glycogen (P=0.66, t-test, Figure 3.5f) or trehalose 
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(P=0.63, t-test, Figure 3.5g) we did find that DR flies had significantly higher levels of 
stored fat as triacylglycerides (TAG) than DR+EAA flies (P<0.001, t-test, Figure 3.5h). It 
is possible that this difference in TAG levels is causative of the longevity differences 
between DR and DR+EAA flies such that increased TAG confers some benefit to survival. 
 
 
 
 
 
 85 
 
Figure 3.5. Phenotype comparisons between DR and EAA-supplemented flies. 
(a) DR+EAA flies showed a decreased resistance to hydrogen peroxide toxicity compared to 
DR flies (P=0.01; n=150 flies per condition). (b) There was no difference between DR and 
DR+EAA flies in their sensitivity to paraquat stress (P=0.52; n=150 flies per condition).  
(c) DR+EAA flies showed a significantly improved tolerance to DDT compared to that of DR 
flies (P=0.04, n=100 flies per condition). (d) DR+EAA flies were significantly more resistant 
to a 39ºC heat stress compared to DR flies (P<0.001; n=40 flies per condition). (e) DR+EAA 
flies were significantly more sensitive to starvation than DR flies (P<0.001; n=100 flies per 
condition). (f) After 7 days of treatment there was no difference in the amounts of glycogen 
measured for DR+EAA flies compared to DR flies (P=0.66; n= 6).  (g) There was no 
difference in the levels of trehalose measured for DR+EAA flies compared to DR flies 
(P=0.63; n=6). (h) DR+EAA flies had significantly reduced levels of TAG compared to DR 
flies (P<0.001; n=6). For figures a-e, P values were calculated using the log-rank test. For 
figures f-h, P values were calculated using the t-test, and error bars represent the s.e.m. 
 
 
3.2.7. The effect of rapamycin to alter DR phenotypes  
 
If the above phenotypes induced by DR are causally linked to longevity through reduced 
TOR signalling, it should be possible to reproduce the same physiological outcomes by 
treating flies with rapamycin. We therefore tested the effect of rapamycin on DR+EAA 
flies for H2O2 stress resistance, starvation sensitivity, heat shock stress resistance and TAG 
levels. Of these, heat stress resistance and TAG levels are particularly interesting because 
the changes observed upon rapamycin treatment of DR+EAA flies meant they more 
closely resembled DR flies. There was no effect of rapamycin on the response of EAA-
treated flies to H2O2 stress (P=0.96, log-rank test, Figure 3.6a) or to starvation stress 
(P=0.07; Figure 3.6b). Like DR, rapamycin treatment increased the sensitivity of EAA-
treated DR flies to a 39ºC heat stress (P<0.001, Figure 3.6c), and increased their TAG 
content (P=0.01, t-test, Figure 3.6d). It is therefore possible that dTOR-mediated lifespan 
extension under DR is a result of the physiological processes that result in higher TAG 
levels, or an alteration in the mechanisms required to respond to a heat stress, or both.  
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Figure 3.6. The effect of rapamycin to alter phenotypic differences between DR and EAA-
supplemented flies. 
(a) Rapamycin had no effect on the sensitivity of DR+EAA flies to H2O2 stress (P=0.96; n=105 
flies per condition). (b) Rapamycin had no effect on the sensitivity of DR+EAA flies to 
starvation stress (P=0.07; n=150 flies per condition). (c) Rapamycin, like DR, increased the 
sensitivity of DR+EAA flies to a 39ºC heat stress (P<0.001; n=30 flies per condition). For 
figures a-c, P values were calculated using the log-rank test. (d) Rapamycin treatment 
increased the triacyglyceride (TAG) levels of DR+EAA flies to the level of DR (P=0.01, t-test, 
n=6, error bars represent the s.e.m). 
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3.3. Discussion 
 
In this chapter, we set out to understand the mechanisms that govern DR-induced 
longevity. We took advantage of a more nutritionally defined intervention than classically 
used in DR studies; supplementing a DR medium with EAAs to mimic the effect on 
lifespan of full feeding by increased yeast. As an initial step, we used fly models for 
genetically downregulated IIS and TOR signalling to pinpoint the nutrient signalling 
pathway(s) that might play a role in mediating the lifespan response to DR. We thus 
identified TOR signalling, an evolutionarily conserved amino acid sensor, as required for 
longevity upon amino acid reduction. We then looked for phenotypic correlates of 
longevity by DR to ask whether the TOR signalling pathway could also alter those 
phenotypes and thus point to mechanisms by which it modifies lifespan. 
 
The lifespan of IIS-mutant flies responded in a similar way to DR as wildtype flies, 
indicating that although IIS downregulation increases lifespan, it is not required for the 
lifespan-extending effects of DR. In support of this finding, other studies in both flies and 
worms have reported that the effect of DR to extend lifespan is independent of IIS 
(Houthoofd et al., 2003; Lakowski and Hekimi, 1998; Min et al., 2008). However, such 
additive interactions do not necessarily prove that DR and IIS act independently, since 
each intervention singly could induce the same longevity mechanism at submaximal levels 
(Gems et al., 2002), suggesting perhaps that DR and IIS work in parallel to increase 
lifespan via a common longevity-assurance mechanism. Our findings appear to contrast 
several other studies that have reported that lifespan modification in response to yeast 
dilution is abolished in some IIS mutant flies (Broughton et al., 2010; Grandison et al., 
2009; Grönke et al., 2010). These differences could be due to the fact that in the current 
study we modulated lifespan by adjusting EAAs alone, rather than by diluting the yeast 
concentration in the diet. In doing so, we report a markedly different sampling of 
nutritional space than for yeast dilution, since we change the ratio of EAAs to all other 
dietary components, such as lipids, carbohydrates, non-essential amino acids, vitamins and 
trace elements. Moreover, these other studies use flies with different genetic manipulations 
of IIS, which could modify the outcomes for interactions with food. Interestingly, our 
experiments also showed that long-lived DR flies had increased sensitivity to DDT, which 
is the opposite phenotype seen for IIS mutant flies, in which longevity is accompanied by 
dFOXO-dependent DDT resistance (Grönke et al., 2010; Slack et al., 2011). Together, 
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these data indicate that if the correlated stress phenotypes seen for IIS mutants are 
causative of longevity, then the mechanism of DR to extend lifespan do not require intact 
insulin signalling. These data suggest that the beneficial effects on lifespan of DR can be 
achieved independently of IIS.  
 
It is known that decreased dTORC1 activity extends lifespan in flies (Bjedov et al., 2010; 
Kapahi et al., 2004). In this study we have shown, through both genetic and 
pharmacological downregulation of dTOR, that the TOR pathway is required for lifespan 
modification in response to EAA availability. Using either method we found that flies 
were as long lived as those under DR in the presence or absence of added EAAs.  
 
We found that increased dRagA activity was associated with decreased lifespan when 
either the UAS-dRagA
WT
 or UAS-dRagA
Q61L
(CA) transgenes were overexpressed under 
DR conditions, consistent with the prediction that high TOR activity shortens lifespan 
(Figure 3.7a-b). Induction of the UAS-dRagA
WT
 transgene did not shorten lifespan as much 
as induction of the UAS-dRagA
Q61L
(CA) transgene, which is consistent with it being a less 
potent activator of signalling through dTOR. However, when UAS-dRagA
WT
 flies were 
supplied with additional dietary EAAs, lifespan was further shortened, consistent with 
further activation of dTOR activity.  
 
 
Figure 3.7. Predicted effects of dRagA transgenes on lifespan.  
In the constitutively active UAS-dRagA
Q61L
(CA) transgene model (a) the dRagA protein does 
not require EAAs for activation, while in the UAS-dRagA
WT
 model (b) dRagA requires 
activation by EAAs. In both models, dRagA activation increases dTOR activity which is 
predicted to lower lifespan. In the dominant negative UAS-dRagA
T16N
(DN) model (c), 
downregulated dRagA activity inhibits dTOR, which is in turn predicted to increase lifespan. 
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We tested whether a dominant negative form of dRagA could rescue the negative effects of 
EAAs on lifespan, as predicted by our model that decreased dRagA activity would dampen 
EAA signalling through TOR, and in turn alleviate the detriment to lifespan caused by 
supplementation of a DR diet with EAAs (Figure 3.7c). EAA supplementation decreased 
the lifespan of control flies by 24%, but only 3% for transgene-expressing UAS-
dRagA
T16N
(DN) flies. This observation is in line with our model in which reduced dRagA 
signalling blocks the effect of EAAs to increase dTOR activity and so prevents their 
lifespan shortening effect. This result is also supported by data from C. elegans, where 
dominant negative raga-1 (the C. elegans homologue of dRagA) lengthened lifespan 
(Robida-Stubbs et al., 2012; Schreiber et al., 2010). This data supports our prediction that 
it is primarily the signalling of EAAs to/through dTOR, rather than the end fate of the 
EAAs themselves, that dictates lifespan. It is likely that dTOR signalling decides the fate 
of the ingested EAAs based on a 'sample' signal that informs about the environmental 
abundance. 
 
The effect of EAAs to reduce lifespan was almost completely abolished in our UAS-
dRagA
T16N
(DN) flies. However, there was still a small, statistically significant reduction in 
lifespan upon EAA addition, suggesting that EAAs may have still been activating the 
functional native dRagA gene product which is still expressed in these flies. Alternatively, 
it may be the case that dTOR is not the only effector of altered lifespan in response to 
EAA addition. Interestingly, under DR conditions overexpression of the UAS-
dRagA
T16N
(DN) transgene resulted in a significant decrease in lifespan compared with 
controls, which indicates a limit for the beneficial effects of reducing dRagA, and in turn, 
dTOR activity (Figure 3.8a). Thus downregulating dTOR activity appears to be 
detrimental to flies under DR conditions, during which dTOR activity is expected to be 
optimal for lifespan, possibly because it may push flies into a state of perceived starvation. 
This can be harmful, for example, if energy stores start to get broken down in order to 
provide energy for short-term survival of the perceived starvation. It therefore may be 
informative to measure fat levels in our UAS-dRagA
T16N
(DN) flies upon DR. There are 
several examples in the literature that demonstrate the detrimental effects of signalling 
being mismatched to the actual abundance of environmental nutrients; one such example 
comes from work using flies lacking the fat-body amino acid transporter, slimfast (slif), as 
a genetic tool to mimic amino acid deprivation (Colombani et al., 2003). These flies were 
shown to exhibit phenotypes similar to that of starved flies, such as low mass and small 
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wing size in the adults, and storage vesicle aggregation in the larvae. Moreover, slif null 
flies have reduced S6K phosphorylation, suggesting that it may lie upstream of the TOR 
pathway. Alternatively, dRagA may also be involved in some other signalling pathway 
that, when downregulated, has negative effects on physiology that decreases lifespan. 
 
Induction of the UAS-dRagA
WT
 transgene under DR conditions shortened lifespan by 9% - 
a small but significant reduction, contrary to our prediction that lifespan would be 
unaffected in this line due to the requirement for additional dietary amino acids to act as 
coactivators of the transgene to enhance dTOR signalling.  
 
Together, our data are compatible with the lifespan response to modified TOR activity, as 
represented by a bell-shaped curve (Figure 3.8a). The position of an organism’s lifespan on 
this curve is subject to changes in TOR activity, which is plotted along the x-axis, and 
lifespan peaks at a narrow window of TOR activity. To the left of the lifespan peak  
survival declines as TOR activity is reduced in response to poor nutrient supply reflecting 
a state of relative malnutrition. To the right of the peak  progressively increased TOR 
activity becomes harmful for survival, due to unknown mechanisms, discussed further 
below. Interventions that reduce TOR activity  such as genetically downregulating dRagA, 
or rapamycin treatment  would shift an organism’s position on the curve to the left. 
Conversely  because EAAs increase TOR activity  an increased EAA supply or genetically 
increasing TOR activity would shift an organism’s position on the curve further to the 
right. Thus  whether an intervention to modify TOR activity lengthens or shortens lifespan 
depends on the starting position of the organism on this curve  Figure 3.8b . 
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Figure 3.8. A schematic showing the relationship between lifespan and dTOR activity and 
the effect of dTOR modifiers to alter lifespan.  
(a) Modifiers that increase dTOR activity, such as upregulation of dRagA activity and dietary 
essential amino acid (EAA) supplementation, are expected to push lifespan in the left-to-right 
direction, where too much dTOR activity becomes detrimental after an optimal level of 
activity. Modifiers that decrease dTOR activity, such as downregulation of dRagA activity and 
rapamycin treatment, are expected to push lifespan in the right-to-left direction, where lowered 
dTOR activity favours lifespan extension to a peak level, beyond which too little dTOR 
activity becomes detrimental. (b) The predicted effects on lifespan of upregulated and 
downregulated dRagA activity on short-lived EAA-supplemented flies. We would expect that 
upon transgene induction with RU486, lowered dRagA activity, and in turn lowered dTOR 
signalling, in UAS- UAS-dRagA
T16N
(DN) flies would extend the lifespan of EAA-treated flies. 
Upon transgene induction, increased dRagA and dTOR activity in UAS-dRagA
WT
 flies would 
be expected to cause a further reduction in lifespan of EAA-supplemented flies. 
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Interestingly, in our experiments the magnitude of the lifespan response to DR was greatly 
reduced with overexpression of the UAS-dRagA
WT
 transgene when compared to control 
flies (44% difference in median lifespan between DR and DR+EAA, to 14% difference 
upon transgene induction). This amelioration of lifespan shortening with additional amino 
acids is somewhat at odds with our initial hypothesis that activation of overexpressed 
UAS-dRagA
WT
 together with EAA supplementation would increase dTOR activity and so 
cause a greater decrease in lifespan than when compared to a case where EAAs are added 
to a normal-functioning dTOR environment (i.e. uninduced transgene) (Figure 3.8b). This 
unexpected result may be explained if we consider that the starting position of the control 
flies on the curve may have been at a level of dTOR activity lower than predicted, and 
increasing dTOR activity with transgene expression may have rescued lifespan so that the 
position of transgene-expressing flies lies closer to the peak of the curve. Alternatively, 
gut-confined expression of the transgene may have somehow disrupted the lifespan 
shortening effects of EAA addition. Also, potential feeding differences, for which we did 
not test, may have affected the amount of nutrients taken in by the flies, and in turn the 
degree to which dTOR signalling was active. 
 
We wanted to determine the effects on egg-laying of altering nutrient dependent signalling 
from dRagA to dTOR. For UAS-dRagA
WT
 flies, transgene induction exaggerated the 
increase in egg-laying with EAA addition, which is in line with what we would expect 
when dTOR signalling, and in turn protein synthesis, is upregulated. The induction of the 
UAS-dRagA
T16N
(DN) transgene did not affect the egg-laying response to food, and any 
difference that we saw in egg-laying arises only from the food type. While we may have 
expected a decrease in egg-laying with dTOR dowregulation, as we saw with rapamycin 
treatment, it is possible that egg production may be controlled by other/additional protein 
synthetic pathways involved in directing nutrient signals to egg-producing processes, 
perhaps in a compensatory manner in response to dTOR activity. One such alternative is 
IIS, which has been implicated in Drosophila oogenesis. IIS within the germline has a 
direct role in regulating germline cyst development, vitellogenesis, germline stem cell 
division (Hsu and Drummond-Barbosa, 2009; Hsu et al., 2008; LaFever and Drummond-
Barbosa, 2005), and indirectly controls follicle cell proliferation (LaFever and Drummond-
Barbosa, 2005). 
  
 93 
 
Together, our data indicate that expression of the UAS-dRagA transgenes significantly 
affected the response of lifespan to EAA addition in a manner that is partially consistent 
with a role for dTOR in mediating these effects. However, the extent to which dRagA is 
involved in nutrient signalling, the exact mechanisms through which it functions, and any 
interaction it may have with other NSPs has yet to be elucidated. Some of the seemingly 
anomalous results we obtained could be explained by deleterious effects of the transgene 
expression itself. For example, the dRagA protein forms a heterodimeric complex with 
dRagC in vivo (Sekiguchi et al., 2001) so perhaps overexpression of any dRagA transgene 
might disrupt heterodimeric dRagA function in an unanticipated way, creating an 
unanticipated dominant negative effect. This can be tested via western blot analysis of 
dS6K phosphorylation, a downstream effector of dTOR. Decreased dS6K phosphorylation 
should indicate decreased dTOR activity, and presumably decreased dRagA activity. 
 
In further work it would be interesting to test whether ubiquitous alteration of dRagA 
affects lifespan and egg-laying in the same way as tissue-specific expression. It may also 
be interesting to disentangle the effects of combined gut and fat-body dRagA alteration by 
using separate drivers that target these tissues singly. Mammalian TORC1 has also been 
shown to be required for skeletal muscle protein synthesis (Dickinson et al., 2011), 
therefore muscle-specific dRagA expression may reveal a specific role for dRagA in 
muscle growth and senescence and how this may in turn impact whole organismal ageing. 
Further, a comparison of these findings with altered dRagC (with which dRagA forms a 
heterodimer) activity could inform us of the dynamics of the Rag heterodimer subunits and 
whether or not their roles are distinct. It would also be useful to investigate whether the 
observed phenotypes are a specific effect of decreased signalling via the amino acid 
sensitive dRagA input to TOR, or whether they are the result of generally decreased TOR 
activity in response to any upstream modifier. This can be tested using flies with 
alterations in pathway components that modify TOR activity, such as dTSC1/2 and 
dRaptor, in combination with flies with altered dRagA activity. These experiments would 
shed light on the question of whether the effects we have observed are specific to amino 
acid stimulation of TOR activity, since other environemtnal factors, such as energy and 
growth factors, also affect TOR activity. Ongoing work in the laboratory is using whole 
transcriptome sequencing to analyse the gene expression profiles of DR, EAA-
supplemented and rapamycin-treated flies to further investigate the molecular signatures 
associated with lifespan regulation via EAA signalling to dTOR.  
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One of the strategies taken to understand the mechanisms by which amino acid abundance 
could modify lifespan downstream of TOR is to seek out correlated physiological changes 
that may provide markers into the treatment’s mode of action. A common mechanistic 
explanation for longevity requires enhancing systems that protect against internal and 
environmental injury, such as the damaging side-effects of aerobic metabolism caused by 
oxidative stress or endogenous lipophilic toxins (McElwee et al., 2004, 2007), and several 
lines of evidence show that the capacity for DNA repair decreases with age (Goukassian et 
al., 2000; Hasty et al., 2003; Lombard et al., 2005), and that this may be due in part to 
reduced energy availability (McCarroll et al., 2004; Meyer et al., 2007). In the case of DR, 
it has been theorised that the limited amount of nutrients available in a DR diet is invested 
into somatic maintenance, at the expense of reproduction, in an effort to increase the 
likelihood of organismal survival to the event of the return of nutrient abundance 
(Holliday, 1989; Kirkwood, 1977). Thus, resources are invested into maintenance 
programmes such as DNA repair and DNA proof-reading mechanisms, which are costly 
resource-consuming reactions. The expected result of this investment is a general increase 
in functional efficiency of biological processes and this would be indicated by greater 
efficiency of stress defense pathways. We measured the survival responses of DR flies to a 
range of stressors. We found no evidence for broad-spectrum enhanced protection against 
stressors under DR, suggesting that the mechanism for increased longevity under DR may 
not involve a general enhanced resistance to stress. If organisms can live long with an 
apparently unaffected capacity for somatic maintenance, what causes ageing? 
 
The Free Radical Theory of Ageing proposes that an accumulation of free radicals, 
harmful by-products of metabolism, cause oxidative damage within cells and that this 
leads to ageing (Balaban et al., 2005; Harman, 1956). DR has been proposed to decrease 
mitochondrial utilisation of oxygen, resulting in the decreased production of free radicals 
and in turn the attenuation of damage, leading to lifespan extension (López-Lluch et al., 
2006; Lopez-Torres et al., 2002; Sohal et al., 1990). However, several conflicting reports 
show that DR animals in fact have increased mitochondrial respiration (Cerqueira et al., 
2012; Hempenstall et al., 2012; Nisoli et al., 2005). We found that DR had no or negative 
effects on resistance to the oxidative stressors paraquat and hydrogen peroxide stress. The 
evidence for the Free Radical Theory of Ageing in the literature is inconsistent (Masoro, 
2000, 2005; Merry, 2004; Sinclair, 2005), and our data does not provide support for it.  
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Studies in C. elegans showing that lifespan could not be extended by alleviation of 
oxidative stress (Doonan et al., 2008; Gems and Doonan, 2009) has led to the hypothesis 
that age-related functional decline, and ultimately death, is caused by 'hypertrophy' 
brought about by inappropriate continuation of early-life growth programmes into later 
life. This mismatch of growth to physiological demand beyond the developmental period is 
physically overwhelming to the organism and manifests as accelerated senescence, causing 
ageing and ageing-related diseases (Blagosklonny, 2006a, 2006b, 2008; Gems and de la 
Guardia, 2013). High levels of TOR signalling driving growth sits at the heart of this 
theory. Our data is not incompatible with this theory, although readouts of growth would 
be needed to substantiate this idea. 
 
The finding that DR flies survive longer under starvation compared to fully fed control 
flies has been observed before (Burger et al., 2007; Chippindale et al., 1993). The higher 
lipid levels of DR flies has been proposed to account for their increased resistance to 
starvation (Rauser et al., 2004), with the reasoning that increased metabolic stores provide 
the flies with a more sustained source of energy. The starvation stress and fat phenotypes 
were not uncoupled from longevity in our experiments, whether lifespan was modified by 
diet manipulation or rapamycin addition. If the enhanced longevity of organisms in 
response to DR evolved as a mechanism to protect animals from food scarcity, it would 
make sense that the post-ingestive storage of limited resources would be central to such a 
mechanism. The question remains - is the storage of nutrients actively increased as a direct 
response to food limitation, or is nutrient storage a secondary effect of decreased fecundity 
due to insufficient resources required to fulfil egg production? In other words - which 
comes first, decreased egg-laying or nutrient storage? Or do both responses occur 
independently? 
 
DR by yeast restriction in Drosophila has previously been shown to increase lipid content 
(Bradley and Simmons, 1997; Chippindale et al., 1993; Skorupa et al., 2008), and several 
rodent studies also show that higher fat levels correlate with increased lifespan (Berryman 
et al., 2004; Coschigano et al., 2000; Flurkey et al., 2001; Harrison et al., 1984; Liao et al., 
2011; List et al., 2009; Liu et al., 2004; Miller et al., 2005; Olsson et al., 2005). The 
counterintuitive nature of these findings suggests that the effect of TAG on lifespan is 
likely to be a complicated relationship and may be accounted for by the fact that TAGs 
exist in various types with different structural and functional properties. TAG fatty acids 
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vary in their chain length and saturation, occupying specific stereopositions on the glycerol 
molecule. The factors that determine the assembly of TAGs are not clear, but this 
stereopositioning determines their specificity as substrates for different lipases and how 
they are metabolised, having distinct effects on cellular processes and physiological 
functions (Karupaiah and Sundram, 2007). The molecular nature of these TAGs and the 
expression levels of enzymes that act on them may be influenced by environmental cues 
and/or internal signals, and collectively these factors may account for the reported 
complexity of the relationship between fat and lifespan.  
 
A recent study from C. elegans proposes that DR promotes expression of lipases that 
hydrolyse lipids  resulting in increased levels of ω-6 polyunsaturated fatty acids, that in 
turn induce autophagy, thereby promoting longevity (Rourke et al., 2013). The study 
hypothesises that these lipid species serve as signals of nutrient scarcity. The findings 
complement our model of TOR-mediated lifespan extension under DR, where long-lived 
flies with downregulated TOR activity have elevated TAG levels, like DR flies. Further 
identifying the specific TAG species that are elevated in these flies and measuring any 
accompanying changes in the levels of autophagy would be informative in determining 
whether the relationship between DR, fat and autophagy is also conserved in flies. 
 
During fasting 20%–50% of fatty acids undergo the energy-costly process of re-
esterification (Weber and Reidy, 2012), which is inconsistent with the role of TAG as an 
energy source, especially during fasting when conservation of energy would be essential 
for survival. It has been suggested that this remodeling of TAGs may have some, as yet 
unknown, important biological function (Kniazeva and Han, 2013). Thus, fat seems to 
have an important physiological role beyond energy storage that promotes the activation of 
protective mechanisms. Indeed, the adipose tissue is being realised as an important 
endocrine organ, and not just a TAG storage organ (Lubbers et al., 2013). The adipose 
tissue produces and secretes adiponectin, a cell-signalling protein, which has been 
positively correlated with longevity (Arai et al., 2011; McKee Alderman et al., 2010). 
Genetically altered mice that express increased levels of human adiponectin have increased 
lifespans, and accordingly some long-lived mice have been shown to have increased levels 
of adiponectin (Lubbers et al., 2013). Moreover, as like mammalian insulin, Drosophila 
Dilps regulate energy metabolism, and it was shown that inhibition of the adiponectin 
receptor in the insulin producing cells (IPCs) in the fly brain resulted in elevated levels of 
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TAG in the whole body, and that this was correlated with accumulation of Dilp2 protein in 
IPCs, decreased levels of circulating Dilp2, and decreased insulin signaling in the fat body 
(Kwak et al., 2013). This study indicates that insulin signalling controls lipid metabolism, 
providing a direct mechanistic link between NSPs and lipid metabolism. It would be 
interesting to investigate whether the TOR pathway plays a role in this system, and 
whether we may be able to reconcile this with our own observed associations between 
TOR, fat and lifespan. 
 
 Katewa et al. (2012) have shown that DR flies have increased TAG levels, and 
demonstrated an increased requirement for muscle-specific fatty-acid synthesis and 
breakdown in extending lifespan under DR. Moreover, some long-lived TOR and IIS 
pathway mutants have increased fat levels (Bjedov et al., 2010; Böhni et al., 1999; 
Teleman et al., 2005; Zhang et al., 2000). Given that not all fat mutants are long-lived 
(Grönke et al., 2005), it is likely that if fat storage is causally involved in extending life, 
the type of fat accumulated is important. It would be interesting in future work to 
determine how lipid profiles change under different dietary conditions, to identify the 
specific types of lipids that are altered, and whether experimental manipulation can 
enhance lifespan. 
 
One of the main limitations of our study has been that the correlations that we have drawn 
between lifespan and phenotype are based on the phenotypes of flies at a single time point 
early in life (7 days old). Thus, our data are unlikely to be wholly indicative of the impact 
of our treatments on ageing per se. However, they may indicate the impact of early life 
physiology on lifespan, if indeed these early-life traits are decisive of the course of longer-
term ageing. Ideally we would sample flies at multiple ages throughout their lifespan to 
deduce if and how the phenotypes change through their lifetime. Some studies have 
demonstrated how traits may change over the lifetime of an organism. Burger et al. (2007) 
report that at 4 days old, DR-treated flies are significantly more resistant to starvation than 
control flies, but by day 20 this is reversed and DR flies are more sensitive than control 
flies to starvation stress, and remain so when sampled at 33 days and 47 days. This study 
also found age-dependent changes in DR and control flies in response to oxidative stress, 
infection and cold stress. Furthermore, it has been shown that mice treated with rapamycin 
exhibit different effects on metabolism in response to different lengths of rapamycin 
treatment (Fang et al., 2013). For example, mice treated with rapamycin for 2 weeks 
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showed no difference in adiposity compared to control mice, whereas 20-week old 
rapamycin-treated mice had significantly lower fat compared to control mice. Detailed 
longitudinal studies on the molecular bases of these changes will be important to 
understand how the phenotypic changes in the flies relate to their longevity. 
 
Our method of DR implementation is different from other studies in that we phenotype DR 
flies as relative to flies supplemented with additional EAAs. This may explain why the 
phenotypes of our short-lived flies are somewhat different from those of other organisms 
subjected to FF. It is thus possible that the associated physiological correlates of lifespan, 
causal or not, that we have observed may be specific to our particular dietary intervention, 
i.e. that the phenotyping profile that we have characterised is specific to DR relative to FF 
as implemented by EAA supplementation, as opposed to FF by increased yeast. These two 
FF controls are very different, since in the latter not only is the level of EAAs being 
elevated, but also the relative levels of all other nutritional components in the yeast. Of 
course, inter-species differences may also be accounted for by the very fact that they are 
different species with distinct physiologies.  
 
Together, our findings implicate a role for the TOR pathway in mediating the lifespan 
effects of DR, as implemented by EAA alteration. In an attempt to understand the 
mechanisms by which longevity is achieved, we have described the physiological and 
metabolic features that define long-lived DR flies. Our data indicate that dietary amino 
acids modify dTOR signalling, which in turn alters lifespan outcomes. We found that both 
dietary EAA manipulation and dTOR modification in flies alter TAG levels, such that 
increased TAG correlated with longer life in our flies subjected to DR or rapamycin 
treatment. Despite finding a requirement for functional TOR in mediating the DR 
response, our data also indicate there are likely to be other mechanisms important for 
longevity. This may include other nutrient sensing pathways. In the next chapter we 
explore the role of the, as yet uncharacterised, general amino acid control (GAAC) 
pathway in DR-mediated lifespan extension. 
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Chapter 4 - Phenotypic characterisation of dGCN2 deficiency in 
Drosophila and its effects on dietary restriction-mediated longevity 
 
 
4.1. Introduction  
 
Organisms require an adequate intake of amino acids, where a deficiency in one or more 
amino acids in the diet compromises growth, development and survival. Thus, sensors of 
amino acid availability are crucial for homeostatic control. Amino acids not only serve as 
the building blocks of protein, but also have important signalling roles to regulate 
processes such as metabolism, development, growth, gene expression, and immunity, and 
are precursors for important bioactive molecules including neurotransmitters and 
hormones (Wu, 2010). It would therefore be expected that mechanisms that ensure 
adequate amino acid intake would be tightly regulated. Indeed, one such proposed control 
mechanism is the general amino acid control (GAAC) pathway, which is a major regulator 
of protein synthesis and is activated by amino acid starvation.  
 
In the GAAC pathway, amino acid limitation is signalled directly via the binding of 
uncharged tRNAs to the GCN2 kinase, which in turn phosphorylates the eukaryotic 
initiation factor-2 (eIF2), resulting in the inhibition of mRNA translation and a decrease in 
global protein synthesis (reviewed in chapter 1.3.3) (Wek et al., 1995; Yang et al., 2000). 
Because GCN2 can bind different species of uncharged tRNAs with similar affinities, the 
GAAC can in theory detect deficiencies in any amino acid. Knockout of GCN2 function 
has been described for rodents. Phenotypically, GCN2 null rodents resemble their wildtype 
counterparts under adequate nutritional conditions. However, phenotypic differences tend 
to reveal themselves under conditions of nutritional stress (Zhang et al., 2002). For 
example, when fed a diet devoid of leucine, GCN2 null mice produced fewer pups than 
wildtype mice, suggesting a role for GCN2 in the control of nutritional stress during 
embryogenesis. Postnatally, GCN2 null mice are more sensitive to leucine deprivation and 
do not survive well compared to control mice, further implicating a role for GCN2 in 
regulating growth under nutritional stress (Anthony et al., 2004). One study investigating 
the role of tryptophan restriction in the resistance to surgical stress following renal 
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ischemia reperfusion showed that GCN2 null mice had increased protection against 
surgical stress, compared to wildtype mice, when fed a complete diet, but did not benefit 
from a tryptophan deficient diet, whereas wildtype mice did (Peng et al., 2012). Moreover, 
some markers of inflammation, such as the level of circulating neutrophils and the levels 
of growth hormone receptor mRNA and Igf1 mRNA, were reduced for wildtype mice, but 
not for GCN2 null mice, upon tryptophan deficiency. It has also been shown that mice 
treated with asparaginase, which depletes levels of the amino acids asparagine and 
glutamine, incurred hepatic triglyceride accumulation and had increased DNA damage 
from oxidative stress and inflammation (Wilson et al., 2013). These observations are 
analogous to those in yeast, where GCN2 mutants have a reduced growth rate relative to 
control yeast when grown on amino acid-deficient media or when treated with inhibitors of 
amino acid biosynthesis (Dever et al., 1992; Kilberg et al., 1994; Zaborske et al., 2009). 
 
In accord with the findings above, Rousakis et al. (2013)  show that GCN2 aids the 
survival of the nematode worm Caenorhabditis elegans under nutrient stress. GCN2 null 
worms under normal nutritional conditions were phenotypically similar to wildtype 
worms, with no difference in lifespan, growth, development, movement or fecundity. 
However, upon concomitant knockdown of genes encoding either lysil- or leucyl-tRNA 
synthetase (as a means of inducing amino acid limitation), GCN2 null worms incurred a 
greater shortening of lifespan compared to wildtype worms, which is consistent with 
previous work showing that animals with loss of GCN2 are more sensitive to conditions of 
nutrient stress. This study also proposes that GCN2 regulates lifespan extension under 
dietary restriction (DR), based on the finding that loss of GCN2 suppressed the longevity 
of eat-2 mutant worms, which are often used as a model of DR due to their pharyngeal 
pumping defects. In addition, the study makes a connection between the GAAC pathway 
and the target of rapamycin (TOR) and insulin/insulin-like growth factor signalling (IIS) 
pathways in worms. They present evidence to suggest that GCN2 mediates lifespan 
extension conferred by inhibition of the TOR pathway and that these two pathways 
converge on the PHA-4/FoxA transcription factor, lying downstream of the IIS pathway. 
 
In this work we set out to characterise the role of the GAAC pathway in regulating the 
physiological responses of Drosophila melanogaster to nutritional stress. We also 
investigate the role of GCN2 in the lifespan response to DR, as well as any connection it 
may have with the TOR pathway.  
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4.2. Results 
 
The kinase activity of the GAAC pathway is dependent on amino acid availability. This 
led us to ask whether, like other nutrient sensing/signalling pathways (NSP), the GAAC 
pathway has a role in mediating lifespan modifications in response to dietary change. 
Using flies deficient in dGCN2, the Drosophila homologue of mammalian GCN2, we 
tested whether the Drosophila GAAC pathway may be involved in mediating lifespan 
extension under DR. Although commercially available Drosophila RNAi lines targeting 
dGCN2 exist, they have been found to have off-target effects (Carlos Ribeiro, personal 
communication). Therefore, we generated a Drosophila line with a knockout of the entire 
dGCN2 gene (see chapter 2.1.2, figure 2.1), in collaboration with Sebastian Grӧnke (Max 
Planck Institute for the Biology of Ageing, Cologne).  
 
 
4.2.1. Physiological characterisation of dGCN2 null flies 
 
Since the function of dGCN2 in flies is only inferred from similarity to yeast GCN2, we 
carried out a number of phenotyping assays to characterise flies lacking dGCN2. We tested 
several phenotypes under varying concentrations of yeast: 0.2x Y, 1x Y, and 2x Y (see 
chapter 2.2.2, table 2.3). 
 
We determined the development time of flies reared on different concentrations of dietary 
yeast, as measured by time to pupal eclosion. None of the diets tested compromised the 
proportion of larvae eclosing as adults. There was no difference in development time 
between dGCN2 null and wildtype flies on 2x yeast (P=0.10, Wilcoxon rank-sum test, 
Figure 4.1a), nor when reared on 0.2x yeast (P=0.37, Wilcoxon rank-sum test). However 
dGCN2 null flies developed slightly quicker than wildtype flies on 1x Y (3.8% 
improvement of median development time, P<0.001, Wilcoxon rank-sum test), suggesting 
that there may be some interaction between dietary protein and dGCN2 to regulate 
development. Interestingly, only development on 0.2x yeast resulted in a significant 
reduction in adult body weight for dGCN2 null compared to wildtype flies (0.2x Y, 
P<0.01; 1x Y, P=0.68; 2x Y, P=0.13; t-test; Figure 4.1b). 
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Figure 4.1. The effect on development time and body weight of dGCN2 deletion for flies 
reared on varying concentrations of yeast (Y).  
(a) There was no difference in development time between female wildtype and dGCN2-/- flies 
on 0.2x Y (P=0.37; Wilcoxon rank-sum test) or 2x Y (P=0.10). On 1x Y, dGCN2-/- flies 
developed significantly faster than wildtype flies (P<0.001). Median development times (days 
from 1
st
 instar larvae): Wildtype: 0.2x Y=14.3, 1x Y=10.3, 2x Y=9.9; dGCN2-/-: 0.2x Y=13.9, 
1x Y=9.9, 2x Y=9.9. n=30 flies per condition per genotype. (b) Body weights of 3-day old 
female flies after eclosion. Measurements were made per 2 virgin female flies, and values are 
expressed as an average. There was no difference in body weight between wildtype and 
dGCN2-/- flies reared on 1x Y (P=0.68; t-test) and 2x Y (P=0.13), but on 0.2x Y wildtype flies 
weighed significantly more than dGCN2-/- flies (P<0.01). n=30 flies per condition per 
genotype.  
 
Several studies have suggested a role for translation in regulating the immune response 
(Lemaitre and Girardin, 2013). Since GCN2 is a key regulator of protein synthesis in yeast, 
we tested the ability of dGCN2 null flies to withstand an immune challenge. We tested 
their resistance to infection with the pathogenic bacterium E. carotovora carotovora (Ecc). 
Adult dGCN2 null flies were significantly more resistant to Ecc infection than wildtype 
flies, as determined by survival analysis following infection by septic injury (P<0.001, log-
rank test, Figure 4.2a; assay done with assistance from Jenny Regan). Unlike adults, 
dGCN2 null larvae were more sensitive to Ecc infection compared to wildtype larvae, as 
measured by pupal eclosion rate following infection by ingestion (P=0.04, t-test, Figure 
4.2b; assay done with assistance from Jenny Regan). 
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Figure 4.2. The effect on survival of an immune challenge in wildtype and dGCN2 null 
adult flies and larvae. 
(a) dGCN2-/- adult flies were more resistant than wildtype flies to infection by septic injury 
with E. carotovora (O.D. 200) (P<0.001, log-rank test, n=75 flies per condition per genotype). 
(b) dGCN2-/- larvae were more sensitive to oral infection with E. carotovora (O.D. 200) 
compared to wildtype flies (P=0.04, t-test, n=30 larvae per condition per genotype). 
 
 
4.2.2. The role of the GAAC pathway in mediating lifespan under DR 
 
The GAAC pathway is considered to be a major nutrient signalling pathway, and so we 
tested how dGCN2 activity might alter lifespan in response to dietary change. We 
manipulated the yeast:sugar ratios of our standard SY food medium to produce our test 
conditions, totaling nine combinations of three yeast concentrations (0.5x, 1x, and 2x) and 
three sugar concentrations  (1x, 2x and 4x). From this data we were able to generate a heat 
map, which graphically displays the median lifespan responses of flies to each treatment 
within the yeast and sugar nutrient space that we tested. It should be noted that these 
surfaces are interpolated from the nine data points available, whose values are indicated on 
the plots. The lifespan heat maps for wildtype and dGCN2 null flies seem to have a very 
similar distribution of lifespan effects within the nutritional frame (Figure 4.3), with 
maximal lifespan at a yeast:sugar ratio of 1x:1x for both genotypes, and at its lowest at 
0.5x yeast : 4x sugar. In fact, for both genotypes, excess sugar relative to yeast seems to be 
more detrimental than the reverse imbalance. Most notably, absence of dGCN2 increased 
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median lifespan on almost all yeast:sugar concentration combinations tested. Analysing 
this data by Cox Proportional Hazards (CoxPH) confirmed a significant effect of genotype 
on lifespan (P<0.001). CoxPH analysis also revealed both a significant effect of yeast and 
sugar, independently, on the lifespan outcomes (P<0.001 for both variables), as well as a 
combined effect of yeast and sugar (P<0.001). We found that genotype affected the 
lifespan response to sugar (P=0.01), but we did not find a significant interaction between 
genotype and yeast (P=0.12). However, genotype altered the interaction between yeast and 
sugar to affect lifespan (P=0.02). In essence, the absence of dGCN2 altered the lifespan 
responses of flies to manipulations in the yeast:sugar ratio. 
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Figure 4.3. The effect of dGCN2 deletion on the lifespan response to dietary yeast and 
sugar manipulation. 
Lifespan was measured in wildtype and dGCN2-/- female flies maintained on 9 different diet 
regimes, varying in their yeast and sugar compositions. The median lifespans for each food 
condition were used to estimate diet response surfaces, with the values indicated on the plots. 
The corresponding survivorship graphs for each response surface plot are also shown. Cox 
Proportional Hazards analysis was carried out to determine the significance of the effects on 
lifespan of genotype, of diet, and of the interaction between them: genotype, P<0.001; yeast, 
P<0.001; sugar, P<0.001; yeast-sugar interaction, P<0.001; genotype-yeast interaction, P=0.12; 
genotype-sugar interaction, P=0.01; genotype-yeast-sugar interaction, P<0.001. n=150 flies per 
genotype per condition. 
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NSPs are often implicated as candidate mediators of the effect of DR to extend lifespan 
and reduce fecundity. Thus, we characterised the lifespans and egg-laying responses of 
dGCN2 null, as well as dGCN2 heterozygous, flies under DR conditions in order to 
establish a role, if any, for the GAAC pathway in mediating the lifespan and fecundity 
responses to DR. Other work has shown that DR is defined only by the yeast axis (Mair et 
al., 2005), and so we imposed DR by altering dietary yeast concentration, while keeping 
the concentration of sugar consistent at lx. The lifespan response of wildtype Drosophila 
has been shown to be typically tent-shaped (Chapman and Partridge, 1996), where lifespan 
peaks at an intermediate food concentration, beyond which higher concentrations are 
associated with shorter lifespan, and in the opposite direction lower concentrations fall into 
starvation. The egg-laying peak usually occurs at a concentration of food higher than that 
which maximises lifespan, but short of concentrations so high that neither trait improves 
(reflecting a general detrimental effect of overfeeding). In order to define the DR response 
range for dGCN2 mutants, we sampled five different concentrations of yeast in our 
standard SY food media; 0.2x, 0.5x, 1x, 1.5x and 2x yeast, and we measured the effects on 
lifespan and egg-laying. 
 
All three genotypes exhibited a tent-like response of lifespan to altered yeast 
concentration, with a decline in lifespan at the lowest and highest yeast concentrations, 
peaking at an intermediate yeast concentration (Figure 4.4). CoxPH analysis revealed 
independent effects of both food and genotype on lifespan (P<0.001 for both variables), as 
well as a significant interaction between genotype and food (P=0.03). The lifespan of 
wildtype flies was highest at 1x and 1.5x yeast, equally, while the lifespan of dGCN2 null 
flies peaked at 1.5x yeast. dGCN2 heterozygous flies were equally long-lived at 0.5x, 1x 
and 1.5x yeast. Noteworthy is that lifespan was extended by dGCN2 deletion on both 1x 
and 2x yeast, representing DR and full-feeding (FF) treatments respectively. In fact, 
dGCN2 null flies were longer-lived than wildtype flies on all concentrations of yeast 
tested. The lifespan response of dGCN2 heterozygous flies were intermediate to wildtype 
and dGCN2 null flies. 
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Figure 4.4. Dietary restriction (DR) lifespan tents and corresponding egg laying for 
wildtype, dGCN2 null and dGCN2 heterozygous flies. 
Points (joined by lines) represent the median lifespans, and bars represent the average number 
of eggs laid per female per day with errors representing the s.e.m. All strains exhibited a tent-
shaped response to DR with the lowest median lifespan values at 0.2x and 2x yeast 
concentrations, and peak values at 1x and 1.5x yeast for wildtype flies, at 0.5x, 1x and 1.5x 
yeast for dGCN2-/+ flies, and at 1.5x yeast for dGCN2-/- flies. For all strains, female fecundity 
showed an incremental increase with yeast concentration. Cox Proportional Hazards analysis 
for lifespan, and a linear model for egg-laying, were used to determine the significance of the 
effects on lifespan of genotype, of yeast concentration, and of the interaction between them: 
both lifespan and fecundity were significantly affected by yeast (P<0.001 for both traits). 
Genotype affected lifespan (P<0.001), but not egg-laying (P=0.20). There was a significant 
interaction effect between genotype and yeast for lifespan (P<0.001), but not for egg-laying 
(P=0.29). n=150 flies per condition per genotype. n=150 flies per genotype per condition.  
 
Egg-laying increased with yeast concentration (P<0.001, linear model, Figure 4.4), and 
despite apparent differences between genotypes, there was no significant difference 
(P=0.20, linear model). There was no interaction effect of genotype and food on egg-
laying (P=0.29, linear model). Together, these data indicate that altered dGCN2 activity 
modifies the lifespan response to DR, but not the egg-laying response. 
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4.2.3. The role of the GAAC pathway in mediating lifespan responses to single EAA 
deficiency 
 
In yeast, GCN2 activity is stimulated by the presence of uncharged tRNAs (Wek et al., 
1995). It is possible that GCN2 binds different tRNAs with different affinities, and in turn 
this may affect downstream effectors differentially, and potentially resulting in different 
physiologies. Comparably, the TOR pathway has been shown to be activated more 
strongly by some amino acids than others. Namely, leucine has been shown to be an 
especially potent activator of the TOR pathway (Proud, 2002). This prompted us to 
investigate the effect of more specific nutritional manipulations on lifespan. We selected 
four essential amino acids (EAA) - one from each functional group; namely arginine, 
tryptophan, methionine and leucine, representing cationic, aromatic, sulphur-containing, 
and branch-chained groups, respectively. We omitted each of these EAAs singly from 
defined media food and measured the lifespans of dGCN2 null flies upon treatment on 
each of these deficient conditions. All four EAA omission conditions were detrimental to 
both wildtype and dGCN2 null flies compared to a complete food medium containing all 
EAAs (P<0.001 for all comparisons, long-rank test, Figure 4.5a). dGCN2 null flies were 
generally more sensitive to EAA deficiency compared to wildtype flies, even though they 
were longer-lived on a complete food medium (P=0.05, log-rank test). The degree of 
detriment caused by the single EAA deficiencies was different for each EAA, and also 
different for each genotype; dGCN2 null flies were more sensitive to arginine, leucine and 
tryptophan omission compared to wildtype flies (P<0.001 for all comparisons, log-rank 
test). Interestingly, however, dGCN2 null flies were more resistant than wildtype flies to 
methionine deficiency (P<0.001, log-rank test). Together, our data indicate a role for 
dGCN2 in regulating survival under conditions of EAA deficiency, particularly methionine 
deficiency.  
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Figure 4.5. The effect dGCN2 deletion on lifespan and egg-laying under conditions of 
single essential amino acid (EAA) deficiency. 
(a) Both wildtype and dGCN2-/- female flies had significantly reduced lifespans when either 
arginine (arg), leucine (leu), methionine (met) or tryptophan (trp) are omitted from the diet 
(P<0.001 for all comparisons, long-rank test). dGCN2-/- flies were more sensitive than 
wildtype flies to single EAA deficiency for all EAAs tested (P<0.001) except in the case of met 
deficiency when they were more resistant than wildtype flies (P<0.001). Median lifespans 
(days) are quoted in brackets on the graph. n=150 per genotype per condition. (b) dGCN2-/- 
flies laid fewer eggs than wildtype flies when maintained on a complete food medium 
(P<0.001, Wilcoxon rank-sum test). Both wildtype and dGCN2-/- flies had significantly 
reduced egg-laying when either arg, leu, met or trp were omitted from the diet (P<0.001 for all 
comparisons). Wildtype and dGCN2-/- flies both laid equally few eggs on all single EAA 
omission conditions, except in the case of met deficiency when dGCN2-/- flies laid 
significantly more eggs than wildtype flies (P<0.001). Egg counts were made at 8 days of food 
treatment. n=100 per genotype per condition.  
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Food type and genotype also had a significant effect on egg-laying independently 
(P<0.001 for both, linear model, Figure 4.5b), as well as interactively (P<0.001, linear 
model). Under all four single EAA-deficient conditions, both wildtype and dGCN2 null 
flies had dramatically lower egg-laying compared to that on the complete medium. 
However, dGCN2 null flies laid more egg-laying when deprived of methionine compared 
to the other EAA deficiencies tested (P<0.001 for all comparisons, Wilcoxon rank-sum 
test), and this was significantly higher than methionine-deprived wildtype flies (P<0.001, 
Wilcoxon rank-sum test), which is particularly noteworthy given that wildtype flies laid 
more than double the number of eggs on a complete medium compared to dGCN2 null 
flies (P<0.001, Wilcoxon rank-sum test). Together, these data suggest that dGCN2 
deficiency confers some protection against the detrimental effects on lifespan and egg-
laying of methionine deficiency specifically. 
 
 
4.2.4. Lifespan correlated phenotypes of dGCN2 null flies 
 
In chapter 3 we identified Drosophila phenotypes that correlated with DR-induced lifespan 
extension. We found that increased triacylglyceride (TAG) fat levels, and increased 
resistance to starvation were characteristics of long-lived DR flies. We assayed dGCN2 
null flies, which are longer lived than wildtpye flies under both DR and full feeding, for 
these DR-correlated phenotypes. We measured TAG levels of flies following a 7-day 
treatment period on the nine combinations of yeast and sugar concentration ratios used for 
lifespan. We generated a heat map to illustrate these findings (Figure 4.6a). dGCN2 null 
flies exhibited the highest levels of TAG when the concentration of sugar was higher 
relative to that of yeast (0.5x yeast: 4x sugar), and the lowest TAG levels were evident in 
the reverse scenario where the concentration of yeast was higher relative to sugar (2x 
yeast: 1x sugar). Wildtype flies, however, showed a very different TAG profile across this 
nutritional space, displaying a peak at 0.5x yeast: 1x sugar, with no apparent increase or 
maintenance of this high TAG across increasing sugar concentrations at this level of yeast. 
Analysing this data using a linear model revealed a significant effect on TAG of both food 
and genotype independently (P>0.001 for both variables), as well as an interaction 
between the two (P<0.001). For the conditions that represent DR (1x yeast: 1x sugar) and 
FF (2x yeast: 1x sugar) there was no difference in the levels of TAG between wildtype and 
dGCN2 null flies (DR, P=0.30; FF, P=0.80; t-test).  
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Figure 4.6. Diet response surfaces for triacylglyceride (TAG) levels and the effect of 
dGCN2 deletion on starvation stress resistance. 
(a) Levels of TAG were determined in wildtype and dGCN2-/- female flies after 7 days of 
treatment on 9 different diet regimes, varying in their yeast and sugar compositions. The 
average TAG content (µg per fly) for each food condition was used to estimate a diet response 
surface. These values are indicated on the plots. Statistical analysis using a linear model 
suggests a significant effect of genotype and food type, both independently and interactively, 
on TAG (P<0.001 for all comparisons). (b) There was no difference in the response of dietary 
restricted (DR) and fully fed (FF) wildtype and dGCN2-/- flies to starvation – for both 
genotypes, DR-treated flies were more resistant to starvation than FF flies (P=0.001 for both 
genotypes, log-rank test). Median survival (days): wildtype DR=8.8, wildtype FF=8.3, dGCN2-
/- DR=7.6, dGCN2-/- FF=7.1). n=105 per genotype per condition. 
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We tested the ability of dGCN2 null flies to resist starvation stress following pre-treatment 
on either DR or FF food. Like wildtype flies, dGCN2 null flies pre-treated on DR food 
were more resistant to starvation than those pre-treated on FF food (P=0.001 for both 
genotypes, log-rank test, Figure 4.6b). Both DR and FF dGCN2 null flies were less 
resistant than wildtype flies to starvation stress (P<0.001 for comparisions of both food 
conditions, log-rank test).  
 
Our data suggests that the effects of dGCN2 deletion on lifespan under DR conditions 
cannot be attributed to TAG levels, or the ability to resist starvation stress. 
 
 
4.2.5. Testing for interaction between the dTOR and GAAC pathways 
 
The TOR pathway interacts with other NSPs, such as IIS, through a complex and extensive 
web of interactions (for review, see Grewal, 2009). To test whether there is any cross-talk 
between the dTOR pathway and the GAAC pathway to alter lifespan, we treated dGCN2 
flies with rapamycin, a pharmacological inhibitor of dTOR, and assessed their survival 
under DR conditions. We previously showed that rapamycin rescues the detrimental 
effects of EAAs on by dTOR downregulation (chapter 3), and we have used this same 
paradigm to test whether dGCN2 null flies are also sensitive to EAA supplementation and 
whether this can be rescued with rapamycin treatment. Indeed, EAA supplementation 
significantly decreased the lifespan of dGCN2 null flies from the level of DR, and this was 
rescued by the addition of rapamycin, as for wildtype flies (Figure 4.7a). CoxPH analysis 
of the lifespan data confirms that there is no interaction between genotype and food 
(P=0.42), despite significant effects on lifespan of genotype and food independently 
(P<0.001 for both variables). 
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Figure 4.7. The lifespan and fecundity effects of rapamycin treatment on dGCN2 null 
flies. 
(a) Both wildtype and dGCN2-/- female flies maintained on dietary restricted food 
supplemented with the essential amino acids (DR+EAA) had significantly shorter lifespans 
compared to flies maintained under DR, and for both genotypes rapamycin addition to the 
DR+EAA condition (DR+EAA+Rapa) rescued lifespan to the level of DR. Cox Proportional 
Hazards analysis, used to determine the significance of the effects of genotype and food 
treatment on lifespan, confirmed a significant effect of food on lifespan (P<0.001), and also an 
effect of genotype (P<0.001), but no interaction effect of genotype and food (P=0.42). Median 
lifespans (days) are quoted in brackets on the graph. n=150 per genotype per condition.  
(b) There was no difference in egg-laying between dGCN2-/- and wildtype flies on any of the 
food conditions. For both genotypes, EAA-supplemented flies laid more eggs than DR flies 
and rapamycin addition significantly reduced egg-laying. Statistical analysis using a linear 
model revealed a significant effect on egg-laying of food condition (P<0.001), but no effect of 
genotype (P=0.29), nor was there an interaction effect between food treatment and genotype 
(P=0.57). Egg counts were made at 8 days of food treatment. n=100 per genotype per 
condition. 
 
Also in a similar manner to wildtype flies, EAA supplementation of DR food boosted the 
egg-laying of dGCN2 null flies, and this was dramatically reduced upon additional 
rapamycin treatment (P<0.001 for the effect of food condition on egg-laying; P=0.29 for 
the effect of genotype on egg-laying; linear model; Figure 4.7b). This response of egg-
laying to food condition was not significantly altered by dGCN2 deletion (P=0.57, linear 
model). Together, these data suggest that the lifespan and egg-laying effects seen for 
dGCN2 null flies are not achieved through alteration of dTOR signalling.  
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4.3. Discussion 
 
In this work we set out to establish a role for the GAAC nutrient signalling pathway in 
mediating the lifespan extending effects of DR. We tested the responses of dGCN2 null 
flies to a range of nutritional manipulations. Our results implicate the GAAC pathway in 
mediating, at least partially, lifespan alteration under DR. 
 
Flies lacking dGCN2, although still being long-lived under DR compared to when fully 
fed  exhibit a lifespan response ‘tent’ to a range of dietary yeast concentrations that differs 
from wildtype flies. While the lifespan response to DR was not completely abolished for 
dGCN2 null flies, the absence of dGCN2 conferred some effect on the way that lifespan 
changed with yeast dilution; dGCN2 deletion shifted the response tent such that lifespan 
peaked at a higher yeast concentration compared to wildtype flies, effectively changing the 
range of foods qualifying as DR. Our data supports a role for dGCN2 in playing a partial 
role in mediating the lifespan effects of DR. It would be interesting to learn whether GCN2 
deletion could change the DR response for worms and rodents. 
 
In order to understand the interaction between dGCN2-mediated lifespan regulation and 
DR-mediated lifespan regulation, we selected phenotypes that we had previously predicted 
to be coupled to lifespan extension under DR (chapter 3), namely, increased TAG levels 
and improved resistance to starvation. We characterised dGCN2 null flies for these 
phenotypes. We found no evidence that dGCN2 modified these phenotypic responses to 
DR, suggesting that dGCN2 downregulation may not extend lifespan via the same 
mechanisms that DR might, if the phenotypic correlates of DR-induced longevity that we 
identified in chapter 3 are indeed causal. Alternatively, increased TAG and starvation 
resistance are not causal for longer life. dGCN2 null flies still exhibit the same response to 
DR as wildtype flies, indicating that if fat is important for both lifespan and starvation 
resistance under DR, then it is likely that they are affected by different types of fat, and 
modification of dGCN2 affects the type that governs the response to starvation. dGCN2 
null flies are equally as fat as wildtype flies when maintained on either a DR or a FF diet, 
yet they are significantly more sensitive to starvation than wildtype flies for both of these 
conditions. This may suggest that they have a defect in utilising stored fat for survival 
under starvation. Indeed, previous studies have implicated a role for GCN2 in the 
regulation of lipid metabolism; GCN2 null mice, upon dietary leucine deprivation, are 
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unable to repress the expression of lipogenic genes and the activity of fatty acid synthase, 
and are unable to mobilise adipose lipid stores. As a result, they develop liver steatosis, an 
accumulation of fat in the liver (Guo and Cavener, 2007).   
 
GCN2 has been shown to be involved in the protective effect of EAA restriction against 
ischemia reperfusion injury, a type of surgical stress, in a mouse model (Peng et al., 2012). 
It is therefore possible that similar protective responses occur in flies upon starvation, and 
this may account for the observation that dGCN2 null flies are sensitive to starvation 
stress. However, we would not expect that GCN2 offers globally heightened stress 
protection, since we found that dGCN2-deficient flies were more resistant to an 
immunological challenge compared to wildtype flies. 
 
The Drosophila lifespan response to DR is often accompanied by decreased egg-laying 
with dilution of dietary yeast. This pattern was observed for both our wildtype and dGCN2 
null flies, indicating no effect of dGCN2 deletion on egg-laying. If dGCN2 does indeed 
regulate the lifespan response to DR, then it is not achieved via altered egg-laying, which 
in turn implies that egg-laying is not intimately linked to lifespan under DR. In other 
words, that increased lifespan and decreased egg-laying are correlated effects of DR, but 
not necessarily functionally coupled to each other. Alternatively, the potential role of 
dGCN2 to regulate lifespan is so subtle that any accompanying egg-laying effect does not 
manifest as a significant change. Further replication would resolve this issue. 
 
The effect on lifespan of dGCN2 heterozygous flies across the yeast dilution 
concentrations that we tested were largely intermediate to that for dGCN2 null flies, as we 
might expect since dGCN2 heterozygous flies have one functional copy of dGCN2, as 
opposed to two functional copies in wildtype flies and no copies in dGCN2 null flies, 
perhaps suggesting a dose dependent effect for dGCN2 activity. This could be tested by 
measuring the phosphorylation of eIF2α as a quantitative readout of dGCN2 activity. 
 
Loss-of-function mutations in yeast and mouse GCN2 have no apparent phenotypic effect 
under standard dietary conditions. However, negative effects have been shown to manifest 
when the mutants encounter dietary imbalanced conditions. We found that dGCN2 null 
flies had very similar development times to wildtype flies on the various dietary yeast 
concentrations that we tested, perhaps suggesting that dGCN2 is not involved in 
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developmental processes. We did, however, see a decrease in body weight for GCN2 null 
flies maintained on 0.2x Y, and this condition may be considered imbalanced since the 
yeast:sugar ratio is changed from that which is optimal for lifespan, egg-laying or most 
aspects of physiology. Given that the phenotypic manifestation of GCN2 deficiency has 
been shown to arise under a dietary imbalance, it is possible that this is the case for the 
body weight phenotype that we have observed here. 
 
Our data indicate a role for dGCN2 in the regulation of lifespan responses to diet in 
Drosophila, satisfying the expectations of the GAAC pathway as a nutrient 
sensing/signalling pathway. Previous studies have shown that GCN2 null animals are more 
sensitive, compared to wildtypes, to nutrient stress (Anthony et al., 2004; Marion et al., 
2011; Rousakis et al., 2013). Interestingly, and counter to this, dGCN2 null flies are longer 
lived than wildtype flies on the lowest yeast concentration that we tested (0.5x Y), which 
either means that this concentration of yeast was not low enough to qualify as a condition 
of nutrient stress, or that in the context of dGCN2 signalling a nutrient stress is defined as 
an imbalance of the constituent nutrients relative to each other, which we do not consider 
to be the case in our 0.5x Y condition since it is just a diluted form of the complete 
medium. This suggests that dGCN2 is activated by the relative deficiency of one or more 
specific nutritional components – most likely an amino acid(s) since it is known that 
GCN2 is activated by uncharged tRNAs. Indeed, we find support for this hypothesis in our 
observation that dGCN2 null flies have heightened sensitivity to omission of a single EAA 
from the diet, compared to wildtype flies, even though dGCN2 null flies are longer-lived 
than wildtype flies on a complete food medium. Our data also indicate that this response is 
specific to a subset of amino acids, since we did not observe the same relative sensitivity 
of dGCN2 null flies to methionine  deficiency. 
 
Unlike for the other EAAs tested, dGCN2 deletion appears to attenuate the detriment to 
lifespan conferred by methionine deficiency, which implies that in a wildtype fly dGCN2 
functions to sensitise the fly to methionine deficiency. dGCN2-deficient flies also lay more 
eggs than wildtype flies upon methionine deficiency. The evolutionary selection of a 
mechanism that decreases lifespan and egg-laying in the face of methionine deficiency 
seems counter intuitive. However, it may have evolved as a protective measure, perhaps 
serving to alert the animal to the dietary insufficiency in its environment, thereby 
prompting the pursuit of a more sustainable food source. In chapter 5 we present data 
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supporting the hypothesis that flies show aversion to deficient food sources, presumably as 
a mechanism to increase the likelihood of subsequent foraging for an alternative food 
source in the environment. 
 
The TOR and IIS nutrient signalling pathways, although have distinct constituent proteins, 
have overlaps within their extended networks, and we hypothesised that the GAAC 
pathway may also lie within this web of interaction. However, we found no evidence to 
suggest an interaction between the GAAC pathway and the dTOR pathway. Despite our 
findings, studies in yeast have shown that rapamycin treatment leads to GCN2 activation 
(Cherkasova and Hinnebusch, 2003; Kubota et al., 2003), and a recent study in C. elegans 
suggests that the GAAC pathway interacts with the TOR pathway to regulate survival 
under nutrient stress (Rousakis et al., 2013). Further work to characterise the relationship 
between the GAAC and TOR pathways in Drosophila would benefit from molecular 
analysis of downstream readouts of both dGCN2 and dTOR, such as eIF2α 
phosphorylation and S6K phosphorylation, respectively. Additionally, generating double 
mutant fly lines that have deficient dGCN2 and dTOR activity could be useful to study the 
reciprocal effects of these pathways. 
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Chapter 5 - Molecular regulation of feeding behaviour 
 
 
5.1. Introduction 
 
An essential physiological objective for all organisms is to monitor and regulate their 
nutritional intake to support requirements for processes such as growth, reproduction, 
metabolism and general physiological maintenance. This regulation seeks not only to 
optimise energy balance  but also to optimise the balance of the macronutrients relative to 
each other. In addition  dietary components such as vitamins  minerals  cholesterol and 
fibre  which do not have a significant energetic value  may still play important roles in 
regulating metabolic and other physiological processes  and their intake must be regulated.  
 
Animals need to be able to sense and adapt to encounters of sub-optimal nutritional 
conditions to avoid malnutrition  and they also need to be able to recognise when they are 
fully nourished to avoid the harmful effects of overeating. How an organism’s internal 
nutritional state is communicated to influence its feeding choices is a question of great 
interest  and several studies have sought to elucidate the mechanisms that dictate the 
behavioural adaptations through which animals attain and maintain a nutritional optimum. 
One of the major drivers of brain evolution is thought to be foraging  and correlations have 
been noted between an animal’s ecological condition and their brain si e. For example  
fruit-eating spider monkeys are considered to be more intelligent than the leaf-eating 
howler monkeys  and this has been attributed to the fact that spider monkeys have to 
forage more extensively to find fruits  which are less abundant than leaves   ilton  1  3 . 
 
The physiological state of an organism can change in response to many factors. For 
example  with the dietary environment  in response to biological processes such as 
development  reproduction and ageing  and in the face of environmental stressors such as 
starvation  infection and toxicity. It is likely that the physiological status of an animal will 
influence how it proceeds to feed in order to optimise survival for that physiological state.  
 
An abundant literature suggests that animals carefully regulate their dietary protein intake 
and this has been demonstrated experimentally with dietary manipulations both in the 
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context of changes in protein quantity and protein quality. Changes in absolute protein 
quantity have been shown to affect feeding in rats, such that diets high in protein suppress 
feeding, diets moderately low in protein increase food intake, and diets with insufficient 
amounts of protein suppress feeding (Bensaïd et al., 2003; Du et al., 2000; Peters and 
Harper, 1985). When given the choice, rats readily abandon high protein food sources for 
the control diet (Peters and Harper, 1984). The hyperphagic response of rats fed a 
moderately low protein diet is thought to be due to an effort to increase protein intake 
(White et al., 1994). However, for food sources with insufficiently low amounts of protein, 
where hyperphagia is not able to overcome the protein deficit, rats were found to abandon 
the food and reduce their intake (Du et al., 2000). Moreover, the hyperphagic effect on the 
moderately low protein diet, was more apparent in young rats compared to older rats, 
likely due to an increased demand for protein for growth in young rats (White et al., 2000). 
Similarly, growing pigs were shown to be able to differentiate between foods differing in 
their protein content and selected between these diets according to their changing demands 
for protein (Bradford and Gous, 1991). Birds bred for high muscle mass choose diets with 
a higher percent protein in comparison to control birds (Forbes and Shariatmadari, 1994). 
Similarly, rats subjected to chronic injections of growth hormone show a higher preference 
for protein (Roberts et al., 1995). In locusts, hunger for protein has been found to be the 
reason for swarming, during which they eat everything in their path, including other non-
swarming locusts, with the aim of attaining a protein intake target (Simpson et al., 2006), 
which is the level of nutrient intake that satisfies an animal’s optimal requirements and 
maximises its performance, where performance can be fecundity, survival, stress 
resistance, etc. The target intake is plastic, as protein demands change with changes in 
physiology. Locusts sated with protein stop swarming (Simpson et al., 2006), and injecting 
amino acids into the haemolymph of protein-deprived locusts reduces their feeding rate 
(Abisgold and Simpson, 1987). 
 
There is also data to suggest that humans subconsciously regulate  to some extent  their 
ingested nutrient balance. However  food choice decisions for humans are influenced by a 
complex social context and by conscious preferences for certain tastes that could 
potentially override any nutritional requirements. Nevertheless  it has been shown that 
people regulate their food intake  and that they regulate protein intake more strongly than 
carbohydrate and fat   artine -Cordero et al.  2012; Simpson and Raubenheimer  2005; 
Simpson et al.  2003 . The protein leverage hypothesis proposes that people have a 
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dominant appetite for protein  and when a diet does not allow both the protein and 
carbohydrate intake targets to be achieved simultaneously  protein intake is prioritised and 
people will eat more of a food source with a low protein to fat/carbohydrate ratio in an 
effort to meet their protein intake target. It has been theorised that this is one of the main 
drivers of obesity  since the consequence of attaining a protein intake target in this way is 
an excess intake of fat and carbohydrate. A test of protein leverage in humans revealed that 
protein intake was maintained at a constant level across a range of diets containing 
different proportions of protein  Gosby et al.  2011 . In this short-term study  subjects had 
ad libitum access to the fixed menus, which were designed to be of similar palatability and 
sensory quality in order to minimise any variability in food-choice attributed to taste. At 
the population level, there has been a progressive reduction of protein intake over the past 
few decades, and this has been associated with an increase in energy intake and obesity 
(Austin et al., 2011; Simpson and Raubenheimer, 2005), perhaps owing to economic 
pressures that encourage greater consumption of cheap sugar and fatty foods (Brooks et al., 
2010), as well as the fact that these foods are generally considered to be more appetising 
(Austin et al., 2011; Simpson et al., 2003). Protein leverage has also been demonstrated in 
several other species  such as non-human primates  Felton et al.  200    pigs  Kyria akis et 
al.  1  1   mice  Sørensen et al.  200    fish  Raubenheimer et al.  2005  and insects 
 Raubenheimer and Simpson  1  7 . In one experiment  rats that were given eight different 
imbalanced but complementary food pairings ingested a similar intake of both protein and 
carbohydrate  Simpson and Raubenheimer  1  7; Theall et al.  1  4 . 
 
 etabolically  protein represents nitrogen  amino acids  and digested peptides  so which of 
these dietary components is being selected for by animals that regulate protein intake?  
Evidence indicates that rather than just aiming towards a bulk nitrogen target, animals 
specifically select amino acids. Animals display aversive behaviour towards amino acid -
deficient or -imbalanced food sources and actively select more balanced foods when given 
the choice, even if the diets contain the same level of nitrogen. Rats appear to be able to 
detect imbalanced diets and avoid them, and will preferentially select a diet containing an 
adequate amount of a particular essential amino acid (EAA) over a diet that is deficient in 
that EAA. Similarly, they will select a diet with a balanced amount of all of the EAAs over 
a diet with excessively high amounts of one or more EAAs (Harper and Peters, 1989). 
Behavioural responses to manipulations of particular EAAs have been demonstrated for 
threonine (Gietzen et al., 1992; Leung et al., 1968), tryptophan (Mori et al., 1991), 
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isoleucine (Naito-Hoopes et al., 1993), methionine (Peng et al., 1975), histidine (Rogers 
and Harper, 1970; Sanahuja and Harper, 1962), lysine (Markison et al., 1999; Torii et al., 
1987) and valine (Murphy and King, 1989). Rats stop eating an imbalanced food before 
satiation, usually within 20 minutes (Koehnle et al., 2003). This timeframe is too long to 
be attributed to taste, but is also too rapid to be explained by a transcriptional response. 
Lysine-deficient rats identified and readily ingested a bitter solution of a lysine and 
hydrochloric acid (HCl), which they preferentially selected within a choice of 15 other 
solutions, to replete their lysine stores (Mori et al., 1991; Tabuchi et al., 1991; Torii et al., 
1996). After being fed a diet containing adequate lysine, the rats no longer opted for the 
lysine HCl solution (Mori et al., 1991).  The same response has also been shown for 
histidine-deficient rats offered a histidine HCl solution (Rogers and Leung, 1977).  
 
There seems to be some physiological mechanism that evaluates the balance of internal 
protein with feedback to regulate dietary protein/amino acid selection. However  it is not 
known whether animals feed for a specific limiting amino acid  whether they seek a 
balance of all amino acids  or whether they just avoid dietary imbalances.  oreover  it is 
not known whether this selection is based on an ability to directly detect these dietary 
components  or whether it is a secondary learned response that couples sensory cues with 
postingestive consequences   orrison et al.  2012 . Internal nutrient sensors may act by 
enabling effector neurons to directly sense the levels of circulating nutrients  or 
alternatively by employing hormones or other such nutrient-sensitive signals to relay 
information about nutrient status to the nervous system to elicit a behavioural response. 
The post-oral gastrointestinal  GI  tract expresses sweet  bitter  and umami taste receptors 
that can ‘taste’ specific nutrients  Raybould  200 ; Tsurugi awa and Torii  2010   and 
given that the GI system co-ordinates the release of gut hormones  it is possible that 
dietary signals can influence the brain in this way. However  the evidence rules out the GI 
system as the chemosensor for dietary amino acid imbalance  and also rules out the 
involvement of smell and taste in this mechanism  Giet en  1  3; Giet en and Rogers  
2006; Giet en et al.  1   ; Harper et al.  1 70; Rogers and Leung  1 73  1 77 . Organs 
such as the liver  which is the site of protein metabolism  and skeletal muscle  which is the 
primary storage site for amino acids  may play significant roles in conveying information 
about amino acid metabolism to the brain  just as leptin from adipose tissue informs about 
internal energy stores.  
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How feeding behaviour is neurologically regulated is the subject of current investigation in 
the field. The first suggestion that the brain is involved in sensing dietary amino acid 
imbalance came from the observation in rats that following an amino acid-imbalanced 
meal  the levels of the limiting amino acid decreased in brain tissue as quickly as it did in 
the plasma  Peng et al.  1 72 .  oreover  amino acid-deficient rats infused with the 
limiting amino acid through the carotid artery showed a reduction in their feeding aversion 
to the imbalanced diet  whereas infusion through the jugular vein had little effect  Leung 
and Rogers  1 6  . The anterior piriform cortex (APC) brain region in particular has been 
shown to play an important role in the feeding response to dietary amino acid imbalance. 
In rats, using brain-lesioning techniques to destroy brain areas associated with food 
selection and feeding, the chemosensor for EAA imbalance was identified to be located in 
the APC (Leung and Rogers, 1971). Rats with lesions in the APC no longer showed 
aversion to an amino acid imbalanced. This was also demonstrated in birds (Firman and 
Kuenzel, 1988). Moreover, amino acid-deficient diets deplete the APC of the limiting 
amino acid within 30 min (Koehnle et al., 2004). The accumulation of uncharged tRNAs, 
indicating low amino acid levels, in this brain region is thought to be responsible for the 
feeding response to EAA imbalanced diets, since microinjection of tRNA synthetase 
inhibitors into the APC of rats decreased food intake just 20 minutes after injection (Hao et 
al., 2005). Reciprocally, other studies have shown that microinjection of a limiting amino 
acid into the APC re-established a level of feeding to that on an EAA balanced diet 
(Beverly et al., 1990; Monda et al., 1997; Russell et al., 2003). Evidence for the 
involvement of the APC in nutrient sensing seems to be limited to the sensing of protein 
quality, rather than protein quantity – lesions of the APC which have been shown to 
prevent aversive behaviour towards EAA-deficient diets do not appear to prevent the 
aversion of rats to high protein food sources (Leung and Rogers, 1971). In one study in 
humans  stimulation of the dorsolateral prefrontal cortex, a brain area involved in 
'executive functions', increased cravings for high-calorie diets (Lowe et al., 2014). Several 
neurophysiological pathways have also been implicated in subconscious food choice 
(reviewed in Cohen, 2008). 
 
The specific search for a molecular mechanism of behavioural aversion to amino acid 
imbalanced foods has led to interest in the potential roles of nutrient sensing pathways 
(NSP), the three best characterised of which are the general amino acid control (GAAC) 
signalling pathway, the target of rapamycin (TOR) signalling pathway, and the 
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insulin/insulin-like growth factor signalling  IIS  pathway  see chapter 1.3 . The GAAC 
pathway has attracted much interest as a potential control mechanism of dietary intake 
since mammalian GCN2 directly binds and is activated by uncharged tRNAs (Hao et al., 
2005). Many reports indicate that GCN2 is involved in the detection of protein quality, 
such that GCN2 null animals are insensitive to EAA imbalance in comparison to their 
wildtype controls, and unlike wildtypes they do not display an aversion to these 
imbalanced foods, likely due to the fact that they cannot detect the inadequacy in the food 
source. A food source deficient in threonine has been shown not only to be rejected by 
wildtype rodents  but also results in the increased phosphorylation of eIF2α, which is a 
downstream effector of GCN2 activity, in the APC. GCN2 null mice do not reject a 
threonine-devoid diet  and also do not show the same increase in eIF2α phosphorylation 
(Gietzen et al., 2004; Hao et al., 2005; Maurin et al., 2005). The GAAC in the APC is 
activated in the requisite 20-minute period for the recognition of amino acid imbalance, 
and brain-specific deletion of GCN2 in mice prevented the aversion to amino acid-
imbalanced diets (Maurin et al., 2005). IMPACT, an actin-binding protein, primarily 
expressed in the rat hypothalamic brain region, was shown to inhibit the activation of 
GCN2, and accordingly decreased phosphorylation of eIF2α (Pereira et al., 2005). The 
lack of IMPACT in the APC brain region is consistent with a role for GCN2 in the APC in 
sensing amino acid imbalances (Gietzen et al., 2007).  
 
Work from Drosophila has shown that larvae exhibit an aversion phenotype on amino 
acid-deficient food, and normal feeding can be restored upon addition of the limiting 
amino acids to the food (Bjordal et al., 2014). This study also pinpoints the neurological 
basis of these observations to the dopaminergic neurons, and proposes that the 
dopaminergic circuitry negatively regulates feeding. Both reduction of dopaminergic 
neuronal signalling and dopaminergic-targeted GCN2 downregulation attenuated the 
aversion phenotype on the amino acid imbalanced food, as did the knockdown of ATF-4, 
which lies downstream of GCN2 in the GAAC pathway. Conversely, targeted 
overexpression of GCN2 in the dopaminergic neurons resulted in the larvae exhibiting 
aversion to both control and amino-acid imbalanced food, and this aversion phenotype was 
also observed in adult flies with overexpression of GCN2 in the dopaminergic neurons.  
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The TOR pathway has also been implicated in the modulation of feeding behaviour 
 Ribeiro and Dickson  2010; Vargas et al.  2010; Wu et al.  2005a   as has the IIS pathway 
 Britton et al.  2002; Wu et al.  2005b; Zhao and Campos  2012 . The TOR nutrient-
sensing pathway regulates feeding via the sex peptide receptor (SPR) (Ribeiro and 
Dickson, 2010). Male and female Drosophila deprived of protein preferentially choose a 
yeast-containing food over a non-yeast food source, and in females this behaviour has been 
found to be dependent on mating status. This feeding decision in females relies on the 
binding of a sex peptide ligand, present in the seminal fluid of males, to the SPR in the 
neurons of the female reproductive tract. This process is regulated by the dTOR pathway, 
possibly functioning to signal the nutritional status of the fly  thereby matching the fly’s 
feeding choices to its nutritional needs. TOR signalling has also been implicated in 
mediating the increased preference of female Drosophila for yeast following mating 
(Vargas et al., 2010). Virgin female flies overexpressing constitutively active dS6K, 
encoding a downstream effector of dTOR, had increased serotonin production in the 
neuronal tissue and exhibited an increased preference for yeast, which was not seen for 
mated females, suggesting a role for dS6K in mediating the post-mating dietary switch in 
flies. It has also been shown that overexpression of the Drosophila insulin-like peptides 
(DILPs) in the neurons of fasted larvae attenuates the hyperphagic feeding upon exposure 
to a sub-optimal food source, and that neuronal dS6K is involved in the regulation of this 
hunger-driven response (Wu et al., 2005a). 
 
In rats, mTOR signalling in the hypothalamus brain region responds to nutrient availability 
to regulate food intake - leucine increases hypothalamic mTOR signalling resulting in an 
inhibition of food intake by 4 hours (Cota et al., 2006). Moreover, the satiety hormone 
leptin was shown to increase hypothalamic mTOR signalling, and inhibition of mTOR 
attenuates the ability of leptin to suppress appetite, suggesting a role for mTOR as a fuel 
sensor in the regulation of energy intake. However, despite its well described role in amino 
acid sensing, in particular leucine, there is no evidence to suggest that mTOR signalling 
plays a role in the detection of amino acid deficiency (Gietzen et al., 2007). Moreover, 
injection of the TOR inhibitor rapamycin into the APC of rats did not affect food intake of 
either an amino acid-deficient diet or a control diet (Hao et al., 2010).  
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Adult Drosophila melanogaster are composed mainly of post-mitotic tissue, and have little 
cell proliferative activity. Therefore, their nutritional requirements are mostly for egg-
laying, physical activity and general somatic maintenance. Reproduction responds rapidly 
to nutrition, such that Drosophila exhibit an increase in egg-laying as well as an increase 
in re-mating frequency (Chapman and Partridge, 1996; Chippindale et al., 1993). In 
particular, egg-laying and lifespan are limited by dietary protein  chapter 3 , (Chippindale 
et al., 1993; Mair et al., 2005; Piper et al., 2005). In this chapter we aim to characterise the 
feeding responses of Drosophila to different nutritional manipulations, starting at changes 
in the amount of total protein, to more specific alterations at the level of single EAAs. 
Using genetic fly models, we investigate the role of nutrient sensing pathways, such as the 
GAAC and IIS pathways, in mediating these behavioural responses to dietary change. 
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5.2. Results 
 
5.2.1. The feeding responses of flies to alterations of dietary protein 
 
To assess the potential role of protein in modifying fly feeding behaviour, we altered the 
concentration of the yeast component in our standard laboratory diet (SY food), which is 
the flies' only source of protein, to 0.2x, 1x and 2x. The highest level of feeding was seen 
on 1x yeast, with slightly lower feeding on 2x yeast, and very low feeding on 0.2x yeast 
(P<0.001, linear model; Figure 5.1a). The 0.2x yeast condition is severely yeast-
compromised, as demonstrated by delayed larval development and low egg-laying (Figure 
5.1b-c).  
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Figure 5.1. Feeding, development and egg-laying phenotypes of wildtype female flies on 
varying yeast concentrations. 
(a) Flies fed at different rates across diets with different yeast concentrations: 0.2x, 1x and 2x 
yeast (of the standard SY diet) (P<0.001, linear model). The lowest level of feeding was 
observed on 0.2x yeast, with peak feeding on 1x yeast. Results from 23 independent trials are 
displayed. Scatter points represent the mean proportion feeding, with grey lines connecting 
cohorts in the same experiment. Box plots indicate the variation between trials. (b) The 
development time of flies increased with each dilution of yeast concentration of the food on 
which they were reared. Flies reared on the 0.2x yeast condition had dramatically delayed 
development times compared to those reared on food containing 1x and 2x yeast (P<0.001; 
Wilcoxon rank-sum test; days from 1
st
 instar larvae). (c) Egg-laying decreased with lowered 
concentrations of dietary yeast (P<0.001 for each comparison; Wilcoxon rank-sum test). Errors 
represent the s.e.m.  
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Since yeast contains essential nutrients other than protein that could be responsible for the 
feeding phenotype we observed above, we further examined the effect of protein dilution 
using a holidic medium, a fully defined diet in which individual nutrients can be 
independently manipulated (Piper et al., 2014; see chapter 2.2.3). In this diet, protein is 
substituted for by a mixture of the 20 standard protein-encoding amino acids. We 
compared feeding in flies maintained on a complete food source containing all 20 amino 
acids to those maintained on food lacking all amino acids but whose composition was 
otherwise unchanged. We found that flies fed, on average, 66% less on food without amino 
acids (P<0.001, linear model; Figure 5.2a).  
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Figure 5.2. Feeding rates and egg-laying of wildtype female flies treated for 5 days 
on food media with manipulations of amino acid content. 
(a) Flies fed at a higher rate on food containing all 20 amino acids (AA), compared to food 
containing no amino acids. Results from 6 independent trials are displayed. (b) Flies fed at a 
higher rate with addition of the 20 AAs in the food media, but there was no observable 
difference in feeding between diets containing 0.5x, 1x and 1.5x AAs (P=0.48, linear model, 
n=1 trial). Egg-laying was higher with each increase in AA concentration (P<0.001, linear 
model). (c) Flies fed at a higher rate on food containing 0.25x AA than on food containing 0.5x 
AA (P=0.03, n=3 independent trials), with an accompanying increase in egg-laying from 0.25x 
AA to 0.5x AA (P<0.001, linear model, n=1 trial). (d) Flies displayed a higher rate of feeding 
(n=2 independent trials) and egg-laying (n=1 trial) on food containing only the 10 essential 
AAs (EAA) than on food containing only the 10 non-essential AAs (NEAA) (P<0.001 for both 
traits; linear model). Scatter points represent the mean proportion feeding, with grey lines 
connecting cohorts in the same experiment. Box plots indicate the variation between trials. 
Bars represent mean egg-laying ±s.e.m from one representative trial. P-values for proportion 
feeding are displayed on the graphs (linear model). 
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We tested whether flies change their feeding upon exposure to different concentrations of 
amino acids (AA). We tested four different concentrations of a solution containing the 20 
AAs: 0x, 0.5x, 1x and 1.5x. Flies showed no difference in feeding between foods 
containing 0.5x, 1x and 1.5x AAs (P=0.48, linear model; Figure 5.2b), but fed at lower 
levels on food containing no amino acids. Consistent with each group of flies ingesting 
equal amounts of an increasingly protein-rich diet, egg laying increased for each increase 
in dietary amino acid concentration (P<0.001, linear model). It is possible that the three 
amino acid -containing foods tested all had too high an amino acid concentration to elicit 
any difference in feeding between them, perhaps because at all three concentrations flies 
were feeding the maximum volume that they physically could. So we extended the range 
of conditions to include an additional, lower amino acid concentration; 0.25x. This time 
we were able to resolve a difference in the rate of feeding between 0.25x and 0.5x AAs, 
where flies fed slightly more on 0.25x AAs than on 0.5x AAs (P=0.03, linear model, 
Figure 5.2c), but laid fewer eggs (P<0.001, linear model). Given that the difference in the 
rate of feeding between flies on these two conditions was not very large, the more 
pronounced difference in egg-laying may be expected. This is similar to the feeding and 
egg-laying responses to 1x yeast and 2x yeast, where there is only a slight difference in 
feeding between flies on these two conditions, but a disproportionally larger difference in 
egg-laying, where flies fed 2x yeast produced more eggs than those fed 1x yeast (Figure 
5.1a, c). 
 
We then asked whether either the ten essential amino acids (EAAs) or the ten non-essential 
amino acids (NEAAs) could account for the lowered feeding observed when all 20 amino 
acids were removed. To test this, we separately omitted EAAs or NEAAs from the food 
and measured the feeding response. Flies fed 30% less on medium lacking NEAAs, 
compared to a complete amino acid medium, but EAA deficiency produced a more 
pronounced difference in feeding than NEAA deficiency, with flies fed an EAA-deficient 
diet feeding 58% less than those fed all 20 amino acids. In fact, flies fed 40% less on the 
EAA-deficient food compared to the NEAA-deficient food (P<0.001, linear model; Figure 
5.2d). Moreover, egg-laying was significantly compromised when either the EAAs or the 
NEAAs were removed from the food compared to that of flies maintained on the complete 
medium (P<0.001; linear model). Similar to the effect on feeding, EAA-deficiency had the 
greatest effect on egg-laying, with 82% fewer eggs laid, compared to 20% lower egg-
laying upon NEAA-deficiency. Interestingly, flies lacking the 10 EAAs, while still having 
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the 10 NEAAs, produced fewer eggs than flies fed a medium containing no amino acids at 
all, suggesting that disproportionate amounts of the EAAs relative to each other is less 
favourable for egg-laying than the absence of all amino acids, highlighting the importance 
of amino acid balance. 
 
 
5.2.2. The feeding responses of flies to single EAA deficiency 
 
We tested whether the difference in feeding could be further resolved at the level of a 
single amino acid. Since the feeding effect was greater for EAA alteration than it was for 
NEAA alteration, and because several rodent studies implicate the importance of EAAs in 
animal foraging behaviour (Morrison et al., 2012), we focussed on the EAAs for 
subsequent investigations. We selected 4 EAAs for testing, covering a range of 
biochemical functional groups; namely arginine, tryptophan, leucine and methionine, 
representing cationic, aromatic, branch-chained and sulphur-containing groups, 
respectively. We singly omitted these EAAs from the food source and measured the 
feeding response of flies to these deficient diets.  
 
We found that flies had significantly lower feeding on diets lacking each of the four EAAs 
that we tested, compared to flies maintained on food containing all 20 amino acids 
(P<0.001 for all comparisons; linear model; Figure 5.3a-d). However, the magnitude of 
this feeding difference varied for each amino acid omission, with tryptophan omission 
producing the greatest difference in feeding, followed by arginine omission, then 
methionine omission, with leucine omission displaying the smallest difference in feeding. 
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Figure 5.3. Feeding rates of wildtype female flies treated for 5 days on food media 
deficient in a single essential amino acid (EAA). 
Omitting the EAAs (a) arginine (n=9 independent trials), (b) tryptophan (n=2 independent 
trials), (c) methionine (n=13 independent trials), and (d) leucine (n=7 independent trials) from 
a complete diet containing all 20 amino acids resulted in lower feeding in each case of the 
deficient diet. Scatter points represent the mean proportion feeding, with grey lines connecting 
cohorts in the same experiment. Box plots indicate the variation between trials. A linear model 
was used to assess the differences in proportion feeding, with P-values displayed on the graph. 
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5.2.3. The role of the GAAC pathway in mediating feeding responses to single EAA 
deficiency 
 
We used dGCN2 null flies to establish whether dGCN2 has a role in mediating the feeding 
responses to the single EAA dropout conditions tested earlier. We analysed these data 
using a standard linear model to establish an effect of food type on feeding, an effect of 
genotype, and an interactive effect between these variables, i.e. do dGCN2 null flies 
respond to the single EAA dropout conditions in the same way that wildtype flies do? We 
combined data from various trials and accounted for this in our statistical model by 
assigning the experimental trial variable as a random effect. We found that across all single 
EAA omission groups tested there was a significant effect of genotype on feeding 
(P<0.001 for all comparisons, linear model; Figure 5.4a-d); dGCN2 null flies exhibited 
generally lowered feeding across all conditions relative to wildtype flies. Similar to the 
response of wildtype flies, dGCN2 null flies also exhibited lower feeding when either 
arginine, tryptophan or leucine were omitted from the diet, compared to their feeding on 
the complete food condition (P<0.001 for all comparisons, linear model). Unlike wildtype 
flies, however, there was no effect on feeding for dGCN2 null flies of omitting methionine 
from the food (Figure 5.4d, P=0.45, linear model). 
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Figure 5.4. The effect of dGCN2 deletion on the feeding rates of female flies in 
response to food media deficient in a single essential amino acid (EAA). 
(a) dGCN2 null flies responded in the same way as wildtype flies to a diet deficient in arginine 
(arg) (n=5 independent trials). (b) dGCN2 deletion reduced the magnitude of the difference in 
feeding between a tryptophan (trp)-deficient diet and a complete diet (n=3 independent trials). 
(c) dGCN2 null flies responded in the same way as wildtype flies to a diet deficient in leucine 
(leu) (n=5 independent trials). (d) dGCN2 deletion completely attenuated the difference in 
feeding between a methionine (met)-deficient diet and a complete diet (n=7 independent trials). 
Scatter points represent the mean proportion feeding, with grey lines connecting cohorts in the 
same experiment. Box plots indicate the variation between trials. A linear model was used to 
assess the independent and interaction effects on feeding of food type and genotype, with the 
P-values displayed. (e) dGCN2 deletion significantly altered egg-laying in response to met 
omission from a complete food medium (n=4 independent trials). Scatter points represent the 
mean egg-laying, with grey lines connecting cohorts in the same experiment. Box plots 
indicate the variation between trials. A linear model was used to assess the independent and 
interaction effects on egg-laying of food type and genotype, with the P-values displayed. 
 
The interaction effect of genotype and each EAA omission on feeding was varied; dGCN2 
null flies did not respond any differently to arginine or leucine deficiency than wildtype 
flies (arginine, P=0.11; leucine, P=0.12, linear model), but there was a significant 
interaction effect in the cases of tryptophan and methionine omission (P<0.001 for both, 
linear model). Loss of dGCN2 resulted in an attenuation of the magnitude of the difference 
in feeding between the tryptophan-deficient medium and the complete medium. 
Interestingly, dGCN2 deficiency resulted in a reversal of the feeding response to dietary 
methionine omission, such that dGCN2 null flies fed more on food lacking methionine. We 
measured egg-laying under these conditions to determine whether a there was a correlated 
egg-laying response. Both wildtype and dGCN2 null flies had lower egg-laying when fed a 
methionine-deficient diet, compared to a complete diet (P <0.001 for both comparisons; 
linear model; Figure 5.4e). In light of the feeding response of dGCN2 null flies on 
methionine-deficient foods, this egg-laying observation suggests an uncoupling of feeding 
and egg-laying responses to methionine deficiency. However, there was considerable inter-
trial variability in the egg-laying response of dGCN2 null flies to methionine deficiency, 
where some trials showed a decrease in egg-laying to varying degrees, while others 
showed no apparent difference between these conditions. Analysis of interaction between 
genotype and methionine deficiency across all trials suggests that, overall, loss of dGNC2 
affects the egg-laying response to methionine deficiency (P<0.001; linear model).  
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5.2.4. Testing a role for IIS in modulating the feeding response to single EAA deficiency 
 
In addition to the GAAC pathway, other NSPs have the potential to modulate feeding in 
response to dietary change. To test whether the IIS pathway has a role in food-choice, we 
used flies with deletions of three of the eight Drosophila insulin-like peptide (DILP) 
genes, dilp2, dilp3 and dilp5 (Grönke et al., 2010). In one trial, deletion of the dilp genes 
attenuated the difference in feeding exhibited by wildtype flies on tryptophan-deficient and 
complete food media, such that dilp 2-3,5 null flies fed at the same level on both foods 
(effect tests: food, P<0.001; genotype, P<0.001; food-genotype interaction, P<0.001; linear 
model; Figure 5.5ai). However, in another trial tryptophan omission resulted in a 
significant decrease in feeding, as seen for wildtype flies (effect tests: food, P<0.001; 
genotype, P<0.001; food-genotype interaction, P=0.84; linear model; Figure 5.5aii).  
 
The same variability for dilp2-3,5 null flies was also observed upon omission of leucine. In 
one trial there was no difference between dilp2-3,5 null flies fed a complete diet or one 
lacking leucine (effect tests: food, P<0.001; genotype, P<0.001; food-genotype interaction, 
P<0.001; linear model; Figure 5.5bi), and in another trial dilp2-3,5 null flies fed 
significantly less upon removal of leucine, like wildtype flies (effect tests: food, P<0.001; 
genotype, P<0.001; food-genotype interaction, P=0.34; linear model; Figure 5.5bii).  
 
When we tested the feeding response of  dilp2-3,5 null flies to changes in dietary 
methionine we found no difference between a complete food medium and one lacking 
methionine, whereas wildtype flies did exhibit a difference in feeding on these conditions 
(effect tests: food, P<0.001; genotype, P<0.001; food-genotype interaction, P<0.001; linear 
model; Figure 5.5c). We have only conducted one trial testing the feeding response of 
dilp2-3,5 null flies to dietary methionine manipulation, and as yet no trials have tested the 
effect of arginine omission for these flies. 
 
In all cases, wildtype flies had significantly lower feeding on the EAA-deficient food 
compared to the complete food (P<0.01 for all comparisons; linear model).  Given the 
variability we observed between trials in previous assays these values are likely to be a 
result of natural biological variation and characterisation of the behavioural response of IIS 
mutant flies to dietary EAA change requires further replication. 
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Figure 5.5. The effect of dilp2-3,5 deletion on the feeding rates of female flies in 
response to food media deficient in a single essential amino acid (EAA). 
(a) i and ii represent independent trials of wildtype and dilp2-3,5 null flies exposed to a 
complete food medium, and one lacking tryptophan (trp). In both trials, wildtype flies fed 
significantly less on trp-deficient food, but dilp2-3,5 null flies had varied responses to trp 
deficiency between trials: in one trial (i) they fed at the same rate on a complete food medium 
and one lacking trp, while in a second trial (ii) they fed less on trp-deficient food.  
(b) i and ii represent independent trials of wildtype and dilp2-3,5 null flies exposed to a 
complete food medium, and one lacking leucine (leu). In both trials, wildtype flies fed 
significantly less on leu-deficient food, but dilp2-3,5 null flies had varied responses to leu 
deficiency between trials: in one trial (i) they fed at the same rate on a complete food medium 
and one lacking leu, while in a second trial (ii) they fed less on leu-deficient food. (c) Wildtype 
flies fed significantly less on methionine (met)-deficient food compared to a complete food 
medium, while dilp2-3,5 null flies fed at the same rate on a complete food medium and one 
lacking met. A linear model was used to assess the independent and interaction effects on 
feeding of food type and genotype, with the P-values displayed.  
  
 139 
 
5.3. Discussion 
 
We have shown that flies are able to discriminate between, and accordingly alter their 
behaviour, to diets of different nutritional values. Flies are sensitive to the presence or 
absence of even a single amino acid. We hypothesised that nutrient signalling pathways 
may have a role in regulating some of these behavioural responses to changes in the 
availability of dietary EAAs, and we have shown that, at least for methionine, the GAAC 
pathway is required. 
 
EAA deficiency confers a greater effect on feeding than NEAA deficiency. It is unlikely 
that the feeding differences that we have observed between EAA and NEAA omission is 
the result of differences in the general nitrogen content of the food, since EAA or NEAA 
omission both result in a similar level of nitrogen loss from the diet used in these 
experiments (Piper et al., 2014). The difference in the level of feeding of flies maintained 
on these conditions is due to the identity of the amino acids themselves, and the 
implication is that fly feeding is largely motivated by the EAA, rather than the NEAA, 
content of the diet. Since the only source of EAAs is from the environment, we may expect 
that organisms have evolved adaptive behaviours that primarily seek out EAAs in the 
environment, more so than NEAAs which can be synthesised in the body. However, there 
is still an effect on feeding in manipulating dietary NEAAs, perhaps suggesting some 
precedent mechanism for seeking out total nitrogen. NEAAs may be costly to produce and 
therefore sought in the environment. Additionally, some EAAs serve as precursors for the 
biosynthesis of specific NEAAs, for example methionine is essential for the synthesis of 
the NEAA cysteine and the EAA phenylalanine serves as precursor for the NEAA 
tyrosine. Thus, reducing the levels of these NEAAs may indirectly create an EAA 
deficiency, and as such it can be expected that mechanisms that regulate NEAA ingestion 
may have been favoured for evolutionary selection. 
 
One interesting observation that we made was that flies that were fed a medium containing 
no amino acids laid significantly more eggs than those fed a medium containing NEAAs 
but no EAAs. This is surprising, given that the latter food condition might be considered to 
be nutritionally more valuable than the former since it contains some amino acids, as 
opposed to no amino acids at all. The fact that the flies that were fed no amino acids laid 
more eggs than those given NEAAs only supports the notion that dietary amino acid 
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balance is as, if not more, important for egg-laying than dietary amino acid abundance. A 
signal indicating the presence of NEAAs without an accompanying EAA signal may 
indicate to egg-making mechanisms that there are insufficient resources to produce eggs, 
and so inhibit egg-laying. However, this latter explanation cannot account for the observed 
increase in egg-production when no amino acids are supplied. Alternatively, the presence 
of the NEAAs without the EAAs to balance/buffer may have been toxic to the fly, thereby 
compromising egg-laying. 
 
A mechanistic question that has arisen from this work is whether the nutritional 
environment alters feeding behaviour to then in turn influence egg-laying (Figure 5.6, 
scenario a), or whether feeding behaviour changes as a response to the demand for egg 
production (Figure 5.6, scenario b). An alternative model is that feeding behaviour and 
egg-laying are influenced by the nutritional environment via distinct, parallel pathways, 
such that nutrients are signalled to regulators of egg-laying and feeding separately (Figure 
5.6, scenario c). For most of the conditions we have tested, we observed a positive 
correlation between feeding and egg-laying, indicating that scenarios a and b are correct. 
Indeed, we would expect that egg-laying would change in response to feeding, since egg-
laying potential is limited by the amount of nutrients ingested (Chapman & Partridge, 
1996). However, dGCN2 null flies, although had a higher feeding rate on the methionine-
deficient diet compared to the complete diet, did not have an accompanying increase in 
egg-laying on the methionine-deficient diet, as would be predicted by scenarios a and b 
from the model in figure 5.6. Instead, it is likely that feeding and egg-laying are governed 
by separate pathways, which, since both are influenced by similar environmental factors, 
often results in correlated changes in feeding and egg-laying. 
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Figure 5.6. A model depicting three possible scenarios to explain the relationship between 
environmental nutrient availability, egg-laying and feeding in flies. 
(a) Feeding changes in response to environmental nutrient availability, which in turn affects the 
availability of resources for egg-laying. (b) Changes in fecundity in response to perceived 
environmental nutrient availability alter feeding to support the resource demand for egg-
production. (c) Environmental nutrient availability affects feeding and egg-laying through 
independent, parallel pathways.  
 
The rate of feeding of dGCN2 null flies was lower than wildtype flies across all food types 
tested, which, if we consider the role of dGCN2 to suppress translation, is perhaps 
unexpected since we might expect that a higher level of nutrient ingestion would be 
required to support a higher level of protein synthesis. One possibility is that dGCN2 null 
flies lower their feeding in an attempt to control excess levels of protein translation. 
However, we have not experimentally verified an increase in protein synthesis for dGCN2 
null flies. We expect that deletion of dGCN2, being a central component of the GAAC 
pathway, would affect both upstream behaviours and downstream molecular changes in a 
way that may disconnect and desynchronise them, the consequences of which are difficult 
to predict. For example, dGCN2 null flies may reduce their feeding because they can no 
longer sense environmental amino acids, and even though translation suppression may be 
decreased in these flies due to loss of eIF2α phosphorylation, translation may still be 
hindered by the lack of resources due to the suppressed feeding. Thus, if the control of 
feeding occurs upstream of translation, the molecular events taking place at the level of 
translation do not directly affect feeding behaviour. It is also likely that feedback 
mechanisms come in to play to balance some of these effects, and for the GAAC pathway 
such potential mechanisms have not yet been identified. Moreover, GCN2 is known to 
have broader functions, such as cell cycle control in yeast (Tvegård et al., 2007) and lipid 
metabolism in mice (Guo and Cavener, 2007), and so it is possible that the phenotypes that 
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we have observed for dGCN2 null flies may be influenced by the effects of other 
molecular pathways that involve dGCN2.  
 
The role of translation in influencing foraging behaviour could be tested by artificially 
downregulating translation, for example by the use of pharmacological inhibitors of 
translation. If wildtype flies begin to display aversive behaviour to a complete food 
medium then it may suggest that translation activation relays a message to the brain that 
promotes foraging behaviour as a means of obtaining the environmental resources required 
to support protein synthesis. However, downregulating translation could induce deleterious 
effects in the fly, making it sick, which may itself cause aversion to food. 
 
dGCN2 null flies fed at a higher rate on food lacking methionine than on a complete 
medium, with feeding at a similar level to wildtype flies on a methionine-deficient 
medium. This suggests either/both that methionine deficiency partially rescues the low 
feeding rate exhibited by dGCN2 null flies on a complete food medium, or that deletion of 
dGCN2 deafens the signal for methionine deficiency, thereby lessening the aversion to a 
methionine-deficient food source. The current mechanistic model for GCN2 provides 
support for the latter, where uncharged tRNAs (i.e. a lack of amino acids) signal to activate 
dGCN2 and cause behavioural aversion.  
 
We find that not only is aversion to methionine deficiency reversed by dGCN2 deletion, 
but that dGCN2 null flies feed at a higher level on food lacking methionine than on a 
complete medium. This implies that dGCN2 deletion confers more than just a rescue of the 
aversive behavioural phenotype to methionine deficiency - it suggests that methionine 
deficiency, rather than methionine abundance, is the dGCN2 effector signal, and this is in 
line with the current model of signalling through the GAAC pathway, where uncharged 
tRNAs (i.e. a lack of amino acids) signal to activate dGCN2. It is noteworthy, however, 
that GCN2 is thought to respond to all uncharged tRNAs, not just those that bind 
methionine. One interpretation of our data is that dGCN2 has a higher affinity for 
uncharged tRNAs that are specific to methionine. Mechanistically, uncharged methionine-
specific tRNAs may activate dGCN2 more strongly than other types of uncharged tRNAs 
do  resulting in eIF2α phosphorylation, and subsequent inhibition of translation. Perhaps 
this inhibition of translation manifests behaviourally as a reduction in feeding, since 
protein synthesis is reduced and with it a decreased demand for resources. This may be 
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tested by the use of amino acid analogs, which are structural isomers of naturally-
occurring amino acids that are of similar shape and size, but which have no biological 
value. They work by competing with natural amino acids, replacing them in proteins, 
thereby producing dysfunctional proteins, which may in turn interfere with protein 
synthesis itself. We might expect that methionine-deficient wildtype flies fed a methionine 
analogue would feed at a similar level to flies on a complete medium. If so, it may suggest 
that the signal that alters feeding in response to methionine abundance is upstream of 
translation, at the level of tRNAs, since the analogue would effectively be charging 
methionine-deficient tRNAs, depleting the amount of uncharged tRNAs that would 
otherwise activate dGCN2. Moreover, because the analogue would have no biological 
value, it may allow us to disentangle the effects on feeding of altered protein synthesis 
from upstream events  such as altered dGCN2 activity or altered eIF2α phosphorylation.  
 
Evolutionarily, it would be beneficial for an animal, in the face of environmental nutrient 
deficiency, to conserve resource-costly egg-making efforts and seek out a more complete 
nutritional environment, thereby increasing its chances of longer-term survival for 
successful reproduction later. Our egg-laying data seems to support this theory - the 
magnitude of the difference in egg-laying between control and methionine-deficient flies is 
attenuated in dGCN2 null flies, lending support to the hypothesis that dGCN2 serves to 
limit egg-production when a dietary imbalance is sensed, and because dGCN2 null flies 
should be unable to detect the environmental imbalance, they do not accordingly reduce 
egg-production, continuing to produce eggs until the lack of methionine itself eventually 
limits egg production. This may be tested by measuring egg-laying at earlier time points, 
from the more immediate onset of methionine imbalance, in order to determine the rate at 
which egg-laying is reduced, compared to wildtype flies. Methionine restriction is known 
to limit egg-laying in flies (Grandison et al., 2009), which could explain the significance of 
an evolved adaptation to environmental methionine deficiency, since evolutionary 
selection for a trait can be driven by its ability to enhance reproductive fitness. If such a 
mechanism is specific to methionine availability, it would suggest that methionine is of 
particular importance for physiological maintenance or fecundity, or both, necessitating 
the conservation of the mechanism. Unless there are equivalent mechanisms that regulate 
the intake of other specific amino acids, this data may indicate that there is greater 
importance placed on the regulation of methionine intake specifically, compared to 
ingestion of other EAAs.  
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Why would such an adaptation have evolved around methionine availability, specifically? 
Methionine is important in metabolism, but it also plays a crucial role in translation. Its 
codon, AUG, is also a universal start codon that indicates the initiation of protein 
translation from mRNA in eukaryotes. Because most of the initiator methionine residues 
are removed by post-translational modification  it is believed that methionine’s primary 
role is in translation initiation and not protein structure, albeit critical for disulphide cross 
links within proteins (Brosnan and Brosnan, 2006). Methionine is also a precursor of the 
amino acid cysteine, and these are the only sulphur-containing amino acids. Methionine is 
the amino acid that is the most susceptible to oxidation by almost all forms of reactive 
oxidative species, forming the oxidation product methionine sulfoxide (Vogt, 1995). 
Oxidation of methionine is countered by the activity of the enzyme methionine sulfoxide 
reductase, and impairment of this enzyme has been associated with reduced lifespan, age-
related diseases and neurodegeneration (Cabreiro et al., 2006; Moskovitz, 2005). However, 
methionine oxidation has also been observed to be a functional activator of some proteins, 
and given the reversibility of methionine oxidation, it may be that methionine oxidation 
and reduction are a part of some refined mechanism that controls some form of 
homeostasis. Methionine is also a constituent of glutathione, an important antioxidant that 
prevents damage from reactive oxygen species, providing further incentive for an evolved 
system to regulate methionine levels. Moreover, methionine is an intermediate in the 
synthesis of taurine, one of the most abundant amino acids in animal tissues (Huxtable, 
1989, 1992). The associated functions of taurine are varied – not only is it a major 
constituent of bile acid (Russell et al., 2003), but it also has a role as an antioxidant (Das et 
al., 2008; Green et al., 1991; Sinha et al., 2008), in osmoregulation (Moenkemann et al., 
1999), in neurotransmission (Foos and Wu, 2002; Olive, 2002) and in membrane 
stabilisation (Birdsall, 1998). Thus, methionine has wide and varied biological roles, and is 
essential for important processes like translation and anti-oxidant defense. Given the 
biological significance of methionine, and its relatively low environmental abundance 
(Lochmiller et al., 1995; Müntz et al., 1998) it would be reasonable to expect that 
mechanisms that sense and seek out environmental methionine would be strongly selected 
for in order to ensure that the organism has an adequate supply of methionine to achieve 
reproductive success. Alternatively, flies may use methionine as an indicator amino acid to 
signal the presence of a high quality source of protein, in which case a methionine-sensing 
mechanism would also be warranted. I have provided evidence that the GAAC pathway 
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plays a role in methionine-sensing. Because NSPs are likely to be involved in DR-
mediated lifespan extension, identifying the specific dietary components that they interact 
with could be useful in understanding how DR works to enhance longevity by providing 
clues as to the underlying physiological changes.  
 
Published work on the GAAC pathway places great importance on the role of the brain as 
its main site of action. It would be interesting to explore whether the role of dGCN2 to 
control feeding behaviour can be pinpointed to specific areas of the fly brain. Indeed, in 
Drosophila larvae it has been shown that the dopaminergic neurons are an important site 
of dGCN2 activity; an amino acid imbalance input causes the activation of three 
dopaminergic neurons to elicit a behavioural aversion response to the diet (Bjordal et al., 
2014). It would be useful to test whether this finding extends to the adult Drosophila brain, 
There are many brain-specific tissue-driver fly lines that cover an extensive range of brain 
regions that could be used to test the effect of genetically up- or downregulating dGCN2 
on the behavioural responses to various dietary deficiencies. 
 
In addition to investigating the role of the GAAC pathway in regulating fly feeding 
responses to EAAs, we also set out to characterise the roles of other NSPs, such as the IIS 
pathway. For the dilp 2-3,5 mutants, repeat trials of the same experiments generated 
different results. Given the very low basal feeding rate of these flies, it is perhaps not 
surprising that they should exhibit so much variability between trials. It may be useful to 
test other IIS pathway mutants, such as UAS-chico, and UAS-InR-DN, which have 
mutations targeting the Drosophila insulin receptor and the substrate, respectively. It 
would also be interesting to test the feeding response to EAAs of TOR pathway mutants, 
especially to dietary leucine, given its ability to activate the TOR pathway (Proud, 2002). 
 
We cannot say that amino acids are the sole dietary modulators of feeding as we have not 
tested the feeding response to manipulations of other dietary components. Moreover, it is 
important to note that changing the concentration of amino acids also changes their ratio 
with respect to all other nutrients in the medium. Thus, it is possible that it is this change in 
amino acid balance relative to other nutrients that may account, entirely or partially, for the 
phenotypes that we have observed. More extensive work will be required to determine the 
influences of each dietary component on feeding, and how these contributions change 
relative to changes in other dietary components.  
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Chapter 6 - General Discussion 
 
 
6.1. Summary of findings 
 
In this work, I set out to understand the mechanisms of lifespan extension due to dietary 
restriction (DR) in Drosophila melanogaster, with particular focus on the role played by 
nutrient sensing/signalling pathways (NSPs). To address this, I first characterised the 
physiological changes during DR to narrow the list of possible mechanisms for lifespan 
extension. I then tested whether NSPs could modify those same phenotypes in a way that 
correlates with extended lifespan under DR, in order to determine the likelihood that a 
signalling pathway could be the mediator of DR. Since NSPs relay environmental nutrient 
conditions to downstream effectors of physiology, I also investigated the role of NSPs in 
modulating the feeding response to nutritional imbalances.  
 
In chapter 3 I took advantage of the recent finding that relatively high levels of essential 
amino acids (EAAs) in the diet account for the negative effect on lifespan of full-feeding  
(Grandison et al., 2009). I used this EAA-supplemented DR condition as the relatively 
high food control condition to which I compared DR effects on physiology. I found that 
DR and EAA-supplemented flies differed significantly in their responses to heat stress, 
starvation stress and in their levels of triacylglycerides (TAG). I then asked whether NSP 
mutants had alterations for these three phenotypes.  
 
Long-lived insulin/IGF signalling (IIS) mutants showed no difference in their lifespan 
response to DR and EAA-supplementation and so I did not further pursue the IIS pathway 
as a mediator of lifespan extension under DR. In contrast, pharmacological down-
regulation of the target of rapamycin (TOR) pathway altered the lifespan of EAA-
supplemented flies as well as their response to heat stress and their TAG levels such that 
they responded more like DR flies than like EAA-supplemented flies, establishing a 
correlation between longevity, decreased heat stress resistance and increased TAG. A case 
for TOR in mediating lifespan extension under DR was reinforced by use of mutants with 
defects in dRagA, the amino acid sensitive upstream component of TOR signalling. 
Downregulating the TOR pathway in this way attenuated the harmful effects of EAAs on 
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lifespan, further indicating that TOR mediated longevity involves dietary EAAs 
specifically. 
 
In chapters 4 and 5 I characterised the phenotypes of mutant flies null for dGCN2, a central 
component of the general amino acid control (GAAC) pathway that, to date, had not been 
explored in flies. dGCN2 deficiency did not block the DR effect on lifespan, but dGCN2-
deficient flies were longer-lived than wildtype flies under almost all nutritional conditions 
tested. I found that dGCN2 deficiency modified the interaction between food and lifespan 
for changes in dietary yeast concentration, as well as in response to changes in the yeast to 
sugar ratio. It appears that dGCN2 serves to offer some protection against the detrimental 
effects on survival of single EAA deprivation, such that dGCN2 null flies were shorter-
lived compared to wildtype flies when deprived of dietary arginine, tryptophan or leucine, 
with the exception of dietary methionine deficiency, where dGCN2 compromised survival 
and egg-laying potential. In fact, the role of dGCN2 in sensitising flies to environmental 
methionine deprivation extended to feeding behaviour, such that dGCN2 null flies fed at 
greater levels on food lacking methionine than on food containing a complete set of all 20 
amino acids, which was the opposite of the response of wildtype flies to methionine 
deficiency, and of the response of both dGCN2 null and wildtype flies to diets lacking the 
other EAAs tested. 
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6.2. Discussion  
 
Our main goal for the work described in this thesis was to understand the molecular 
mechanisms by which DR extends healthy lifespan, using Drosophila as a model system. 
Our objectives were to explore this in the context of DR as defined by amino acid balance, 
to characterise the physiological profiles that define DR vs. fully fed flies in order to 
identify causation factors for lifespan extension, and to investigate how nutrient intake 
changes with the nutritional environment. The DR field has started to move away from the 
longstanding idea that calorie restriction per se confers lifespan and healthspan benefits, 
moving instead towards an outlook of DR that affords more importance to dietary balance 
- that is, the balance of nutrients in the diet relative to other nutrients (Mair et al., 2005). In 
particular, the balance of proteins, or amino acids, relative to other dietary components, as 
well as the balance of the individual amino acids relative to each other, have shown to be 
important in mediating longevity (Grandison et al., 2009), and the work in this thesis 
corroborates the importance of dietary amino acid balance in mediating lifespan changes 
under DR. The restriction of certain individual amino acids, such as methionine and 
tryptophan, have previously been demonstrated to promote longevity in mammalian 
models (Ables et al., 2014; Miller et al., 2005; Zimmerman et al., 2003), and it has been 
known that the availability of amino acids is sensed by NSPs, such as IIS, TOR and 
GAAC. However, little is known about how these nutritional signals are relayed through 
these molecular pathways to downstream effector pathways that influence longevity. It is 
possible that specific amino acids modulate the effects of different NSPs on lifespan. 
Indeed, some NSPs have a greater affinity for specific amino acids. For example the 
branched chain amino acids, and in particular leucine, stimulate the TOR pathway as 
effectively as does a combination of all amino acids (Efeyan et al., 2012; Kimball and 
Jefferson, 2006; Proud, 2002), whereas the GAAC pathway is thought to be stimulated by 
the absence of all amino acids.  
 
TOR signalling has long occupied the spotlight as a primary candidate mediator of lifespan 
extension under DR (Kaeberlein and Kennedy, 2009; Stanfel et al., 2009; Vargas et al., 
2010), and evidence for this is largely based on observations from yeast, worms and flies 
that DR does not further increase lifespan when TOR signalling is reduced, suggesting that 
DR and downregulated TOR signalling extend lifespan by common mechanisms. 
Moreover, in flies rapamycin has been shown to attenuate the negative effects of full 
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feeding on lifespan (Bjedov et al., 2010), further supporting a role for TOR in mediating 
the lifespan effects of DR. The data in this thesis adds to the mounting evidence that 
reduced TOR signalling under DR is responsible for its effects on lifespan. Uniquely, we 
show that the protective effects of rapamycin work via alleviation of the negative effects of 
full feeding as implemented by dietary amino acid imbalance, suggesting that it is the 
signalling of the EAAs, specifically, that accounts for the negative effects of increased 
TOR activity on fly lifespan, and this was supported by use of genetic models. We also 
took a novel approach to understanding the mechanisms behind these observations by 
asking how a downregulation of TOR signalling could alter DR-associated phenotypes in 
flies. By this method we were able to narrow the possible effects of DR on lifespan as 
relating to TAG regulation and thermotolerance, opening avenues for further exploration 
of the relationship between these physiological traits and TOR pathway activity under DR.  
 
The link between fat and animal longevity is complex and not fully understood, and recent 
findings have propelled this topic to the forefront of DR research (Brock et al., 2007; Liu 
and C aja  2013; O’Rourke et al.  200 ; Shmookler Reis et al.  2011; Vrablik and Watts  
2012). Counter to the common belief that fat is negatively correlated with health and 
lifespan, some long-lived rodent models have increased adiposity (Berryman et al., 2004; 
Coschigano et al., 2000; Flurkey et al., 2001), and genetically obese mice live longer than 
wildtype mice under DR (Harrison et al., 1984). In humans, counterintuitive correlations 
between moderate obesity and improved survival has been referred to as the ‘obesity 
paradox’ (Kalantar-Zadeh et al., 2003, 2004). It has been postulated that, in some cases of 
chronic disease, body fat may impart some protective benefit. This phenomenon has been 
commonly observed in wasting conditions such as congestive heart failure, end-stage renal 
disease, advanced malignancies, and AIDS, and it has been theorised that high fat levels in 
such conditions may serve as a metabolic reserve, providing nutrients to enhance survival 
under the stress of the illness (Habbu et al., 2006), but this has yet to be experimentally 
verified. Alternatively, methodological bias that do not control for the inherently higher 
mortality risk in patients with low BMI, who usually exhibit a more severe disease, may be 
accountable (Hu, 2008). A recent study following 10,500 patients with type 2 diabetes 
over 10 years found that although overweight and obese patients had a higher incidence of 
cardiac events (such as heart failure) compared to patients of normal weight, the 
overweight group lived longer than normal-weight patients, and that normal-weight 
patients had a mortality risk similar to that of obese patients. In fact, underweight patients 
 150 
 
had the worst prognosis (Costanzo et al., 2015). Another study showed that not all obese 
people are metabolically unhealthy – some have higher fitness levels than others, do not 
suffer from common obesity-associated problems such as insulin resistance or high blood 
pressure, and have a 30–50% lower risk of mortality and morbidity compared to their 
metabolically abnormal obese peers (Ortega et al., 2013). Moreover, it has been speculated 
that different types of fat can have varied impacts on health. For example, it was reported 
that normal-weight patients with coronary artery disease had a higher risk of mortality if 
they had increased visceral fat, compared to obese patients with coronary artery disease 
who had a lower waist-to-hip ratio (Coutinho et al., 2013). Thus, the role of fat in lifespan 
regulation is emerging as a complex but potentially significant association warranting 
further study. 
 
Our own findings suggest that TOR-mediated lifespan extension in flies occurs through 
regulation of TAG levels (chapter 3). We also report that GAAC pathway mutant flies 
have altered TAG levels under different nutritional conditions, but in a way that does not 
necessarily correlate with longevity (chapter 4). These inconsistencies do not necessarily 
rule out a role for TAG in regulating lifespan in response to changes in nutrient sensing – 
they may in fact be highlighting the complexity of the relationship between fat and 
lifespan. This relationship is likely to be complicated by the fact that there are different 
kinds of TAGs, varying in their fatty acid chain lengths and the stereopositions of these 
chains on the glycerol molecule. These structural properties determine the different 
functional properties of the TAGs as well as their specificity as substrates to different 
enzymes, which in turn determine how they are metabolised and their effects on cellular 
processes (Karupaiah and Sundram, 2007). Future work on the effect of DR on lifespan 
would benefit from characterisation of the TAG species profiles of DR and FF animals, 
and experimentally testing whether any differences between these profiles can account for 
the differences in lifespan. It may also be worth investigating how the expression of lipase 
enzymes change in response to the relative abundance of the different lipids, and how the 
nutritional environment and NSPs can influence these responses to affect physiology and 
lifespan.  
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The GAAC pathway plays an important role in coordinating a systemic response to 
nutritional stress, which involves a downregulation of global protein synthesis and a 
concomitant adjustment of gene expression patterns that shifts cells from a state of nutrient 
utilisation and growth to one of resource conservation (Spriggs et al., 2010; Wei et al., 
2009). Indeed, activation of the GAAC has been shown in vivo to have survival benefits 
under conditions of various types of stresses, such as mitochondrial and hypertonic, and 
this protection is thought to be due to the attenuation of translation (Baker et al., 2012; Lee 
and Strange, 2012; Liu and Lu, 2010). Mammalian studies have shown that GCN2 
activates key transcription factors, such as ATF4 and NF-kB, in order to manage stress 
(Wek et al., 2006). Our data supports a role for the GAAC in protecting against nutritional 
stress in flies, namely starvation stress and single amino acid deficiency, and further work 
is required to verify the hypothesis that this protection is attained through a 
downregulation of global protein synthesis. Such mechanisms of transcriptional and 
translational reprogramming are employed as a common cellular response to stress, and 
have been shown to be important in modulating stress resistance and lifespan extension in 
the context of other NSPs as well (Hansen et al., 2007; Kaeberlein et al., 2005; Rogers et 
al., 2011; Zid et al., 2009). The benefits to lifespan conferred by a reduction of translation 
may be due to the process of translation itself causing damage that increases the rate of 
aging, and/or because reduced translation induces a stress response that extends lifespan, 
for example by enhancing the ability to repair or prevent damage that may otherwise 
accelerate senescent decline (Syntichaki and Tavernarakis, 2006). Ageing is accompanied 
by alterations in protein synthesis, and because the NSPs play a major role in the 
regulation of global protein synthesis and have been implicated in the regulation of 
lifespan, they have become the focus of much investigation into the effect of 
transcriptional and translational changes on stress tolerance and ageing.  
 
While the TOR pathway is an established regulator of ageing, less is known about how 
changes in the activity of the GAAC pathway mediate lifespan changes. Because the 
GAAC pathway senses nutrients, interest is focussed on the role that it might play in 
mediating lifespan in response to the nutritional environment. GCN4, a component of the 
GAAC pathway, has been shown to be involved in the extension of yeast replicative 
lifespan achieved by the reduction of 60S ribosomal subunit biogenesis (Steffen et al., 
2008), and recently it was shown that GCN2 null C. elegans are more sensitive than 
control worms to amino acid limitation, with compromised survival under these conditions 
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(Rousakis et al., 2013). Loss of GCN2 also supressed the extension of lifespan in a genetic 
model of DR in worms, and abolished the extended longevity of TOR pathway mutant 
worms. This study implicates the GAAC pathway as a mediator of lifespan under DR in 
worms, and in mediating the lifespan effects of altered TOR pathway activity. The impact 
of GCN2 function on lifespan had not yet been investigated in flies. Our work provides the 
first genetic evidence in flies that the GAAC pathway can alter the influence of diet on 
lifespan. In support of the data from worms, we show that dGCN2 null flies are too more 
sensitive to amino acid limitation compared to controls, and although we have not 
observed an attenuation of lifespan extension in DR flies with loss of dGCN2 our data does 
ascribe a complex role for the GAAC pathway in regulating the lifespan responses of flies 
across a wide nutritional landscape, including survival responses to single amino acid 
deficiencies. In particular, we describe a novel role for the GAAC pathway in mediating 
the lifespan, fecundity and feeding responses to methionine deficiency. In contrast to the 
data from worms, we did not observe a significant effect of dGCN2 in altering the lifespan 
response to TOR pathway downregulation as imposed by rapamycin treatment, which may 
reflect divergent functions of GCN2 in worms and flies. Since the GAAC pathway has an 
established role in the management of cellular responses to stress, it may be interesting to 
investigate how GAAC-mediated stress-induced reprogramming could affect lifespan, 
while being mindful that longevity is not always linked to increased stress resistance, as 
we have seen in this work (chapter 3). Such an association is likely to be dependent on 
genetic and/or environmental backgrounds (Pan et al., 2011; Ristow and Zarse, 2010; Sun 
et al., 2012). Further work to elucidate the relationship between GAAC-mediated stress 
resistance and longevity will require the identification of the specific downstream effectors 
of GCN2 and further investigation of any potential interaction with other NSPs. 
 
The GAAC pathway has largely been studied in the context of feeding behaviour and has 
been established as an important modulator of food choice in rodent models, particularly in 
the regulation of responses to amino acid-imbalanced diets. Characterising how feeding 
decisions change with changes in the nutritional environment is important in understanding 
how animals regulate the intake of macronutrients to optimise different traits under 
different environmental conditions and how this can in turn affect overall lifespan. 
Characterisation of the metabolic and molecular adaptations induced by alterations in 
amino acid intake could provide clues about the physiological changes that give rise to the 
lifespan and health benefits of DR. The GAAC-mediated feeding response is activated in 
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response to a wide range of different amino acid deficiencies and is phenotypically 
characterised by behavioural aversion to the deficient food source. In this thesis we 
describe a more specific role for the GAAC pathway in sensing methionine deficiency to 
elicit a behavioural response, which complements our finding that the GAAC pathway has 
a specialised role in regulating physiological changes in response to methionine 
deficiency. We propose that the GAAC response is an adaptation to methionine deficiency 
specifically, which is an important finding given the growing amount of data 
demonstrating the lifespan and health benefits of methionine restriction in several 
laboratory animals. 
 
It has been suggested that the effect of methionine restriction to extend lifespan is a result 
of an evolved adaptation to survive environmental methionine shortages, where short-term 
survival mechanisms are induced to enable the fly to endure until there is a renewed supply 
of methionine, thereby maximising reproductive success. The details of such a mechanism 
are not known. Increased lifespan tends to correlate positively with cellular stress 
resistance, and several studies suggest that such ability to tolerate stressors may underlie 
the beneficial effects of methionine restriction on lifespan; examples from various 
organisms suggest that methionine restriction induces general stress tolerance that is 
associated with enhanced survival – methionine-restricted organisms have shown 
increased levels of autophagy (Ruckenstuhl et al., 2014), resistance to heavy metal stress 
(Hwang et al., 2007; Singh and Sherman, 1974), decreased levels of reactive oxygen 
species (Sanz et al., 2006), increased glutathione levels (Richie et al., 1994), resistance to 
heat stress, reduced acid accumulation and upregulation of the retrograde response 
(Johnson and Johnson, 2014), upregulation of endocrine factors, and slowing of age-
related changes in immunity (Miller et al., 2005). Additionally, methionine is metabolised 
through the trans-sulfuration pathway, and genetically upregulating the activity of this 
pathway has been shown to increase lifespan in flies (Kabil et al., 2011). Inhibition of the 
trans-sulfuration pathway attenuates the effect of DR to increase lifespan. Thus, it may be 
interesting to consider the trans-sulfuration pathway in further investigating the lifespan 
effects of the GAAC pathway, especially in the context of methionine restriction, which 
we have highlighted as being a particularly important activator of the GAAC pathway.  
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6.3. Outlook  
 
If the TOR pathway is a central mediator of lifespan change under DR in humans, and if it 
does so through the regulation of physiological lipid content/dynamics, as our data 
suggests in flies, then characterising the basal TOR activity profiles and/or lipid profiles of 
an individual could determine the type of DR regimen that would be the most beneficial 
for them. As a long-term outlook, the efficacy of a DR diet for humans would benefit 
greatly from pharmacogenetic studies that could allow for the development of tailor-made 
diets according to an individual's genetic makeup. For example, genetic markers indicating 
the efficacy of NSPs and/or associated physiological markers of metabolism could 
determine the optimum dose of rapamycin, for example, or the required ratio of nutrients 
to maximize the beneficial effects of DR.  
 
Our findings offer the potential for further development of interventions that target NSPs 
for treating age-related diseases in humans. Rapamycin serves as a pharmacological tool 
with which to manipulate TOR signalling. Recently it has been found that differential 
expression of TOR signalling is associated with ageing in humans (Harries et al., 2012; 
Passtoors et al., 2013), making the TOR pathway a relevant target for intervention in 
humans. Moreover, upregulation of autophagy in humans has been shown to have anti-
aging effects, while decreased autophagy is associated with premature aging, 
neurodegenerative disorders, cancer and inflammation (Kuballa and Xavier, 2010; Madeo 
et al., 2010). Rapamycin is already approved by the Food and Drug Administration for 
human use as an immunosuppressant to prevent organ rejection in transplant patients and 
for the treatment of renal cell carcinoma. Remarkably, the longevity benefits of rapamycin 
may be reaped even when treatment is started at an advanced age, as demonstrated in mice 
(Harrison et al., 2009; Miller et al., 2011). Such an anti-ageing intervention that is effective 
when initiated relatively late in life could prove to be useful for clinical application as a 
means of treatment, as well as for prevention, of age-related decline in health. However, 
rapamycin has numerous reported side effects in humans, such as increasing susceptibility 
to viral and fungal infections, since it is an immunosuppressant (Mahe et al., 2005), and 
can cause alopecia, edema, apthuos ulcers, mucositis, rash, reduced fertility in males, 
hyperlipidemia and diabetes (Gyurus et al., 2011; Mahe et al., 2005; Zuber et al., 2008). 
Understanding the mechanism of action of rapamycin may not only offer insights into the 
underlying biology of the ageing process, but further pharmacogenetic research could 
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facilitate the development and refinement of rapamycin for use as an effective anti-ageing 
treatment for long-term use, so as to maximise its efficacy and reduce its side effects.  
 
In light of my research, if TAG is a target of TOR-mediated longevity, and if an 
individual’s lipid profile could be indicative of the rate at which they will age, then 
tailoring rapamycin dosage according to an individual's lipid profile may maximise the 
efficacy of the drug as a therapeutic treatment for ageing and age-related disease. The 
additional benefit of rapamycin as a therapeutic treatment for ageing is the relative ease 
with which it could be undertaken, compared to potentially rigorous DR regimes that may 
require a greater strength of will and extensive diet planning. Other drugs have also been 
shown to reduce TOR signalling, such as aspirin (Din et al., 2012; Gao et al., 2003) and 
metformin, which has been shown to directly inhibit the Rag GTPases (Kalender et al., 
2010), and have reportedly fewer side-effects than rapamycin, making them candidate 
drugs for development for the treatment of ageing and age-related diseases. Moreover, 
supplementation of ω-6/ω-3 polyunsaturated fatty acids could potentially increase 
autophagy and elicit similar health and lifespan benefits to that seen in worms (Rourke et 
al., 2013). 
 
The development of lifespan-prolonging dietary regimes for humans will prove to be 
challenging. DR, in the sense of a scale-down of total food intake at the level shown to 
extend lifespan in other animals, is a demanding regime to maintain long-term. Thus, 
dietary regimes where a specific dietary component is limited, like methionine restriction, 
may prove to be a more practical approach. A vegan diet, for example, is typically low in 
methionine, and is a diet that can be undertaken with relative ease. The concentration of 
methionine relative to other amino acids, as well as to other dietary components, will be an 
important balance to establish, and on which the success of a methionine restriction diet 
will depend. The safety of the diet will also depend on this balance as too little or too much 
methionine can be detrimental (Garlick, 2006; Pulikkunnel and Thomas, 2005). Moreover, 
this ratio balance may be different for different people, depending on several 
environmental and genetic factors, such as gender, weight, height, level of activity, disease 
state, etc, and this will be extremely difficult to work out without understanding the 
underlying mechanism of the lifespan-extending effects of methionine restriction at the 
physiological level at least. 
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Much work is still needed to uncover the molecular details of ageing, but progress has 
been greatly aided by the use of genetic mutants and pharmacological agents that target 
biological pathways implicated in the regulation of longevity. The DR paradigm holds 
much promise for developing interventions that enhance longevity and healthspan, and 
nutrient sensing/signalling pathways, such as TOR, IIS and GAAC, have shown great 
potential as targets for therapeutic treatment of age-associated diseases and disabilities.  
Understanding the biological mechanisms through which DR promotes health and 
longevity is an important requirement for developing DR mimetic drugs for human use. 
However, given the variability of the reported effects of DR interventions in laboratory 
organisms, achieving these objectives will be challenging and a greater research effort will 
be required to dissect the organism-specific effects of DR in a way that can be informative 
about DR for humans. The prospect of enhanced vitality in old age is one that warrants 
continued scientific effort, and the progress currently being made in the field inches us 
closer to this goal. 
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INTRODUCTION  
 
Dietary restriction (DR) is an intervention whereby a 
considerable reduction of food intake, just short of 
malnutrition, extends lifespan. This has been 
demonstrated to be effective in a wide range of 
evolutionarily diverse organisms, from yeast [1] to 
invertebrates [2] and mammals [3], and is considered 
one of the most robust environmental interventions to 
extend lifespan in laboratory organisms. Moreover, the 
longevity promoting effects of DR are accompanied by 
a range of health benefits. DR rodents had a delayed 
onset or a lesser severity of age-related diseases such as 
cancer, autoimmune diseases and motor dysfunction [4–
6] and improved memory [7]. In C. elegans, DR was 
shown to reduce proteotoxicity [8]. DR rhesus monkeys 
were found to have improved triglyceride, cholesterol 
and fasting glucose profiles, and a reduced incidence of 
diabetes, cancer, cardiovascular disease and brain 
atrophy [9].  
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The molecular mechanisms underlying the physiological 
changes elicited by DR have yet to be elucidated, 
however, experimental data point towards nutrient 
signalling pathways as playing an important role. The 
evolutionarily conserved Target of Rapamycin Complex 
1 (TORC1) pathway senses amino acid availability and 
signals to enhance translation via activation of S6 kinase-
1 (S6K1) and inhibition of eIF4E binding protein-1(4E-
BP1). TORC1 also regulates transcription and autophagy 
in response to a range of signals, including nutrient 
availability, cellular energy levels, and growth factors, in 
such a way that growth rates match resources [10]. 
Experimental validation of a role for TORC1 in 
determining lifespan has come from a range of laboratory 
organisms. Lifespan extension by inhibition of TORC1 
pathway genes has been demonstrated in S.cerevisiae 
[11], C.elegans [12], D. Melanogaster [13] and in mice 
[14–19]. How TORC1 inhibition promotes longevity is 
unknown. 
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show that pharmacological downregulation of TOR  signalling, but not reduced IIS, modulates the lifespan response to DR
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Another nutrient sensing pathway that is commonly 
associated with modified ageing is the insulin/insulin-
like growth factor signalling (IIS) network. Mutations in 
components of the IIS pathway have extended lifespan 
in a host of model organisms [20]. Because the IIS 
pathway senses nutrients, considerable effort has been 
made to assess the role for IIS in modulating the 
longevity responses to DR. While IIS does not seem to 
be solely accountable for DR, some experimental data 
suggest overlapping mechanisms for IIS- and DR-
mediated lifespan extension [21]. 
 
Recent work has shown that adjustments to the dietary 
amino acid balance can mimic the benefits to lifespan 
by DR in D. melanogaster [22]. Supplementing a DR 
diet with the ten essential amino acids (EAA) 
phenocopy the effects of full feeding (FF) on lifespan 
and fecundity, indicating that the beneficial effects of 
DR are a consequence of improved amino acid balance. 
Experimentally, the addition of EAAs to DR (DR+EAA) 
offers a sharper instrument with which to dissect the 
potential causes of lifespan change in response to 
nutritional balance than the FF condition, which is 
achieved by increasing the concentration of dietary yeast. 
Here we characterize physiological and metabolic 
parameters that define DR and fully fed flies with the aim 
of identifying candidate factors for causation of the 
lifespan response to DR.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
 
TORC1 signalling but not IIS signalling is required 
for the effect of EAA on lifespan and fecundity 
 
Dietary restricted (DR) flies are longer-lived than fully 
fed flies, but produce fewer eggs. The effect of full 
feeding to shorten lifespan and increase egg laying can 
be mimicked by the addition of the 10 essential amino 
acids (EAA) to DR food (Figures 1a-1c). 
 
To assess the role of the longevity-associated nutrient 
signalling pathways as potential mediators of the effect 
of EAA on lifespan, we tested the response to DR of 
flies that are long lived due to deletion for genes 
encoding three of the Drosophila insulin-like peptides, 
(DILPs) ilp2, ilp3 and ilp5. We found no difference 
between the responses of wild type and DILP mutant 
flies to the addition of EAA to DR food, indicating that 
IIS is not required for the lifespan extension by DR 
(data not shown). In contrast, addition of the TORC1 
inhibitor rapamycin extended the lifespan of flies on 
DR+EAA such that their lifespan was not shorter than 
those subjected to DR (Figure 2a). Rapamycin treatment 
also prevented the increase in egg laying seen for EAA 
addition to DR food, in fact egg laying was effectively 
blocked  by  rapamycin treatment.  We  also  found  that  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Amino acids mediate lifespan and fecundity changes under DR. (a) Summary of Drosophila median
lifespans under dietary restriction  (DR),  full  feeding  (FF) and essential amino acid supplementation of DR  (DR+EAA)
(n=13 biological replicates; DR vs FF, P<0.001; FF vs DR+EAA, P=0.9383; DR vs DR+EAA, P=0.002;  Wilcoxon rank‐sum
test) (b) A representative lifespan experiment: adding EAAs to DR food shortened lifespan (P< 0.001) to that of FF flies
(P=0.194); n=150 per treatment; compared using the  log‐rank test. (c) Adding EAAs to DR food  increased egg‐laying
(P<0.001) to that of FF flies (P<0.936). Fecundity: mean±s.e.m.; n=15; compared using the Wilcoxon rank‐sum test.  
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phosphorylation of the TORC1 target S6K was reduced 
by the addition of rapamycin (Figures 2b, 2c). Together,  
these data are consistent with TORC1 signalling playing 
a role in mediating the change in lifespan upon DR. 
 
EAA supplementation alters responses of DR flies to 
H2O2 stress, heat stress, starvation stress, and TAG 
levels 
 
We set out to identify phenotypic correlates of lifespan 
change under our dietary conditions in order to 
understand the causal mechanisms of increased lifespan 
under DR. Long-lived animal models often have an 
associated increase in the ability to resist environmental 
stresses and this is assumed to reflect a general increase 
in their health. Long-lived insulin/IGF-like signalling 
(IIS) mutant flies have been shown to be resistant to 
acute toxic doses of DDT, paraquat and hydrogen 
peroxide (H2O2) [23–25]. We tested whether long-lived 
DR flies are protected from the harmful effects of these 
compounds. We found that DR flies were significantly 
more resistant than DR+EAA flies to a toxic dose of 
H2O2, whereas no difference was apparent for paraquat 
(Figures 3a, 3b). Surprisingly, DR flies were more 
sensitive to a toxic dose of DDT than DR+EAA flies 
(Figure 3c), indicating that, at least for DDT resistance, 
DR does not protect against this toxin in the same way 
that lowered insulin signalling does.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Long-lived DR C. elegans have increased resistance to 
heat stress [26,27]. Upon testing the response of flies to 
heat shock stress, we found that DR flies were 
significantly less resistant than DR+EAA flies (Figure 
3d), indicating that longevity associated with amino 
acid reduction comes at a cost to heat stress resistance. 
 
Finally, we found that DR flies showed greater 
resistance to starvation than DR+EAA flies (Figure 3e), 
suggesting a possible mechanistic relationship between 
longevity and starvation resistance. Resistance to 
starvation stress could depend on the availability of 
enhanced energy stores within the fly. While we found 
no difference between groups in the levels of the 
storage carbohydrates glycogen or trehalose (Figure 3f, 
3g) we did find that DR flies had significantly higher 
levels of triacylglycerides (TAG) than DR+EAA flies 
(Figure 3h). It is possible that this difference in                    
TAG levels is causative of the longevity differences 
between DR and DR+EAA flies such that increased 
TAG confers some benefit to survival. 
 
Increased TAG and decreased heat-stress resistance 
correlate with increased lifespan with DR 
 
If the above phenotypes induced by DR are causally 
linked to longevity through reduced TORC1 signalling, 
it should be possible to reproduce the same 
Figure 2. Effect of Rapamycin treatment on EAA‐supplemented flies. (a) Rapamycin treatment extended
the  lifespan  of  DR+EAA  flies  beyond  that  of  DR  (DR+EAA  vs  DR+EAA+Rapamycin,  P<0.001;  DR  vs  DR+EAA,
P<0.012).  n=150  per  treatment;  log‐rank  test.  (b)  Rapamycin  treatment  decreased  the  lifetime  fecundity  of
DR+EAA  flies  (P<0.001). Fecundity: mean±s.e.m.; n=10; Wilcoxon rank‐sum test.  (c) Levels of phospho‐T398‐S6K
were measured from whole‐fly protein extracts. Treatment with rapamycin for 7 days decreased phospho‐T398‐
S6K levels in DR+EAA+Rapamycin flies relative to DR+EAA flies. 
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physiological outcomes by treating flies with 
rapamycin. We therefore tested the effect of rapamycin 
on DR+EAA flies for H2O2 stress resistance, starvation 
sensitivity, heat shock stress resistance and TAG levels 
(Figures 4a-d). Of these, heat stress resistance and TAG 
levels changed upon rapamycin treatment  of  DR+EAA  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
flies, such that the responses became more similar to 
DR flies; Like DR, rapamycin treatment increased the 
sensitivity of EAA-treated DR flies to a 39ºC heat 
stress, and increased their TAG content. There was no 
effect of rapamycin on the response of EAA-treated 
flies to H2O2 stress or to starvation stress. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Phenotype  comparisons between dietary  restricted  flies and  those  supplemented with EAAs.  (a)
DR+EAA flies showed a decreased resistance to hydrogen peroxide toxicity compared to DR flies (P=0.013; n=150 flies per
condition). (b) There was no difference between DR and DR+EAA flies in their sensitivity to paraquat stress (P=0.517; n=150
flies per condition). (c) DR+EAA flies showed only a marginal, but significantly improved tolerance to DDT compared to that
of DR  flies  (P=0.042, n=100  flies per  condition).  (d) DR+EAA  flies were  significantly more  resistant  to a 39ºC heat  stress
compared  to DR  flies  (P<0.001; n=40  flies per condition).  (e) DR+EAA  flies were significantly more sensitive  to starvation
than DR flies (P<0.001; n=100 flies per condition). (f) After 7 days of treatment there was no difference in the amounts of
glycogen measured  for DR+EAA  flies  compared  to DR  flies  (P=0.656; n= 6).  (g) There was no difference  in  the  levels of
trehalose  measured  for  DR+EAA  flies  compared  to  DR  flies  (P=0.630;  n=6  flies  per  condition).  (h)  DR+EAA  flies  had
significantly reduced  levels of TAG compared to DR flies  (P<0.001; n=6 flies per condition). For figures a‐e, P values were
calculated using the log‐rank test. For figures f‐h, P values were calculated by T‐test, and error bars represent the s.e.m. 
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DISCUSSION 
 
We have described the physiological and metabolic 
features that define long-lived DR flies in order to 
understand the mechanisms by which longevity is 
achieved. Our data indicate that dietary amino acids 
modify TORC1 signalling, which in turn alters lifespan 
outcomes. We also found that both dietary amino acid 
manipulation and TORC1 modification in flies alter 
TAG levels, such that higher body fat may play a causal 
role in enhancing fly lifespan in response to dietary 
restriction. 
 
We found that the lifespan of insulin-mutant flies 
responded in a similar way to DR as wild-types, 
indicating that reduced IIS is not required for the 
lifespan-extending   effects  of   DR.   This   appears  to  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
contrast previous studies that have reported interacting 
effects of IIS on DR, such that lifespan modification in 
response to yeast dilution is abolished in some IIS 
mutants [22,23,28]. These differences could be due to 
the fact that in the current study we modulated lifespan 
by adjusting EAA alone, rather than yeast. In doing so, 
we report a markedly different sampling of nutritional 
space than for yeast dilution, since we change the ratio 
of EAAs to all other dietary components, such as lipids, 
carbohydrates, non-essential amino acids, vitamins and 
trace elements. This may also explain why the 
phenotypes of our long-lived flies are somewhat 
different from those of other organisms subjected to 
DR. Interestingly, our experiments also showed that 
long-lived DR flies had decreased resistance to DDT, 
which is the opposite phenotype seen for IIS mutant 
flies, in which longevity is accompanied by dFOXO-
Figure  4.  The  effect of  rapamycin  to  alter phenotypic differences between DR  and DR+EAA  flies.  (a)
Rapamycin had no effect on  the sensitivity of DR+EAA  flies  to H2O2 stress  (P=0.963; n=105  flies per condition).  (b)
Rapamycin had no effect on the sensitivity of DR+EAA flies to starvation stress (P=0.071; n=150 flies per condition). (c)
Rapamycin, like DR, increased the sensitivity of DR+EAA flies to a 39ºC heat stress (P<0.001; n=30 flies per condition).
For  figures  a‐c,  P  values  were  calculated  using  the  log‐rank  test.  (d)  Rapamycin  treatment  increased  the
triacyglyceride (TAG) levels of DR+EAA flies to the level of DR (P=0.011; n=6; T‐test; error bars represent the s.e.m). 
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dependent DDT resistance [23,29]. Together, these data 
suggest that the beneficial effects on lifespan of DR can 
be achieved independently of IIS, similar to that 
reported by Tatar [21]. Moreover, it has been suggested 
that the effects of IIS on longevity are dependent on the 
status of TOR activity [30]. 
 
One of the strategies taken to understand the 
mechanisms by which dietary or genetic treatments 
enhance longevity is to seek out correlated 
physiological changes that may provide insights into the 
treatment’s mode of action. A common mechanistic 
explanation for longevity requires enhancing systems to 
protect against the damaging side-effects of aerobic 
metabolism, such as that caused by oxidative stress or 
endogenous lipophilic toxins [31,32]. In our analyses, 
we found no evidence for broad-spectrum enhanced 
protection against stressors under DR. Thus, the 
mechanism for increased longevity under DR may not 
involve enhanced resistance to stress. Similar 
observations in studies on worms [33,34] has led to an 
alternative hypothesis that “hypertrophy” caused by 
inappropriate continuation of early-life growth 
programmes into later life is detrimental to an organism 
and causes ageing [35–38]. This explanation also 
implicates high levels of TOR signalling as its 
mechanism.  
 
We found increased TAG levels correlated with longer 
life in our flies subjected to DR or rapamycin treatment. 
DR by yeast restriction in Drosophila has also been 
shown to increase lipid content [39–41], and several 
rodent studies show that higher fat levels correlate with 
increased lifespan [42–44]. In a recent study, Kapahi 
and colleagues showed that DR flies have increased 
TAG, and demonstrated an increased requirement for 
muscle-specific fatty-acid synthesis and breakdown in 
extending lifespan under DR [45]. Moreover, some 
long-lived TOR and IIS pathway mutants have 
increased fat levels [46–49]. Given that not all fat 
mutants are long-lived [50], it is likely that if fat levels 
are causally involved in extending life, the quality of fat 
accumulated is important. It would be interesting in 
future work to determine how lipid profiles change 
under different dietary conditions, to identify the 
specific types of lipids that are altered, and whether 
experimental manipulation can enhance lifespan. 
 
EXPERIMENTAL PROCEDURES 
 
General Methods 
 
Standard laboratory food . Dietary restriction medium 
(1xSYA) contained100 g/l yeast (1x; MP Biomedicals, 
OH, USA), 50 g/l sucrose (Tate & Lyle, London, UK), 
15 g/l agar (Sigma-Aldrich, Dorset, UK), and 30ml/l 
nipagin (Chemlink Specialities, Manchester, UK) and 
3ml/l propionic acid (Sigma-Aldrich, Dorset, UK).This 
diet and its method of preparation is described in Bass 
et al., 2007 [51]. The fully fed medium (2xSYA) was 
prepared in the same way, except that it contained 
200g/l yeast. 
 
Experimental food. Rapamycin (LC Laboratories, MA, 
USA) was dissolved in ethanol and added to 1xSYA 
food at a final concentration of 200µM. Essential amino 
acids (Sigma-Aldrich, Dorset, UK) were dissolved in 
MiliQ water, and added to 1xSYA food at 
concentrations shown in Table 1. As control measures, 
ethanol alone was added to the food conditions that did 
not contain rapamycin, and water was added to food 
conditions that did not contain essential amino acids. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fly stocks and husbandry. The wild-type Dahomey 
strain was originally collected in 1970 from Dahomey 
(now known as the Republic of Benin) and since 
maintained as a large outbred stock with overlapping 
generations at 25oC on a 12h light:12h dark cycle. 
These conditions allow for inter-generational breeding 
and the life expectancy of flies remain similar to that of 
newly caught wild flies [52]. Flies used for 
experimentation came from parental flies of the same 
age at egg laying, thereby controlling for the effects of 
parental age on lifespan [53]. 
 
Insulin-signalling mutant flies lacking the Drosophila 
insulin-like peptides (DILPs) ilp2, ilp3 and ilp5 were 
generated as described in Gronke et al., 2010 [23]. 
These flies were backcrossed into a control whiteDahomey 
background stock, which was derived by backcrossing 
w1118 into the outbred wild-type Dahomey background 
[24]. All mutations were back-crossed into their control 
backgrounds for a minimum of 6 generations. 
Table 1. Quantities of each of the essential amino acids 
added to 1l of 1xSYA food medium 
 
Essential amino acid 
(Sigma-Aldrich) 
Concentration in 1xSYA 
medium (g/l) 
L-arginine 0.43 
L-histidine 0.21 
L-isoleucine 0.34 
L-leucine 0.48 
L-lysine 0.52 
L-methionine 0.10 
L-phenylalanine 0.26 
L-threonine 0.37 
L-tryptophan 0.09 
L-valine 0.40 
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Lifespan. All experiments were conducted at 25oC on a 
12h light:12h dark cycle, at a constant humidity of 65%. 
Flies were reared at a standard larval density of ~300 
flies per bottle, and all experimental adults were 
collected within a 12 hour period after eclosion. Flies 
were allowed to mate for 48 hours after eclosion before 
the experimental females were separated out under CO2 
anaesthesia. Females were then randomly allocated to 
the experimental food treatments and housed in plastic 
vials containing food at a density of 10 flies per vial, 
with 15 vials per condition (n=150). Flies were 
transferred to a fresh food source 3 times per week, 
during which any deaths and censors were recorded. 
 
Fecundity. Lifetime fecundity was measured as the 
cumulative total for days 7, 14, 21 and 28 of the mean 
number of eggs laid per female fly over each 24-hour 
period. Eggs in each vial were counted by eye using a 
light microscope after 18-24 hours exposure to flies. 
Western blots. Protein extracts for western blot analysis 
were made from whole flies, sampled after 7 days of 
food treatment, using a TCA-based extraction protocol. 
10µl of each sample was loaded into a 12% SDS-PAGE 
gel and blots were probed with anti-phospho-Thr398-
S6K antibody (#9209, Cell Signaling Technologies, 
MA, USA), and total-S6K (re-made using a peptide 
sequence previously used to generate the total S6K 
antibody in Stewart et al., 1996 [54]). Both antibodies 
were used at a dilution of 1:12000 and normalised by 
probing with an anti-actin antibody at a dilution of 
1:5000. Secondary antibodies conjugated to HRP 
(AbCam, Cambridge, UK) were used at a dilution of 
1:5000, and the signals were detected by 
chemiluminescence.  
 
Stress Experiments 
 
Experimental flies were reared and housed as described 
for the lifespan experiment. Mated female flies were 
kept on the experimental food types for 7 days before 
being transferred to the stress conditions. 
 
Paraquat, DDT and H2O2 Stress. The orally 
administered stressors were as made up follows: 1xSYA 
containing 20mM paraquat (Sigma-Aldrich, Dorset, 
UK), 1xSYA containing 0.03% w/v DDT (Supelco 
Sigma-Aldrich, Dorset, UK), 1.5% agar medium 
containing 5% H2O2 (Sigma-Aldrich, Dorset, UK) and 
50g/l sucrose, or plain 1.5% agar medium for the 
starvation experiment. 
 
Heat Shock. Experimental flies were transferred singly 
into dry empty 2ml glass vials, plugged with cotton 
wool and placed into a water bath set at 39oC. The time 
taken for each fly to fall onto its back and stop 
twitching (knockout) was recorded. 
 
Metabolic measurements 
 
Experimental flies were reared and housed as described 
for the lifespan experiment. Mated female flies were 
kept on the experimental food types for 7 days before 
being frozen in liquid nitrogen. 6 replicas of 5 flies per 
condition were used for all metabolic measurements. 
 
Triacylglyceride measurement. Flies per condition were 
homogenised in 0.05% Tween 20 (Sigma-Aldrich, 
Dorset, UK) according to Gronke et al., 2003 [55]. TAG 
content was quantified using the Triglyceride Infinity 
Reagent (Thermo Fisher Scientific, Surrey, UK). 
 
Glycogen measurement. Flies were homogenised in 
200µl saturated Na2SO4 solution and centrifuged for 1 
min. 80µl of each sample was transferred to new 
Eppendorf tubes and 800µl chloroform:methanol (1:1) 
solution was added. Samples were centrifuged for 5 
minutes and the supernatant was removed. The 
remaining pellet, containing precipitated glycogen, was 
resuspended in 1ml anthrone solution (anthrone in 50 
ml 70% H2SO4) and incubated at 90oC for 20 minutes. 
200µl of each sample was dispensed into the wells of a 
flat-bottomed 96-well plate, and the absorbance in each 
well was measured at 620nm and compared against a 
set of glycogen standards ranging from 0-2µg/µl 
(protocol adapted from Van Handel, 1965 [56]). 
 
Trehalose measurement. Trehalose levels were 
measured using the Glucose Infinity Reagent (Thermo 
Fisher Scientific, Surrey, UK), as described in 
Broughton et al., 2005 [24]. 
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